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Wound healing involves a complex series of interactions between cells of the dermis and
epidermis and their extracellular matrix (ECM). Studies suggest that the ECM, far from
being an inactive bystander, actively orchestrates the key events in wound healing and
regeneration. In particular, collagen and peptides derived from collagen have been shown
to be chemotactic towards a variety of cell types including neutrophils, monocytes and
fibroblasts. CNBr-derived collagen peptides also effect the attachment and migration of
neural crest cells.
This study involved the isolation and purification of collagen peptides and characterisation
of the effects of these peptides on cell behaviour. In vitro experiments were carried out on
CNBr-derived peptides from collagens I and III, these were shown to stimulate fibroblast
growth and chemotaxis. Peptides CB3 and CB8 from collagen a 1(1) and peptides CB4 and
CB8 from collagen al(III) showed the most potent stimulation. A chemotactic peptide, 22
amino acids in length, obtained by sequential enzymatic digestion of collagen I with
bacterial collagenase and chymotrypsin was isolated, this peptide was also found to be a
potent chemoattractant for fibroblasts. A tetra-peptide with the amino acid sequence Gly-
Pro-Ala-Gly was identified as one of the most chemotactically active regions in the
collagen molecule.
The collagen peptide (22 amino acid sequence) was also tested in vivo for its ability to
stimulate cellular infiltration and granulation tissue formation using the PVA (polyvinyl
alcohol) model system in rats. The peptide was injected into PVA sponges which had been
implanted into rats. After 7 or 10 days the sponges were removed and analysed both
histologically and biochemically. The levels of collagen, DNA and protein in the PVA
sponges injected with the peptide increased significantly compared to control sponges,
after 10 days. This effect was concentration dependent, with the optimum tested
concentration being 10p.g/ml.
Experiments were also carried out on cell surface interactions. Binding of the peptide to
fibroblasts was not inhibited by antibodies to integrins otipi, (X2P1, 013P1, suggesting that
collagen-receptor interaction in this case may be non-integrin mediated.
From this work, it was shown that peptides isolated from collagens I and III were
chemotactic for fibroblasts both in vitro and in vivo.
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BAEC Bovine aorta endothelial cells
BM Basement membrane
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BSE Bovine spongiform encephalitis
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Physical trauma has always faired high on the list ofman's problems. Tissue repair is
fundamental to guaranteeing the survival of living organisms. Wound treatment and
healing is an ancient art (Majno 1975). Evidence of traumas with their related
consequences have been found in vertebrate remains by archaeologists. Many skulls
found from archaeological excavations have holes which show evidence of bone
healing. Wounds can be dated back to our ancestor, Australopitheus africanus, who
needed to deal with injuries as violence and war appeared in his culture (Majno 1975).
Also by analogy with many modern races, ritual circumcision in both sexes was
carried out so that the care of surgical wounds was by no means unknown to
primitive man. In wound healing, the use of plants, biological fluids such as urine and
blood, and animal products such as honey and pieces of fresh meat, mixed with
folklore and magic, was common among ancient peoples (Doanati et al., 1994). The
first suturing of wounds by primitive man was by sewing them together with fibres or
shreds of tendon. The oldest suture dates back to Ancient Egypt. The use of
adhesives tapes and gum adhesives can be dated back four thousand years (Quinn
1996).
Wound healing is the complex response to tissue injury controlled by both local and
migrated cells. Wound healing involves inflammation, proliferation of cells, e.g.
fibroblasts, re-epithelisation, angiogenesis, synthesis and deposition of connective
tissue and apoptosis, depending on the injury (reviews: Pierce & Mustoe 1995; Clark
1996; Martin 1997).
There is a complex series of events in the wound healing process between cells in the
dermis and epidermis and their extracellular matrix (ECM). Many cell types,
cytokines, coagulation factors, growth factors, complement activation and matrix
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proteins such as fibronectin and collagen contribute to healing in various ways (Clark
1993). The functions and precise mechanisms of these cellular, humoral and local
factors are unclear and poorly understood (Hunt & La Van 1989; Gailit & Clark
1994).
An injury may be defined as an interruption in the continuity of tissues. Repair of the
injury is achieved primarily by proliferation, migration, and differentiation of involved
cells (neutrophils, macrophages, fibroblasts, endothelial and epithelial cells). There are
two processes involved in wound healing: repair and regeneration (Johnson 1990).
The repair process is the replacement of tissue defects by a scar which binds the
surrounding tissues together. All tissues and organs of the body, with the possible
exception of teeth, are capable of repairing injuries (McMinn 1967, Needham 1952).
Regeneration is the replacement of destroyed tissue with normal functioning cells of
the type lost in the initial injury. Regeneration is under the control of positive and
negative growth-regulating substances and is only possible in tissues that have a
sustained population of cells capable of undergoing mitotic division (Lipowitz 1985).
Neurons, for example are incapable ofmitosis and hence regeneration.
Adult wound repair includes the stages of haemostasis, inflammation, proliferation
and remodelling (Longaker & Adzick 1991). Haemostasis is the body's natural
mechanism for preventing excessive bleeding, and involves vasoconstriction, platelet
aggregation and degranulation, blood clotting and fibrin formation. Three major
events occur during the inflammatory response; an increased blood supply, increased
capillary permeability and cellular infiltration beginning with polymorphonuclear
leukocytes (PMNs) and followed by macrophages and lymphocytes. This stage is
responsible for defending against bacteria and for the secretion of numerous growth
factors, cytokines and extracellular matrix components. The proliferative stage
involves multiplication of fibroblasts, endothelial and epithelial cells. In the final
remodelling stage there are progressive changes in the rates of synthesis of collagen
types and crosslinks in order to form a mature scar (Quinn 1998).
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1.1.2 Cellular Constituents ofWound Healing
Many cell types are actively involved in the wound healing process. Platelets adhere
to exposed subendothelial collagen in damaged vessels where they release numerous
vasoactive substances, growth factors which stimulate the proliferation of smooth
muscle cells and fibroblasts (Clark 1993). Platelets thus play a role in the early
initiation of fibroblast activity within the healing wound.
Neutrophils migrate into the wound within minutes of injury. Their role has been
considered to be confined to defence against bacterial infection with their numbers
decreasing in the absence of infection (Gabka et al., 1995). However, studies have
now shown that neutrophils are also a source of pro-inflammatory cytokines that
serve as some of the earliest signals to activate local fibroblasts and keratinocytes
(Martin 1997). In the absence of neutrophils there is increased infection and impaired
wound healing, a lack of neutrophil-released factors is also detrimental (Harding &
Leaper, 1998).
Macrophages, in contrast to neutrophils, have a central role. It is the crucial effector
cell type that co-ordinates adult wound repair (Knighton & Fiegel 1989).
Macrophages are phagocytic cells derived from monocytes and their cell numbers are
maximal within 24 hours (Peacock 1984). These cells are important in the induction
of fibroblast activity by the release of chemotactic substances (Hopkinson-Woolley et
al., 1994). Macrophages must be stimulated in order to induce this activity.
Stimulated macrophages injected into the cornea induce fibroplasia, increased
collagen synthesis, and neovascularisation (Robertson et al., 1993). Macrophages also
take part in wound debridement (i.e. removal of necrotic tissue and tissue
remodelling). They are important producers of growth factors, which act as chemical
signals triggering the activation and replication of cells, synthesis of structural
proteins and vessel formation (Becker 1988). Transforming Growth Factor-beta
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(TGF-P), Platelet Derived Growth Factor (PDGF), Fibroblast Growth Factor (FGF),
Epidermal Growth Factor (EGF) and Transforming Growth Factor alpha (TGF-a) are
common growth factors which are secreted at the site of the wound (Mian et al.,
1992).
Fibroblasts are responsible for production of collagens that fill the wound void. These
cells migrate into the wound area by means of cytoplasmic extensions known as
ruffled membranes, which use fibrin and fibronectin as a scaffold for migration (Probst
& Bright 1985). Fibroblasts migrate into the wound before endothelial buds but
behind macrophages. Further migration is inhibited by a process of contact inhibition
when the ruffled membranes of two or more fibroblasts come together. Fibroblasts
then begin secreting glycosaminoglycans and collagen which are responsible for
binding the wound edges (Irvin 1981). In normal (uninjured) tissue, fibroblasts are
sparsely distributed throughout the connective tissue matrix. After injury, fibroblasts
are activated to migrate from adjacent tissue into the wound site, where they
proliferate and produce collagen, elastin and proteoglycans, which then reconstruct
the connective tissue. Fibroblasts can now be considered an important early
participant in inflammatory responses (Hogaboam et al., 1998). Fibroblasts can be
activated (by bacterial products, in particular) to display new functions important in
controlling extracellular matrix synthesis and producing cytokines. This signals the
recruitment of immune cells to the site of infection (Smith et al., 1997). It has recently
been shown that in skin grafting the best healing was observed with a high number of
fibroblasts cultured for 10 days prior to grafting (Lamme et al., 2000).
Myofibroblasts are a unique group of smooth-muscle like fibroblasts that have a
similar appearance and function regardless of residence (review: Powell et al., 1999).
These are specialised cells containing contractile filaments and were first described by
Johnston in 1979. They play a central role in wound healing. The number present is
proportional to the need for wound contraction. Myofibroblasts become activated and
proliferate in the early stages of wounding. They respond to proinflammatory
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cytokines and additional growth factors. As wound contraction and epithelialisation
nears completion, the number of myofibroblasts decreases by apoptosis following
repair or scar formation (Desmouliere et al., 1995). Following migration into the
wound, myofibroblasts form intercellular connections as well as attachments to the
wound bed and surrounding dermis. Myofibroblasts contain smooth muscle myosin
isoforms in addition to a-SM actin, which is responsible for the ability to contract and
to move (Powell et al., 1999). In mammals, Rho A, a small GTPase, acts on the actin
cytoskeleton to cause change of shape or motility of myofibroblasts (Aspenstrom
1999). The contraction of the myofibroblast is responsible for wound contraction
(Gabbiani 1992). Myofibroblasts express a and P integrins that are part of the
adhesion mechanism of myofibroblasts to matrix proteins (Racine-Samson et al.,
1997).
T lymphocytes and their soluble mediators play a modulatory role in wound healing.
Defined subsets of T cells express stimulatory or inhibitory effects on repair
mechanisms and take part in a balanced system of wound cell regulation (Shaffer &
Barbul 1998). B lymphocytes synthesise antibodies which provide immunity against
invading organisms. These cells are also involved in the regulation of wound healing,
mediated by release of cytokines/growth factors. Recent work has shown that human
wound-associated lymphocyte populations are modulated during healing, with
increased levels of both CB8+ T-suppressor lymphocytes and B lymphocytes (Boyce
et al., 2000).
1.1.3 Stages ofWound Healing
It is convenient to describe the local process of wound healing in five stages although,
in reality, this is a continuous process with one stage merging into the next. The
timings are merely a guide and are relevant to both humans and animals. They can
change depending on conditions i.e. temperature, infection, open wounds, chronic
wounds.
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1.1.3.1 Stage I: The haemostatic phase (seconds - minutes)
The first priority is to stop bleeding. The severed arterioles contract and the spilled
blood clots. Blood is triggered to clot by either coming in contact with collagen or by
mixing with a 'tissue factor' released by injured cells. Platelets also begin to pile up on
the mouths of the bleeding vessels and create plugs called thrombi. The products of
the clotting mechanisms help activate the healing process. Thrombin, the enzyme that
generates fibrin, attracts and causes fibroblasts to replicate. Platelet-derived growth
factor (PDGF), released by degranulating platelets, is also a mitogen and a
chemotaxin for fibroblasts (review by Majno & Joris, 1996).
1.1.3.2 Stage II: The phase of traumatic inflammation (0-3 days)
This phase demonstrates all the features of acute inflammation due to infection
(redness, swelling, heat), however infection plays no part. The phase begins within a
few minutes of wounding and lasts for about three days. When tissue is disrupted,
blood vessels are injured and bleed into the space created. Platelets and the
coagulation system cause blood to clot around the wound. Injured blood vessels
thrombose and the bleeding stops. Damaged tissue and mast cells secrete histamine
and enzymes, causing vasodilation of surrounding capillaries and exudation of serum
and white cells into the damaged area (Clark 1985). The increased blood supply with
oedema and engorgement of surrounding vessels accounts for the inflammatory
appearance, warmth and throbbing sensation experienced by the patient. At this stage,
two important cell types arrive in the wound. Polymorphonuclear leukocytes and
macrophages serve to combine in defence against bacteria and begin the process of
repair by clearing debris, damaged tissue and blood clots (Turk et al., 1966).
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1.1.3.3 Stage III: The destructive phase (2-5 days)
Now the polymorphs and macrophages clear the wound of devitalised and unwanted
material. Macrophages are essential to the repair process and play a central role
whereas repair occurs even with a major reduction in the number of polymorphs.
Macrophages attract further macrophage migration and stimulate the formation and
multiplication of fibroblasts (Johnston 1990).
1.1.3.4 Stage IV: The proliferative (or fibroplasia) phase (3-24 days)
Fibroblasts line up behind the macrophages and begin to produce the fibres of
collagen which are the main constituent of skin, tendons, ligaments, bones, cartilage,
fascia and scar tissue. The peak rate of synthesis of new collagen in a primarily
healing wound occurs around the 5th to the 7th day (Weber et al., 1995). This
considerable cellular and chemical activity during the proliferative phase results in the
formation of 'granulation tissue'. Granulation tissue is a loose collection of
fibroblasts, inflammatory cells and neovasculature in an edematous matrix consisting
of residue fibrin, glycoproteins, collagen and glycosaminoglycans (Clark 1985). As
the proliferative phase proceeds there is a rapid increase in the tensile strength of the
wound, as a scaffolding of collagen is laid down progressively.
1.1.3.5 Stage V: The Maturation Phase (24 days-1 year)
During this phase there is a progressive decrease in vascularity of the scar, shrinkage
of the fibroblast, enlargement and reorientation of the collagen fibres and an increase
in tensile strength. While the strength of the wound increases rapidly from the 6th to
the 21st day, only 50% of the normal tensile strength of a skin wound is regained
within the first 6 weeks, and in all healing tissues the amount of collagen in the scar
increases for several months.
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Contraction and epithelisation of the wounded tissue occurs during the Maturation
Phase. Contraction is the process by which large wounds become small without the
need for secondary closure or skin graft. The mechanism of wound contraction is not
clearly understood, but myofibroblasts, a special type of contractile cell, are involved
(Powell 1999). Contraction begins on the 4th day and proceeds side by side with
epithelisation and the cellular and biochemical process ofwound healing.
Epithelisation is often regarded as the final step in the healing process (Goslen 1988).
The process of epithelial resurfacing is a critical part of the wound healing scenario.
Skin has a covering of epithelial cells, called keratinocytes. When there is a defect in
this covering, these cells migrate towards the area of deficit. This migration begins
within hours of wounding during the inflammatory period and is a direct event that
does not require a preliminary increase in cellular proliferation (Slavkin 2000).
1.1.4 Growth Factors
Although the sequence of histologic changes in healing wounds has been known for
many years, the molecular factors that regulate these processes in vivo are poorly
understood. Peptide growth factors (or cytokines) appear to play key roles in
initiating the phases of tissue repair (reviewed by Slavin 1996; Pierce & Mustoe
1995). Growth factors are soluble proteins or glycoproteins that regulate cell
proliferation and induce the migration of cells as well as controlling various processes
involved in tissue repair (Robson 1991). They are synthesised and secreted by many
types of cells involved in tissue repair including platelets, inflammatory cells,
fibroblasts, epithelial cells and vascular endothelial cells. The growth factors may act
on the producer cell (autocrine stimulation), adjacent cells (paracrine stimulation) or
distant cells (endocrine stimulation; Steenfos 1994). All peptide growth factors initiate
their effects by binding to and activating specific high-affinity receptor proteins
located in the plasma membrane of target cells. Activation of the receptors eventually
results in stimulating a number of processes, including those involved in wound
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healing (Bennett & Schultz 1993). There are five major growth factor families that
appear to contribute significantly to the healing process (Mutsaers et al., 1997):
epidermal growth factor (EGF; Nanney & King 1996), transforming growth factor-
beta (TGF-P; Sporn & Roberts 1993; Bruijn et al., 1994; O'Kane & Ferguson 1997),
insulin-like growth factor (IGF; Lund 1994), platelet-derived growth factor (PDGF;
Heldin & Westermark 1999), Fibroblast growth factor (FGF; Slavin 1995). It has
been shown that in wounds of diabetic patients, which heal very slowly, or not at all,
levels of growth factor and their receptors are reduced (Braddock et al., 1999).
1.1.5 Scarless Healing
In almost every organ and tissue, scarring following injury or trauma is a major
problem. Skin wounds made in early embryos/fetuses heal without scarring. One
critical difference between scarfree embryonic healing and scar forming adult healing
is the inflammatory response. Embryos mount a poor inflammatory response to
wounding with the recruitment of only a small number of inflammatory cells
(Ferguson 1998).
It is the level of TGFP3 on the one hand and TGFpi and TGFP2 on the other, which
is important for scar formation. Decreasing the levels of TGFpi and TGFP2 relative
to TGFP3 appears to be the key to the anti-scarring therapy (Ferguson 1998).
1.1.6 Wound Healing and the Extracellular Matrix (ECM)
An intimate involvement of the ECM in all aspects of tissue remodelling and wound
healing has expelled the historic notion of the ECM being nothing more than an inert
scaffold around cells. Recent observations suggest that the ECM far from being
inactive in the wound healing process, actively orchestrates the key steps in the










































Figure 1.1: Cell-matrix interaction modulate many mechanisms in
wound healing (from Raghow, 1994)
1.2 EXTRACELLULARMATRIX
1.2.1 Introduction
Connective tissue is a multiphase, supporting, interstitial material present throughout
mammalian organs and parts. This tissue joins the other tissues of the body together.
Connective tissue takes the stress and strain of movement, maintains shape, and can
be considered a composite of insoluble fibres and soluble polymers (Ayad et al.,
1994). It is comprised of cells, intercellular fibres, intervening matrix materials and
interstitial fluid. Interactions between cells and extracellular matrix are essential for
normal tissue homeostasis and also in wound healing, though the mechanisms
involved are still poorly defined.
The principal fibres in the ECM are collagen and elastin, while the soluble molecules
include proteoglycans and glycoproteins (Labat-Robert et al., 1990; Piez 1997). The
structure (and hence function) of any connective tissue depends on the relative
proportions and organisation of these constituent molecules. Those tissues which
have to withstand large tensional force (such as tendon) tend to be particularly rich in
fibrillar collagens, while a tissue that has to withstand compressive forces (such as
cartilage) contains high levels of proteoglycans.
1.2.2 Elastin
Elastin is the major protein of the elastic fibres that form a randomly orientated,
interconnected network in many tissues (reviewed by Rosenbloom et al., 1991;
Mecham 1999). Elastin content may vary from 2% of dry weight in skin to over 70%
in the nuchal ligament of grazing animals. A high content of hydrophobic amino acids
makes elastin one of the most chemically-resistant and proteinase-resistant proteins in
the body (Landeau et al., 1994). Its principal function is to provide elasticity and
resilience to tissue (Oxlund et al., 1988). Tissues whose function demands elasticity
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include elastic cartilage, skin, ligaments, lung, intestine, and blood vessels, particularly
the thoracic aorta. Elastin levels fall with increasing age. This loss of elasticity causes
increasing rigidity of the arterial wall, leading to functional decline of the
cardiovascular system (Robert 1996).
Elastin synthesis has been documented in fibroblasts, smooth muscle cells,
chondrocytes and endothelial cells (Mecham et al., 1981; Burke & Ross 1979;
Quintarelli 1979; Cantor 1980). Elastin is difficult to extract from tissue because of its
insolubility (Sandberg et al., 1969). The soluble precursor of mature elastin,
tropoelastin (72kD) has a distinctive composition, being rich in hydrophobic amino
acids (Vrhovski & Weiss 1998). Thus glycine (Gly), proline (Pro), alanine (Ala),
valine (Val), phenylalanine (Phe), isoleucine (lie) and leucine (Leu) predominate while
aspartic acid (Asp), glutamic acid (Glu), lysine (Lys) and arginine (Arg) make up less
than 5%. Elastin is cross-linked through desmosine and isodesmosine residues
(Partridge et al., 1963, Thomas et al., 1963). Glycine constitutes one-third of all
amino acid residues, but there is no regularly repeated sequence (Gly-X-Y) as in
fibrillar collagen. In tropoelastin, hydroxyproline (Hyp) constitutes about 1% of all
residues, but tryptophan (Trp), histidine (His), methionine (Met) and hydroxylysine
(Hyl) are absent and there is no attached carbohydrate (Mecham 1999). The human
tropoelastin molecule consists of 786 amino acid residues, and its complete primary
structure is known (Indik et al., 1987). It contains repeated hydrophobic sequences
such as Val-Pro-Gly-Val-Gly and Pro-Gly-Val-Gly-Val-Ala, which produce a (3-spiral
conformation, a structure not found in other mammalian proteins (Rosenbloom et al.,
1993). There are also a-helical segments that include eight Ala-rich sequences in
which two or three residues are preceded by a sequence of between three and nine
Ala residues. These peptides are the site of cross-linking, a process that transforms
tropoelastin into insoluble elastin (Bailey & Light 1989).
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1.2.2.1 Elastin Degradation
In normal tissues, degradation occurs in the course of very slow elastin turnover
(Murphy et al., 1990). Elastin is degraded by elastases isolated from polymorphs,
macrophages, platelets and the pancreas (Werb et al., 1982). However, in chronic
wounds, the continued presence of neutrophils and macrophages results in a high level
of elastase production (Kim & Kang 2000). Elastases are serine proteases specific for
small hydrophobic amino acid residues such as Val, Leu and lie. Elastases are
therefore not specific for elastin; they are also capable of degrading type III and IV
collagens, fibronectin and proteoglycans. These enzymes can hydrolyse insoluble
elastin fibres, usually hydrolysing peptide bonds at the carbonyl side of Gly, Ala or
Val residues. Once soluble elastin fragments are generated, hydrolysis can be
completed by other neutral proteases like stromelysin and gelatinase. The activity of
elastases can be controlled by inhibitors such as a1-antitrypsin and a2-macroglobulin
(Hood et al., 1993).
1.2.2.2 Biological properties
The presence of an elastin receptor on several cell types confers to elastin peptides
several biological functions: chemotactic activity on monocytes, fibroblasts and
smooth muscle cells (SMC), stimulation of elastin fibre adhesion to vascular SMCs
and fibroblasts, release of lytic enzymes and oxygen free radicals from leukocytes,
cellular proliferation and modulation of vascular tone (reviewed by Fulop et al.,
1998).
Elastin is chemotactic towards fibroblasts, both in its precursor form of tropoelastin
and in its fragments (Senior et al., 1982). Even though the desmosine cross-link is not
required for elastin-dependent chemotaxis (Postlethwaite et al., 1978; Hunninghake el
al., 1981), this is also a chemoattractant to fibroblasts (Kunitomo & Jay 1985).
Hydrophobic repeating peptides of elastin are also able to generate directed cell
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movement in human monocytes and bovine ligamentum nuchae fibroblasts where the
latter are capable of synthesising elastin (Senior et al., 1984). Elastin-like synthetic
nonapeptides are chemoattractants for bovine aortic endothelial cells (Long et al.,
1989). Pro-Gly-Ala-Ile-Pro-Gly, a repeating hexapeptide of both bovine and human
tropoelastin, is chemotactic for neutrophils and tumour cells as well as for fibroblasts
(Grosso & Scott 1993).
The hexapeptide VGVAPG has been found to be chemotactic towards monocytes
(Bisaccia et al., 1994) and induced cellular proliferation (Wachi et al., 1995). It is
also thought that this peptide generated at the site of proteolysis during vascular
injury may have angiogenic activity (Tummalapalli & Tyagi 1999).
1.2.3 Glycoproteins
Glycoproteins (Heinegard 1986, Brockenhausen et al, 1998) are widely distributed in
the body. Most plasma proteins, with the notable exception of albumin, are
glycoproteins. Glycoproteins are important components of the mucus of the
gastrointestinal, respiratory and reproductive tracts. A carbohydrate content of up to
85% is important in endowing these glycoproteins with their mucoid properties. Cell-
surface glycoproteins are integral proteins which float on the lipid bilayer and expose
their oligosaccharides exclusively on the external surface of the cell. Plasma
membrane glycoproteins, together with glycolipids, are crucial to cell recognition
phenomena. Glycoproteins consist of one or more oligosaccharide units attached
covalently to a protein core (Kobata 1992). Proteoglycans are thus a particular form
of glycoprotein, and collagens are glycoproteins because of their glucose-galactose
moieties (section 1.3). Typical monosaccharide constituents are N-acetlyglucosamine
(GlcNAc), mannose (Man), galactose (Gal), fructose (Fuc), sialic acid, occasionally
N-acetylgalactosamine (GalNAc) and rarely, glucuronic acid (G1A). Fuc and sialic
acid always occupy non-reducing positions in the oligosaccharide, and Gal is often the
next sugar residue.
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Several multidomain ECM glycoproteins have been characterised. These include
fibronectin, laminin, vitronectin, thrombospondin, tenascin and nidogen (Yamada
1991). Fibronectin and laminin are the major glycoproteins involved in wound healing.
1.2.3.1 Fibronectin
The term fibronectin (Carson 1990; Romberger 1997; Hynes 1999) has been given to
a family of glycoproteins found on cell surfaces, and in most extracellular matrices
and basement membranes. The functions of fibronectin include roles in cell adhesion
and migration, cytoskeletal organisation, embryological development and
morphogenesis, haemostasis, thrombosis, wound healing and malignant
transformation (Potts & Campbell 1994).
Fibronectin has a molecular weight of 440kDa, and consists of two subunits of
molecular weight 220kDa connected by disulphide bonds. Fibronectin contains 4%
carbohydrate as four to six oligosaccharide units connected to a protein core via Asn
linkages. The main monosaccharide components are Man, Gal, GlcN and sialic acid
with lesser amounts ofFuc and possibly Glc (Mosher 1993).
In each fibronectin subunit, the protein is organised in tightly folded globular domains,
resistant to proteolytic attack, and connected by regions of polypeptide susceptible to
proteolysis. Controlled digestion by proteases therefore 'dissects' fibronectin into its
constituent globular domains, which can then be separated to allow study of their
individual properties. Domains with binding sites for collagens, gelatin, heparin, cell
surfaces, fibrin and bacteria are now recognised (Romberger 1997). A 30kDa domain
at the amino terminus binds to fibrin, heparin, actin and S. aureus cells. Next is a
40kDa domain that binds to gelatin and native collagens. The cell-binding domain
(15kDa) is within a 75kDa region. There are second domains for heparin and fibrin
binding next to this (Yamada et al., 1982). Within the domains, three types of short
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amino acid sequence (namely types I, II and III) are repeated many times, together
accounting for some 95% of the total sequence of fibronectin. The type I and type II
sequences, each of about 50 amino acid residues, are repeated 12 times and twice
respectively, in each fibronectin subunit, while the type III sequence, of 90-95 amino
acids, is repeated 15-17 times (Hynes 1999). Fibronectin type III repeats are
particularly widespread, being found in many ECM proteins, cell adhesion proteins
and cell surface receptors.
The S.aureus binding site is important in disease. S.aureus is a natural inhabitant of
mammalian skin and being an opportunistic pathogen is a major cause of serious
infections especially in the hospital environment. The fibronectin-binding site of
S.aureus is involved in binding to fibronectin allowing bacterial colonisation and
initiation of disease (Brennan et al., 1999).
Fibronectin binds equally well to denatured collagen types I, II and III but less
strongly to type V. Collagens have several binding sites for fibronectin (Lapiere et al.,
1994). Fibronectin also interacts with cell surface proteoglycans (Engel 1991),
hyaluronan (Nakamura et al., 1994), heparan sulphate (Drake et al., 1992) and
heparin (Busby et al., 1995).
Fibronectin and fibronectin fragments, from degradation by proteinases from
polymorphonuclear leukocytes, are chemotactic for monocytes, polymorphs,
fibroblasts and endothelial cells. The release of fibronectin from these cells enhances
their adherence at the inflammatory site. In wound healing (Welch et al., 1990),
fibronectin promotes migration of keratinocytes (Peltonen et al., 1989), platelet
adhesion (Booyse et al., 1982) and stabilisation of the clot. Neutrophil motility,
chemotaxis (Jarstrand et al, 1982), and adhesion to endothelial cells (Wall et al.,
1982) or material surfaces (Barber et al., 1978) are promoted by fibronectin.
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Synthetic peptides derived from fibronectin sequences have become very useful tools.
They have been used to modulate cell migration and tumor metastasis in vivo and to
interfere with platelet aggregation (Davies et al., 1994). Fibronectin-derived peptides
have also been used to block lymphocyte attachment in rheumatoid arthritis tissues
(Elices et al., 1994) and to attenuate chronic inflammatory changes in bacterial-
induced arthritis (Wahl et al, 1994).
The appearance of fibronectin in tissues prior to and during cell migration, assists in
the direction of cell differentiation and morphogenetic movement (Dufour 1988).
Fibronectin appears in the migratory pathways of neural crest cells.
Fibronectin appears to be important in both monocyte migration and phagocytosis. It
has been reported that fibronectin promotes monocyte adhesion to material surfaces
(Bevilacqua et al., 1981), and both the intact molecule (Yonemasu et al., 1983) as
well as fibronectin fragments (Norris et al., 1982) were found to be chemotactic for
monocytes.
Fibronectin enhances the opsonin-independent pathway of phagocytosis by monocytes
(Ginsberg 1979). Fibronectin also stimulates secretion of monocyte derived growth
factor for fibroblasts (Martin et al., 1983). Adhesion of fibroblasts to material
surfaces (Grinnell 1978) and denatured collagen (Kleinman et al., 1981) is promoted
by fibronectin. This glycoprotein has been found to be chemotactic for fibroblasts
(Postlethwaite et al., 1981), suggesting that fibronectin is very important for
fibroblast migration into the wound bed. This chemotactic activity has been shown to
be restricted to a defined region of the fibronectin molecule which is the same for
various fibroblast strains. The active domain is localised between the collagen binding
site and the major heparin binding site, about 170kDa from the N-terminal and about
70kDa from the C-terminal ends of the two subunit peptide chains (Albini et al.,
1983).
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Fibronectin may also be essential in the organisation of the granulation tissue matrix,
as in vitro studies have shown that collagen, heparan sulphate proteoglycan and
chondroitin sulphate are co-deposited with fibronectin (Hedman et al., 1982).
Endothelial cell adhesion (Macarak & Howard, 1983) and chemotaxis (Bowersox &
Sorgente 1982) are promoted by fibronectin. It is also an attachment and spreading
factor for keratinocytes (Gilcrest et al., 1982; Stenn et al., 1983). Fibronectin-coated
material surfaces provide a suitable substratum for epidermal cell migration in situ
(Donaldson et al., 1983). These results suggest that fibronectin could be the substrate
for keratinocyte migration during wound healing. Fibronectin has been shown to
promote the phagocytosis of latex particles by keratinocytes (Takashima & Grinnell
1985). Finally, the reorganisation of the basement membrane beneath the epidermal
cells after their migratory activities have ceased may be promoted by fibronectin
(Brownell et al., 1981). Fibronectin is encoded by one single gene, and diversity is
generated by alternative splicing of the primary transcript (Shwarzbauer et al., 1983).
Different forms of fibronectin are expressed at the wound site (alternate splicing).
Wounding activates fibronectin synthesis in the underlying and surrounding dermis
and this fibronectin is of the splice type commonly seen in embryonic situations
associated with proliferation and migration (Hynes 1989).
1.2.3.2 Laminins
Laminins are a family of large glycoproteins that are distributed ubiquitously in
basement membranes (reviewed by Engel 1992; Tryggvason 1993; Ekblom et al.,
1998). These molecules are multifunctional, performing key roles in development,
differentiation and migration. They interact with cells via cell-surface receptors and
with other basement membrane components such as type IV collagen,
entactin/nidogen and heparan sulphate proteoglycan (Tanzer et al., 1993). Laminins
represent a protein family of a, P, chain heterotrimers primarily located in basement
membranes but also in some mesenchymal components. So far 11 different chains
have been identified giving rise to laminins 1-11 (Sasaki & Timpl 1999).
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Like fibronectin, laminin can influence cell adhesion, growth, morphology,
differentiation, migration, and agglutination as well as the assembly of the
extracellular matrix (Tanzer et al., 1993). By limited cleavage with elastase,
chymotrypsin, pepsin or cathepsin, laminin can be cleaved into biologically active
fragments (Aumailley et al., 1987; Hershkoviz et al., 1995). Laminin primarily affects
cells of epithelial origin, and the response varies depending on the cell. It binds to
various components of the basement membrane and probably links these to one and
other (Terranova 1980) to form an integrated complex (Dziadek 1995). Laminin
promotes haptotactic migration of murine B16 melanoma cells (McCarthy & Furcht
1984) as well as being chemotactic for PMN (Terranova et al., 1986) and for
bronchial epithelial cells (Rickard et al., 1993).
1.2.4 Proteoglycans
Proteoglycans (reviewed by Kjellen & Lindahl 1991; Hardingham & Fosang 1992;
Lander 1999) are complex macromolecules that contain a core protein to which at
least one glycosaminoglycan (GAG) chain is covalently bound. This simple definition
encompasses a wide range of structures involving different core proteins, different
classes of GAG, and different numbers and lengths of GAG chain. This enormous
versatility at molecular level allows proteoglycans to serve many diverse structural
and organisational functions in tissues. These diverse groups of heterogeneous
macromolecules are found in almost all mammalian tissues and are especially
prominent in connective tissues (Kuettner & Kimura 1985).
Glycosaminoglycans are linear anionic polysaccharides with repeating disaccharide
units containing a hexosamine residue and usually, but not always, a hexuronic acid
residue. With the exception of hyaluronic acid, they are almost always sulphated. The
GAGs can be divided into four classes: chondroitin and dermatan sulphates, keratan
sulphates, heparan sulphates and heparin, and finally hyaluronic acid. Each
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proteoglycan has a trivial name that refers either to biological activity (eg decorin,
which binds to and decorates the surface of collagen fibrils; Fleischmajer et al., 1991)
or to sequence (e.g. serglycin, which contains a large alternating sequence of serine
and glycine residues; Avraham et al., 1989). Proteoglycans can be either secreted and
deposited in the ECM (e.g. aggrecan, versican, biglycan, decorin, fibromodulin; Esko
1991) or located intracellularly in secretory glands (e.g. serglycin; Avraham et al.,
1989). The most extensively studied proteoglycans are those from mammalian
cartilages. Proteoglycans are central to the proper functioning of cartilage, which is to
be able to reversibly absorb loading forces (Muir 1983).
The breakdown and degradation of proteoglycans has been extensively studied,
primarily in relation to cartilage degradation (Buttle et al., 1993). Neutral proteinases
have been identified that act on the protein core, the initial cleavage probably
occurring near the hyaluronate binding region of the protein core. The GAG side
chains can be degraded by glycosidases and the hexoses cleaved off by specific
iduronidases and glucuronidases.
The extreme variety of proteoglycans is associated with a wide range of functions
(Bailey & Light 1989), of which many are mediated by interactions of proteoglycans
with other molecules. Proteoglycans can act as space filling molecules which limit
diffusion of other molecules through the tissue. Dermatan sulphate proteoglycans
control rigidity and flexibility of the tissue matrix (Kresse et al., 1994).
Proteoglycans are known to be important in several physiological aspects of wound
healing. Heparan sulphate proteoglycans, which are located in basement membranes
(BM), are associated with cell membrane receptors and may be involved in cell matrix
interactions (Ihrcke et al., 1993). Such interactions may be important in cell adhesion
(Wight et al., 1992). It is becoming clear that heparan sulphate proteoglycans have an
important role to play in tissue repair (McGrath & Eady 1997). The findings of
Andriessen et al., 1997, suggest that their levels vary with time after healing,
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suggesting a correlation between normalisation of epidermal proliferation, BM
permeability and regeneration ofBM heparan sulphate.
Hyaluronic acid (HA), also known as hyaluronan, is one of the most hydrophilic
molecules in nature and this characteristic is probably the key Contibutor to many of
its biological functions (reviewed by Chen & Abatangelo 1999). Hyaluronic acid is the
principal glycosaminoglycan present in fetal wounds and is thought to contribute to
the scarless healing of wounds (Adzick & Longaker 1992). HA has also been shown
to play a role in the inflammatory phase ofwound healing (Kobayashi & Terao 1997),
as well as being involved in angiogenesis (Noble et al., 1998) and re-epithelisation
(Tuhkanen et al., 1998). A HA-rich matrix is permissive for cell motility (Toole 1997)
and proliferation (Adzick & Lorenz 1994). West et al., 1997, have shown that in
adult and late gestation fetal wound healing, removal of hyaluronan results in fibrotic
scarring. A hyaluronan-rich matrix may reduce collagen deposition, leading to
reduced scarring.
The breakdown products of HA have been reported to have biological activities. In
vivo degradation of HA within fetal rabbit wounds results in an altered healing
response such that there is a marked increase in fibroplasia, collagen deposition and
neovascularisation (Mast et al, 1994). Partially cleaved HA also promotes
angiogenesis in vivo and in vitro and stimulates migration and proliferation of normal




The word collagen derives from the Greek Kolla, meaning glue, and the term 'glue-
former' or 'collagen' was originally used in the 19th century for the component in
skin, bone, cartilage and tendon, which when the tissues were boiled in water and the
extracts evaporated to produce glue (Weiss & Ayad 1982). The economic importance
of collagen has been recognised for thousands of years. Collagen, the main constituent
of skin (review by Olsen & Ninomiya 1999), is also the raw material of leather and
gelatin, which have long been commercially important medical commodities (Kielty et
al., 1993).
Collagens are proteins present throughout the animal world. Most of the body
scaffolding in mammals is composed of collagen (Burgeson 1988; Fleishmajer 1990)
which provides the essential framework of connective tissues (Kuhn 1986, Nimni
1988). Many cells lie on a collagenous basal lamina or exist within a collagenous
matrix. Cell-collagen interactions are essential to cell movements in inflammation,
wound healing, trophoblast implantation, fetal development and cancer (Minafra et
al., 1995).
Collagen itself is a glycoprotein, unique in this classification since it contains no amino
sugars and in fact has only two types of carbohydrate residues - glucose and galactose
- in its structure. It is a large extracellular protein which is composed of three
polypeptide chains (called a-chains) each of which contains long sequences of
repeating tripeptides based on the general structure Gly-X-Y (where X is commonly
proline and Y can represent any amino acid but is often the modified amino acid
hydroxyproline; van der Rest & Garrone 1991). All collagens also contain varying
quantities of the amino acid hydroxylysine which is formed by the enzyme-catalysed
hydroxylation of lysine residues in newly synthesised a-chains (Bailey & Light 1989).
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Because of this primary sequence the collagen polypeptide a-chain adopts a left
handed polyproline type triple helix (Ramachandran & Kartha 1954, 1955;
Ramachandran & Reddi 1976; Ramachandran 1988). Each chain assembles with two
other chains in right handed superhelix in which every glycine residue is buried along
the axis of the helix (Traub & Piez 1971, Piez & Miller 1974).
1.3.2 Collagen Types
Collagen, known for its versatility, is found in many different parts of the body, taking
different forms to fulfil various functions, which may explain why so many different
types of collagen are found (Prockop & Kivirikklo 1995). As the number of collagen
types defined in the literature has increased (19 to date; Ricard-Blum et al., 2000), it
has been considered appropriate to attempt to discuss the collagens in terms of groups
or classes. The collagen numbering system (Roman numerals for each collagen type
and Arabic numerals for individual a-chains) to some extent reflects the relative
abundance of the various collagens, in that generally the more abundant collagens
were identified earliest.
Collagen types form a wide range of structures (van der Rest & Garrone 1991;
Prockop & Kivirikklo 1995; Tryggvson 1995; Olsen & Ninamiya 1999). Most notable
are: i) fibrils that are found in most connective tissues and which are made of alloys of
fibrillar collagens (types I, II, III, V and XI) and ii) sheets constituting basement
membranes (type IV collagens), Descemets' membrane (type VIII collagen), worm
cuticle, and the organic exoskeleton of sponges (Scott 1995).
Other collagens, present in smaller quantities in tissues, play the role of connecting
elements between these major structures and other tissue components. Collagens
known as FACIT (fibril associated collagens with interrupted triple helix), such as
types IX, XII, XIV, XVI, XVIII and XIX associate with the surface of fibrils and
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modify their interactive properties (Olsen 1989; Ricard-Blum et al., 2000). Type VII
collagen assembles into anchoring fibrils that bind epithelial basement membranes and
entrap collagen fibrils from the underlying stroma to glue the two structures together
(Burgeson 1993). Type VI collagen forms thin-beaded filaments that may interact
with fibrils and cells (Timpl & Chu 1994). The molecular configuration,
supramolecular structure and tissue distribution for types I-XIX collagens are listed in
Table 1.1.
In terms of the whole body collagens, types I, II and III are quantitatively the most
important and are generally considered to account for over 70% of the total (Kuhn
1987). These collagen types constitute the classical fibril-forming collagens. They are
synthesised intracellularly as large precursor procollagens comprising a continuous
triple helix, at each end of which are non-helical domains (propeptides). The
propeptides are cleaved extracellularly by specific N- and C-proteinases during
fibrillogenesis giving rise to the collagen monomers consisting of the triple helix
flanked by non-helical regions. The monomers spontaneously assemble to form the
fibril, each monomer staggered by 234 amino acid residues. This results in maximal
electrostatic and hydrophobic interactions between adjacent monomers and allows
specific lysine/hydroxylysine residues in the helix and non-helical regions to form
stable covalent cross-links (Bishop & Laurent 1995).
A collagen triple helix has a relatively high thermal stability and it is resistant to
digestion by the majority of proteases in the extracellular matrix (Murphy & Reynolds
1993). The stability of the triple helix is provided by interchain hydrogen bonds
between the amide of glycine and the carbonyl oxygen of an X-position residue on an
adjacent chain (Prockop & Kivirikklo 1995). Additional hydrogen bonds that involve
the hydroxyl group of hydroxyproline, a water molecule and a backbone carbonyl
further stabilise the molecule (Klein & Huang 1999). Thus in the absence of
hydroxylation the triple helix of type I collagen denatures at about 27°C (Brown et
al., 1994), but with complex hydroxylation the denaturation temperature is about
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Table 1.1: Vertebrate collagens




I a 1(1), a2(I) Fibrillar Bone, skin, cornea,
lung, tendon
II al(II) Fibrillar Cartilage, vitreous
humour





V al(V), a2(V), a3(V) Fibrillar Collagen I containing
tissue
VI al(VT), a2(VI), a3(VI) 'Beaded' microfibrils Most connective tissues
vn al(VII) Anchoring fibrils Basement membrane
(skin, oral mucosa,
cervix)
vni al(VIII), a2(VIII) Hexagonal arrays Descemet's membrane,
endothelial cells




X al(X) Hexagonal arrays Hypertrophic and
mineralising zones of
cartilage








xra a 1 (XIII) ? transmembrane most connective
tissues?




XV al(XV) unknown Widespread
XVI al(XVI) unknown Human fibroblasts
(from cDNA)
XVII a 1 (XVII) transmembrane Human skin (from
cDNA)
XVIII al (XVIII) unknown Widespread, most
abundant in liver and
lung
XIX al(XIX) unknown Basement membrane
(liver, kidney, spleen)
References: Types I-XIV (Hulmes, 1992; Brown and Timpi, 1994), Types XV-XVIII (Mayne and
Brewton 1993), Types XV, XVII and XVIII (Pihlajameini and Rehn, 1995), Type XIX (Myers el al.,
1997), Types VI, VII, VIII, IX, X, XIV, XVI, XIX (Richard-Blum et al., 2000).
42°C. It is likely that other factors, especially charge-to-charge interactions,
contribute to the stability of the triple helix; although these factors have been
recognised for some time, their importance is often overlooked (Naito et al., 1994).
Once denatured, the sensitivity of the chains to most proteases ensures normal
turnover.
1.3.3 Biological Properties
Apart from mechanical strength and ability to bind other matrix components,
collagens show additional important properties, these are described below.
1.3.3.1 Cell Attachment and Proliferation
Many cell types, including human fibroblasts, attach in vivo to collagen as their
natural substratum and bind equally well to types I, II, III or IV (Anderson 1992). It
was in 1956 that Ehrmann and Gey made the initial observation that collagen gels
enhance the growth of many cell types in vitro. The effect of adhesion to the
substratum could be direct or be mediated via collagen-bound factors such as
fibronectin, laminin or chondronectin (Hay 1991).
The C-terminal propetide of type I collagen is a constituent of bone and is thought to
play a role in cell-attachment of osteoblasts (Mizuno et al., 1996).
Type V collagen inhibits proliferation of human endothelial cells (Fukuda et al.,
1988). The mechanism remains unknown, but it appears to be related to the
detachment of cells. The disassembly of F-actin filaments was observed in cells
cultures on Type V (Yamamoto et al., 1992) In general, however, other types of
collagen have been found to stimulate endothelial cell (EC) proliferation in vitro
(Thoumine et al., 1995).
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Collagen VI promotes cell attachment, spreading and proliferation (Ruhl et al, 1999).
1.3.3.2 Effect on haemostasis
Exposure of collagen to blood and subsequent aggregation of platelets is important in
haemostasis, as is coagulation (Morton et al., 1987; Asselin et al., 1997). Adhesion of
platelets to collagen fibres triggers release from platelet granules of serotonin,
adrenaline, adenosine diphosphate and thromboxane A% which stimulate platelet
aggregation. Collagen may also activate the intrinsic coagulation pathway either
directly or indirectly, by release of, or exposure to, coagulation factors bound to
platelets. The ability to induce platelet aggregation seems to be a property of tertiary
and quartenary structure rather than that of collagen type and the adhesive process is
mediated by von Willebrand factor (Fitzimmons et al., 1988). Integrin 0.2(31 mediates
adhesion to collagen, thereby allowing platelet interaction with a lower affinity
receptor (Alberio & Dale 1999).
1.3.3.3 Collagen-derived peptide activities
Types I, II and III collagens and their derived-peptides have been shown to be
chemotactic towards a variety of cell types. Over the years several groups have
studied collagen peptides and their activities, conflicting results being found in many
cases (Postlethwaite et al., 1976. 1978; Albini & Adelmann-Grill 1985; Malone et al.,
1991).
The degradation products of collagen, released from necrotic tissue, were first shown
to be involved in neutrophil infiltration by (1971). Recent work by Thomas et al.,
1999, suggests that necrotic tissue is composed partly of low molecular weight ECM
proteins, representing the degradation products of autolytic debridement.
Postlethwaite & Kang (1976) followed this initial discovery of Houck & Chang by
showing that native tropocollagen and its peptide fragments, derived by degradation
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with cyanogen bromide (CNBr), pepsin and also bacterial collagenase, were all
chemotactic for monocytes. On the other hand, neutrophils did not recognise any of
these as chemotactic stimuli. Collagen peptides as small as three amino acids long
were shown to be chemotactic for monocytes (Postlethwaite & Kang 1976). The size
of collagen fragments is not constant as the molecule undergoes degradation by non¬
specific proteases, resulting in peptide of various sizes (Murphy & Reynolds 1993).
Native collagen and its constituent a chains are chemotactic towards fibroblasts
(Postlethwaite et al., 1978). Collagen types I, II, and III after digestion with bacterial
collagenase, are all fibroblast chemoattractants. The synthetic di and tri peptides Gly-
Pro-Hyp, Pro-Hyp and Gly-Phe-Ala are also chemotactic for fibroblast cells, though
the individual amino acids are not (Postlethwaite et al., 1978). In contrast only
collagen peptides formed after cleavage with mammalian collagenase were
chemoattractants for fibroblasts. Contradictory to this past evidence (Postlethwaite et
al., 1978), bacterial collagenase abolished this activity (Albini & Adelmann-Grill
1985).
Collagen peptides, both native and synthetic, have been shown to induce a neutrophil
influx in rats (Riley et al., 1984). Collagen digested with bacterial collagenase and
CNBr-generated-peptides were found to be potent chemoattractants for neutrophils.
The synthetic peptides (Pro-Pro-Gly)s and (Pro-Hyp-Gly)5 produce a maximal
induction of chemotaxis at 5-10nM (Laskin et al., 1986).
Malone et al., (1991) examined intact Type I collagen, TC^ and TC® (two
characteristic products of collagen generated by mammalian collagenase digestion -
see section 1.3.4.2) and Type I gelatin peptides for chemotaxis, using monocytes and
neutrophils. Intact Type I collagen was chemotactic for monocytes but not
neutrophils.
Most recently, Laskin et al., (1994) found that collagen digested with bacterial
collagenase or CNBr, as well as small molecular weight synthetic polypeptides in the
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form (Pro-Pro-Gly)5 were all potent chemoattractants for rat alveolar macrophages
inducing migration in the nanomolar concentration range. These peptides also
stimulated the release of superoxide anion and hydrogen peroxide, as well as elastase
and gelatinase. Synthetic peptides containing hydroxyproline also stimulated
superoxide anion and hydrogen peroxide release, but not chemotaxis. In contrast
synthetic peptides containing Pro and Gly induced migration of macrophages.
Peptides of the form (Pro-Pro-Gly)5 were active in inducing chemotaxis while longer
peptides e.g. (Pro-Pro-Gly)io displayed negligible activity. This indicates that peptide
length plays a significant role in chemotactic potency and that a critical length may be
required.
From all the previous studies, it is thought that the breakdown products of collagen
play an active role in the repair of wounded tissue, by attracting cells capable of
contributing to repair into the wounded area.
Cyanogen bromide-derived collagen peptides have also been shown to effect the
attachment and migration of neural crest cells (Perris et al., 1993), with CB3 from the
type I collagen al chain promoting greatest cell attachment and migration. CB3, as
well as CB6, CB7 and CB8 from the same collagen chain, also support platelet
adhesion (Saelman et al., 1993). CB3 and CB4 from the al chain of type III collagen
also has platelet adhesion activity (Perris et al., 1993). It has been suggested that the
sequence Lys-Asp-Gly-Glu-Hyp-Gly may serve as a platelet recognition site in the
collagen fragment al(III) (Morton et al., 1991). CB3 from the al chain of type IV
collagen participates in cell binding (Vandenberg 1991) but also inhibits proliferation
of melanoma cells (Han et al., 1997). Barnes et al., have studied the platelet reactivity
of fragments of collagens I and III. al(III) CB4 was highly aggregatory, a 1(1) CB3
only supported platelet adhesion with negligible aggregatory activity. It was thought
that the lysyl residues were important for its platelet reactivity. Collagen-platelet
interaction involves a basic recognition of the triple helix.
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Work by Knight et al., 1999, showed that platelet activation by collagen involves the
highly specific recognition of the Gly-Pro-Hyp sequence by platelet glycoprotein VI.
Their work demonstrates that a two-step process for collagen-platelet interaction was
needed, in which both integrin a2pl and GpVI are essential.
Collagen peptides from type IV collagen (major collagenous component of basement
membranes) have also been shown to be bioactive, promoting cell-adhesion,
spreading and motility (Li et al., 1997). Collagen IV also inhibits PMN activation.
The inhibitory activity was localised in the non-collagenous domain of the a3 chain
containing residues 185-203 (Ziaie et al., 1999). The CD47-aVP3 integrin complex
was found to be the receptor for the a3(IV) peptide (Shahan et al., 2000).
1.3.4 Collagen Degradation
1.3.4.1 Introduction
The collagen triple helix is highly resistant to the action of most proteinases, but
connective tissue cells have been shown to synthesise and secrete a group of
proteinases that act on collagen and function under physiological conditions and
which are, therefore, important in matrix metabolism. These proteinases can be
divided into four classes: aspartic, cysteine, metallo- and serine dependent (Barrett
1980). Collagen degradation (reviewed by Murphy & Reynolds 1990; Birkedal-
Hansen et al., 1993; Shingleton et al., 1996) occurs as part of normal tissue turnover.
Tissue turnover is increased in development, growth, tissue remodelling, wound
healing, some disease processes and also in the involuting uterus and parturient cervix
(Woesnner 1991).
Complete collagen degradation is usually the result of the synergistic action of several
matrix metalloproteinases (MMPs), also called matrixins (MT), active at neutral pH
(Matrisian 1992; Magnatti et al., 1996; Murphy & Knauper 1997; Sternlicht & Werb
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1999). These enzymes (see Table 1.2) require both Zn2+ and Ca^+, and are secreted
in latent proenzyme forms by cells such as fibroblasts, chondrocytes, osteoblasts and
endothelial cells (Werb 1982). Collagens are cleaved at specific sites by MMPs
(Vankemmelbeke et al., 1998). The breakdown of collagen is summarised in Figure
1.2.
The activity of MMPs is tightly regulated, mainly through the tissue inhibitors of
metalloproteinase or TIMPs (reveiwed by Harcharan & McCormick, 1997). To date 4
TIMPs have been described (TIMP-1, 2, 3, 4), each being a separate gene product.
The TIMPs function is to regulate the activity by stabilising the proenzyme and by
inhibition of the active species (Iredale 1997).
The expression of most MMPs is transcriptionally regulated by growth factors,
hormones, inflammatory cytokines, cell-matrix interactions and cellular transformation
(Nagase et al., 1999). The equilibrium between synthesis and degradation of ECM
components is tightly controlled by MMPs and TIMPs to maintain homeostasis and
tissue integrity (Forget et al., 1999). Disruption of this balance may result in diseases
associated with uncontrolled proteolysis of connective tissue such as arthritis, tumor
cell invasion and metastasis, atherosclerosis and fibrosis (Nagase et al., 1999).
1.3.4.2 Degradative Enzymes
The best characterised proteinase is the mammalian collagenase MMP1 which is a
Zn2+-metallo-endopeptidase capable of cleaving the collagen molecule across the
three chains to give two triple helical fragments. Gross and Lapiere (1962) first
described this enzyme, as it was released into tissue culture medium or tissue explants
from tadpole tails undergoing morphogenesis. Fibroblasts, chondrocytes and related
cells have been reported to synthesise and secrete collagenase. The enzyme is capable
of cleaving all the fibrous collagens, although Type II is cleaved at a slower rate than
Types I and III, which are cleaved at approximately the same rate. It has been
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Table 1.2
(adpated from Greenwald & Woesnner 1999 and Forget et al., 1999)








laminin; gelatin; fibronectin; collagens I,
II, IV, V, VII, X, XI; aggrecan; elastin;
vitronectin; type IV collagenase
3 Stromelysin proteoglycans; laminin; gelatin;
fibronectins; collagens I, III, IV, V, IX, XI;
aggrecan; link protein; elastin; transin;
tenascin; decorin; vitronectin; procollagen
peptides; proteoglycanase
4, 5,6 not used
7 Matrilysin proteoglycans; laminin; fibronectin;
gelatins; collagen IV; elastin; entactin;








gelatin; fibronectin; collagens II, IV, V,
VII, X, XI; aggrecan; elastin; vitronectin;
type V collagenase
10 Stromelysin 2 proteoglycans; laminin; gelatins I, III, IV,
V; fibronectin; collagens I, III, IV, V, VIII,
IX; aggrecan; elastin
11 Stromelysin 3 N-terminal domain cleaves casein; al
proteinase inhibitor
12 Macrophage elastase proteoglycans; laminin-1; elastin;




collagens I, II, III, VII, X; aggrecan;
gelatin
14 MTI-MMP activates MMP-2 and -13; laminin B chain;
gelatin; fibronectin; collagens I, II, III;
aggrecan; tenascin; vitronectin; perlecan;
dermatan sulphate; nidogen
15 MT2-MMP activates MMP-2; laminin; gelatin;
fibronectin; collagens I, III; aggrecan;
tenascin; perlecan; nidogen
16 MT3-MMP activates MMP-2; collagens; gelatin
17 MT4-MMP activates MMP-2; collagens; gelatin
18 Collagenase 4




























Digestion by lysosomal proteinases
(acid pH)
Figure 1.2: Pathways for the degradation of collagen
Initial fragmentation of cross-linked insoluble collagen occurs
extracellularly. Cleavage within the collagen triple helix, produces
fragments TCA and TCB . These fragments denature at 37°C and
breakdown further producing small peptides and amino acids
(Murphy & Reynolds 1993).
established that the binding of the enzyme is conformational^ dependent since it acts
on the collagen triple helix at a discrete locus across all three peptide chains, but has
little action on the same site on individual a-chains (Fields 1991). Cleavage occurs at
the Gly-Ile peptide bonds at residues 775-776 in the al(I) chain and Gly-Leu in the
a2(I) (Highberger et al., 1979). This locus is three-quarters the length of the molecule
from the amino terminal end, thus yielding two triple helical fragments, designated
TC^ and TC^ (Gross & Nagai 1965). Both fragments retain their triple helical
character but have a denaturation temperature below that of the intact molecule
(39°C) and therefore denature at physiological temperatures (Stark & Kuhn 1968).
The denatured chains are readily digested by most proteinases, in contrast to the
enzymic resistance shown by the triple helix.
Bacterial collagenases were discovered long before their mammalian counterparts.
They have been used mostly in laboratories but also as pharmacological agents (Keil
1988). The best characterised bacterial collagenase is produced by Clostridium
histolyticum. This bacterium produces a group of collagenases with molecular
weights ranging from 68 kDa to 125 kDa (Harper 1980). They are metalloproteinases
that require zinc and calcium (Bond & Van Wart 1984) which cleave peptide bonds in
native, triple-helical collagen (Mandl et al., 1953). The enzyme degrades the helical
regions in native collagen preferentially at the Y-Gly bond in the sequence -Pro-Y-
Gly-Pro- where Y is most frequently a neutral amino acid, leaving the collagen
monomer split into many tripeptide (Gly-X-Y) fragments. C. histolyticum -derived
collagenase cleaves different collagen types at nearly the same rate (Hatz et al.,
1994). It has been suggested that bacterial collagenases may be capable of activating
latent mammalian collagenase, thus contributing to the degradation of collagen
indirectly (Harrington 1996).
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1.4 USES OF COLLAGEN
Collagen, as previously mentioned, has a number of desirable and unique physical and
biological properties. Due to these properties, Type I collagen has been used
extensively to formulate medical materials (Pachence et al., 1986; DeLustro et al.,
1987). Collagen-based medical devices have had a major impact in the field of soft
tissue repair. Collagen has been used in medicine as far back as 175 A.D. by Galen
who used absorbable cat gut sutures (Katz & Turner 1970). This protein has also
been used as a burn dressing; the advantages of collagen dressings were pointed out
by Chvapil (1977, 1982). Collagen sponges were shown to cover large wounds, so
providing good adherence and protection against mechanical and bacterial infection,
whilst preserving fluid and diminishing pain. These dressings have also been
developed to function as artificial skin (Yannas & Burke 1980; Murphy et al., 1990).
Collagen sponges have also been used as dressings for other wound types such as
pressure sores and leg ulcers (Chvapil et al., 1986). The advantages of using collagen
sponges for these applications are the formation of new granulation tissue,
epithelialisation of the wound, minimisation of contracture and minimum antigenic
response. Collagen sponges also produce less inflammation and a lower incidence of
infection.
Collagen matrices containing hyaluronate and fibronectin can increase fibroblast
proliferation and improve the deposition of organised repair tissue (Doillan et al.,
1987, 1988). Chemically modified collagen membranes have been used as drug
carriers for the slow release of ophthalmic medication (Miyata et al., 1979).
Reconstituted collagen has been successfully used in the treatment of highly
vascularised soft tissues such as liver and spleen (Magarit et al., 1987; Sakon et al.,
1989). Collagen in an injectable form, zyderm collagen implant (ZCI), has been
successfully used as an implant in the management of ageing face, trauma surgery and
infection (Matton et al., 1985). Collagen Replacement Therapy is the most common
collagen used for replenishment of natural skin collagen. Recently, a new form of
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injectable collagen that is prepared from the patient's own tissue has been introduced
by Collagenesis Inc. (Beverly, MA, USA). This collagen material named Autologen,
persists longer and minimises the risk of allergic reactions (Ruszczak & Schwartz
1999). In the form of fibres, collagen can be used as suture material, and can be
inserted into vascular prostheses (Stenzel et al., 1974), blood-vessel prostheses,
catheter cuffs and urinary sphincter implants (Ruszczak & Schwartz 1999).
In the last ten years, numerous collagen-based medical devices have been approved,
and a few have reached commercial success, see Table 1.3.
One of the reasons that collagen has become the biomaterial of choice for a number of
important medical applications is that large quantities of medical grade collagen
(collagen, from closed herds, in its purest form) can be easily and cheaply obtained.
Also, there are already a number of established collagen products. Collagen has a
good safety profile as a biomaterial. Another reason is that collagen can be used in
forms that are easily used in minimal invasive procedures. Finally, the understanding
of collagen's role in wound healing, metabolism and catabolism, and the interaction
between cells and collagen has greatly improved.
Despite these useful properties of collagen, few collagen products have become a
commercial success. It is hoped that further advances in the use of collagen will occur
in the years ahead. Early efforts using collagen in the form of gels, non cross-linked
sponges and films failed to show adequate clinical success. For example, cross-linked
collagen films have been shown to function as biocompatible barriers, but have poor
oxygen permeability, enhance pooling of wound fluids and ultimately will not support
tissue growth (Pachence 1996).
Questions of the antigenicity of collagen have also been raised (Cucin & Barek 1983).
Approximately 3% of patients develop a hypersensitivity to injected collagen. A
relationship between the use of injectable collagen and the autoimmune diseases
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Cardiovascular Anti-infectious Catheter Cuffs
Arterial Puncture Repair
Plastic and Reconstructive Wound Dressings
Surgery
Artificial Skin
Urology Bulking Agent for Incontinence
Drug Delivery Cancer Therapeutics; Growth
Factors
Orthopedics Bone Repair
polymyositis/dermatomyositis (PM/DM) has been suggested, but there has never been
any statistical proof for these claims (Soo et al., 1993). Another problem with
collagen has been with the use of bovine-derived products, since the outbreak of
bovine spongiform encephalitis (BSE) in European cows. This has led to closer
monitoring of all bovine products.
Recently approved products in the fields of hard tissue repair and relief of urinary
incontinence lends support for the collagen renaissance. The bovine collagen product,
which was developed under the name 'artificial skin', is now known as Integra
Artificial Skin and commercialised (Integra Life Sciences, Plainsboro, NJ, USA).
Another product, originally named 'living skin equivalent', made from living-cell-
containing bovine collagen is commercially available as Apligraf (Organogenesis Inc.,
Canton, MA, USA). Similar collagen type I material derived from equine (instead of
bovine) Achille's tendons (Collantamp-E-Fascie, Immocoll GmbH) has recently been
approved in the European Community.
The above mentioned commercially available collagen products all utilise collagen's
physical properties, rather than its biological properties. As stated in section 1.3.3,
collagen and collagen-derived peptides have been shown to be involved in cell
attachment, proliferation, haemostasis and chemotaxis. To date, no commercially
available collagen products utilising these biological functions have become




Cell migration is a key aspect of many normal and abnormal biological processes,
including embryonic development, defence against infections, wound healing and
tumour cell metastasis (Martin 1997). Animal cells move by crawling and the active
force is derived primarily from the co-ordinated assembly and disassembly of actin
filaments (Nobes & Hall 1999).
Chemotaxis, first described by Pfeffer (1884) is the directional locomotion of
organisms or cells in relation to sources of chemical attractants or repellants.
During chemotaxis, cells respond to a chemical factor (chemoattractant) and move in
the direction of an increasing concentration of that factor. There is a multitude of
chemotactic factors (chemoattractants) and there is considerable specificity in the
ability of cells to respond to a given attractant (Wilkinson & Haston 1988). The
presence of the appropriate cell surface receptor is required (usually) for a specific
cellular response to a particular chemical factor (Martin et al., 1983). Owing to this
requirement, most chemotactic factors recruit a single class of cells, such as
inflammatory cells, connective tissue cells, or endothelial cells. Distinct
chemoattractants arise in a wound at different times and these co-ordinate the influx
of cells and blood vessels (Fig. 1.3). A lack of chemotactic factors for connective
tissue cells may impair the rate of repair, whereas overproduction of a
chemoattractant could result in excessive repair or scarring. Chemoattractants show
an enormous range in their effective dose in vitro, suggesting different functions in
vivo.
Although it has not been shown in all systems, the first event in chemotaxis is
detection of the chemoattractant by specific cell surface receptors (Schiffman 1979).
Cells lacking such receptors are unresponsive. Responding cells are able to detect






















Figure 1.3: Diagram of the cascade of chemotactic factors produced
during wound repair (Grotendorst, 1984)
the cell surface are coupled to mechanisms that amplify the signal and activate the
cells' motility. Both spatial and temporal mechanisms have been proposed in the
detection of the concentration gradient of chemoattractant and the establishment of
the direction ofmovement (Lackie 1986).
It is known that the interaction of an attractant with a cell receptor sets off diverse
reactions and that these reactions occur even without a concentration gradient (Raif-
Preminger et al., 1995). Thus, it is unlikely that the intracellular reactions required for
directed motion differ from those required for random motion. In the case of a
chemoattractant, a gradient across the cell body would be expected to cause a
differential receptor occupancy along the cell surface. The degree of receptor
occupancy is proportional to the magnitude of the chemical reaction it triggers, and
the rate of these reactions are greatest in those portions of the cell exposed to the
highest concentrations of attractant. This gives rise to an internal gradient in the cell
whose polarity could establish direction and whose magnitude could establish the rate
of cell movement (Raif-Preminger et al., 1995).
Chemoattractants once bound to the surface receptor stimulate a pleiotropic response
in target cells. Specifically, all chemoattractants stimulate both sodium and calcium
ion fluxes and changes in lipid metabolism, such as phosphoinositol metabolism and
phosphorylation ofmany membrane proteins as well as cytoplasmic proteins (Downey
1994). These events occur within seconds to minutes after the binding of the
attractant by the cell surface receptor. Without the appropriate receptor, no attractant
signal can be initiated. Biochemical evidence supports the concept that the
biochemical events that regulate cell motility are very similar within a variety of cell
types, including endothelial cells, fibroblasts, smooth muscle cells, and even
leukocytes. Therefore, whether a fibroblast or an endothelial cell is responding to its
attractant, virtually the same internal biochemical mechanisms are at work (Caterina
& Devreotes 1991).
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The accumulation of cells in a particular site does not constitute evidence for a
chemotactic response, and separating the effects of a gradient of chemokinetic factor
(affecting random movement) from a chemotactic response (affecting directional
movement) is important (Wilkinson et al., 1998). An assay for chemotaxis which has
been widely used is the Boyden chamber, in which two compartments are separated
by a micropore filter (see section 2.6.1). A method for distinguishing the
chemokinetic and chemotactic effects of a substance, the so-called Checkerboard
assay (Zigmond & Hirsch 1973), is also widely used.
The injury to connective tissue by immunological, mechanical, physical or chemical
injury is followed by an orderly process wherein fibroblasts migrate into the area from
surrounding locations, expand their numbers by proliferation and then synthesise and
remodel new matrix to constitute scar tissue (Cohen 1979). The mechanisms involved
in fibroblast migration are not completely understood, but it is known that as they
migrate, they send out lamellipodia which adhere to the substrate (Harris & Dunn
1972). The body of the fibroblast is believed to be drawn up to the new adhesion site
by activation of a system of contractile filaments within the cell (Abercrombie et al.,
1972). Fibroblasts were first shown by Braum (1971) to migrate in vivo and migrate
at the site of tissue injury. In a given inflammatory reaction a number of different
chemoattractants may be available to recruit new neighbouring fibroblasts to the site
(Wilkinson 1988). Table 1.4 shows examples of known fibroblast chemoattractants.
This redundancy of chemoattractants may exist to assure that tissue repair is effected,
thereby contributing to the survival of the host.
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factor for fibroblasts (LDCF-F)
Postlethwaite et al., 1976
Serum (C5)-derived chemotactic
factor for fibroblasts
Postlethwaite et al., 1979
Collagen types I, II and III, a
chains, and hydroxyproline
peptides
Postlethwaite et al., 1978
Fibronectin Seppa et al., 1981
Tropoelastin and elastin peptides Senior et al., 1982
Platelet-derived growth factor
(PDGF)
Seppa et al., 1982
Leukotriene B4 Mensing & Czarnetski 1984
PDGF-like factor from
SV40/NIH/3T3 cells
Bleiberg et al., 1985
Breast carcinoma cell line-
derived factor
Gleiber & Schiffman 1984
1.6 INTEGRINS
Recent research indicates that the major role of the ECM is in the regulation of
cell/cell communication rather than passive support of cells (MacNeil 1994). Specific
attachment sequences on ECM proteins are recognised by cell surface receptors called
integrins (Ruoslahti & Pierschbacher 1987; Ruoslahti 1991; Yamada & Geiger 1997),
which are thought to maintain integral cell contact through a bridge between the
extracellular structural protein matrix and the cell's internal cytoskeleton. Integrin-
dependent cell adhesion regulates not only cell structure and morphology, but also
proliferation, migration and differentiation (Cheresh 1991). Integrins are not only
biologically important, their medical importance is beginning to be appreciated as
well. Integrins have been found to play a role in platelet aggregation, immune
functions, tissue repair and tissue invasion (Ruoslahti et al., 1994). The adhesion of
cells to each other and to extracellular matrices is a pre-requisite for many cellular
functions. Since integrins are cell adhesin receptors, they play fundamental roles in
these adhesive events. Integrins can either allow or prevent adhesion. Therefore, they
can discourage inflammation and encourage wound healing (Green et al., 1998).
Integrins are a family of transmembrane glycoproteins in which each molecule is a
dimer consisting of noncovalently associated a (120-180KDa) and (3 (90-110KDa)
subunits, encoded by separate genes. With 16 a units and 8 (3 units, there are at least
22 possible integrins (Hemler 1999). It is thought that the particular integrins which a
cell expresses are largely responsible for determining whether and how that cell will
interact with the ECM. Some cultured mammalian cell lines express only a few
integrins whereas others can have as many as 10 (Vogel et al., 1990). Signalling
information originating from binding interactions between integrins and ECM
molecules (ligands) is transduced across the plasma membrane into a variety of signal
transduction pathways in a process termed "outside-in signalling" However,
intracellular regulators modify external integrin ligand binding properties in a process
termed "inside-out" signalling (Yamada 1997). If the integrin is not expressed, the cell
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will not attach to ECM proteins. A low level of expression may allow light attachment
and the possibility to migrate along the protein. High level expression may result in
the cell being anchored in place to the ECM. ECM proteins act as chemical
messengers by interacting with the cell surface through specific receptors i.e. the
ECM can stimulate chemical messages from which cell behaviour can be altered
(Meredith et al., 1993). Tyrosine-phosphorylated proteins have recently been detected
in a range of cells following integrin ligand binding, (Juliano & Varner 1993). An
increase in cytoplasmic pH has also been detected, and integrin activation can lead to
gene expression for cytokines and metalloproteinases (Ingber 1991). The specificity
and affinity of a given integrin receptor on a given cell are not always constant. Both
activation and deactivation of integrin functions have been reported. There is
increasing evidence that integrins do mediate information transfer into cells (Juliano &
Haskill 1993).
Most integrins are expressed on a wide variety of cells, and most cells express several
integrins. Individual integrins can often bind to more than one ligand. Equally,
individual ligands may be recognised by more than one integrin. Integrins cqPi and
ct23l are the major integrin collagen receptors (Knight 2000). The aiPi and a2Pl
integrins are known to bind collagen and laminin with the sequence Asp-Gly-Glu-Ala
(DGEA) often being recognised (Vandenberg et al., 1991).
The recognition site for many of the integrins that bind to extracellular matrix and
platelet adhesion proteins is the tri-peptide arginine-glycine-aspartic acid (RGD)
(Ruoslahti & Pierschbacher 1987). There are many RGD sequences in collagens, but
judging from lack of inhibition by RGD-containing peptides of the integrin binding to
collagen in many cell types and integrin-binding activity in collagen fragments that do
not contain any RGD sequence (Gullberg et al., 1992), at least most of the collagen-
mediated cell attachment is not RGD dependent.
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Integrins that recognise collagen can modulate cell behaviour, including adhesion and
spreading, migration, division, metabolism and the expression of the differentiated
phenotype. These important processes are physiologically relevant to growth and
development, wound repair and angiogenesis and in pathological processes such as
thrombosis and tumour metastasis (Knight 1998).
It has been demonstrated that the integrin a2Pl mediates the Mg2+-dependent
adhesion of platelets to collagen (Santoro et al., 1986). Adhesion by the a2pl
receptor is specific for collagen. Collagen types I, II, III, IV and VI support adhesion
via this receptor while other adhesive proteins do not (Staatz et al., 1989). The a2Pl
integrin serves as a cell surface collagen receptor on platelets, fibroblasts, endothelial
and some epithelial cells. The binding site for this integrin has been shown to be
contained within the al(I) CB3 fragment of collagen (Staatz et al., 1990). As
previously mentioned, this fragment is involved in platelet adhesion. The amino acid
sequence Asp-Gly-Glu-Ala (DGEA) is an important determinant of the 012P1
recognition site (Staatz et al., 1991). Also in Type IV collagen, a dominant al
integrin binding site is located in the CNBr fragment CB3 (Vandenberg et al., 1991).
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1.7 AIM
Peptides derived from collagen, elastin, fibronectin and laminin display chemotactic
activities towards neutrophils, macrophages, fibroblasts, endothelial and epithelial
cells. These breakdown products have been shown to a play a role in the healing
process. However, the characterisation of active peptides has not been performed
previously in a systematic manner and comparison of potencies is difficult. Therefore,
the aim of this study was to isolate and identify naturally occurring peptide sequences
from collagen which have biological activities. The target responses chosen were
chemotaxis, proliferation and cellular attachment to a substrate in populations of
fibroblasts and endothelial cells. Since these cells are of critical importance in tissue
repair, a further aim of the study was to assess the potential for the development of
small collagen-derived peptides as a therapeutic treatment for impaired wound
healing. The implications being that the peptide(s) could eventually then be used in




2.1 PREPARATION OF COLLAGEN
A mixture of collagen types I and III was extracted from the skin of
stillborn pigs (see below). Type V collagen; from pig placenta was given
as a kind gift from Dr. Gordon Paul (Bristol).
2.1.1 Pepsin extraction of collagen
The method used for the pepsinisation of collagen was based on that of
Miller and Rhodes (1982). Pepsinisation aids in the separation of Type I
and Type III collagens.
Pig skin, containing collagen (60g), was digested with pepsin (6g; Sigma,
Poole, Dorset) in a ratio of (collagen:pepsin) 10:1 (w/w), in 1 litre of
0.5M acetic acid at 4°C for 24hrs (Figure 2.1). This method relies on the
cleavage of the cross-linked non-helical terminal peptide region of
polymeric collagen and the resistance of the collagen triple helix to
enzymatic degradation below its denaturation temperature. The collagen
triple helix is unique in being both resistant to pepsin and soluble at acid
pH, so that the end product of digestion is a mixture of solubilised
collagen types.
2.1.2 Salt Precipitation
Salt fractionation was adopted to separate the collagen types (Figure 2.1).
This method is based on the principle that various collagen types have
different solubility properties at different salt concentrations.
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60g pig skin + 6g pepsin
in 1 litre 0.5M acetic acid












1.7M NaCl, pH7.5 (1 litre)
Precipitate Supernatant
2.4M NaCl, pH7.5 (1 litre)
Precipitate Supernatant
Figure 2.1: Procedure for the isolation of collagens
(adapted from Miller & Rhodes, 1982)
All procedures were carried out at 4°C (to minimise proteolytic digestion)
and centrifugations were at 30,000g for lhr. Collagens were then dialysed
against H20 and freeze-dried. Purity and identification of collagens was
carried out by SDS-PAGE analysis.
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2.2 SODIUM DODECYL SULPHATE-POLYACRYLAMIDE GEL
ELECTROPHORESIS (SDS-PAGE)
2.2.1 Introduction
SDS-PAGE is used to resolve and separate individual components of
protein mixtures, in this case collagen components (chains and peptides).
Discontinuous SDS-PAGE is a widely used technique, which separates
proteins according to their molecular weight (Garfin 1990). SDS is a
negatively charged detergent that solubilises and binds to proteins such
that approximately 0.5 mol of SDS is bound per amino acid residue. This
large amount of anionic detergent is sufficient to overwhelm the intrinsic
charge on the polypeptide chain so that the net charge per unit mass
becomes approximately constant. In the presence of SDS and the
reducing agent P-mercaptoethanol (which reduces disulphide bonds)
proteins are denatured and adopt an extended coil configuration.
Electrophoretic migration is then determined by the effective molecular
length or approximate weight of the polypeptide chain. Molecular weights
can be estimated from a plot of distance migrated versus log molecular
weight, using proteins of known molecular weights as standards.
Polyacrylamide gels result from the polymerisation of acrylamide
monomer into long chains and the crosslinking of these chains by
bifunctional compounds such as N,N'-methylene bisacrylamide (BIS).
Ammonium persulphate initiates this polymerisation, with N,N,N',N'-
tetramethylethylenediamine (TEMED) catalysing the formation of free
radicals from the persulphate. In the gel media, the passage of any particle
is hindered by the structure of the matrix, and the extent depends upon
the relative sizes of the particles and pores in the gel network. The pore
45
size is altered by changing the acrylamide concentration.
2.2.2 Method
Discontinuous SDS-PAGE was performed in vertical slab gels using the
buffer system of Laemmli (1970). Gels containing 4.5% (stacking gel),
6% or 12% (separating gel) were prepared from a stock solution of 30%
(w/v) of acrylamide and 0.8% (w/v) of N,N'- methylene bisacrylamide.
The final concentrations in the separating gel were as follows: 0.375M
Tris-HCl (pH 8.8) and 0.2% (w/v) SDS. The gels were polymerised
chemically by the addition of tetramethylethlenediamine (TEMED;
25pl/75ml separating gel) and ammonium persulphate 2% w/v
(1.5ml/75ml separating gel). Gels 13cm x 14cm were prepared in 16cm x
18cm glass plates with 1.5 mm spacers. The stacking gels of height 2cm
contained 0.125M Tris-HCl (pH6.8) and 0.2% SDS (w/v) and were
polymerised chemically by the addition of TEMED (25pl/25ml stacking
gel) and 2% (w/v) ammonium persulphate (0.625ml/25ml stacking gel).
The electrode buffer (pH 8.3) contained 0.025M Tris, 0.192 M glycine
and 0.25% SDS (w/v). The samples contained the final concentrations:
0.1M Tris-HCl (pH 6.8), 2% (w/v) SDS, 10% (v/v) glycerol, 3% (v/v) p-
mercaptoethanol and 0.001% bromophenol blue as tracking dye. The
proteins (lmg collagen/ml) were completely denatured by immersing the
samples, in microcentrifuge tubes, for 3 minutes in boiling water. The
samples (100pl) were then loaded into the wells using a lOOpl
microsyringe (Hamilton Bonaduz AG., Bonaduz, Switzerland).
Electrophoresis was carried out at 40mA constant current per gel until
the bromophenol blue marker reached the bottom of the gel (about 3%
hrs). Gels were fixed and stained simultaneously overnight in 250ml 8%
(v/v) acetic acid/50% (v/v) methanol containing 0.1% (w/v) Coomassie
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Brilliant Blue R-250. Gels were then destained 5-6 hrs by continuous
shaking in several changes of 8% (v/v) acetic acid. Gels were destained
until background staining levels were minimal.
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2.3 DEGRADATION OF COLLAGEN
2.3.1 Cleavage of peptides with CNBr
The action of CNBr upon proteins is unique in its selective attack on
methionine (Gross 1967). When a methionine residue reacts with CNBr it
is converted to a residue of homoserine lactone, which under acidic
conditions is in equilibrium with a residue of homoserine. The formation
of homoserine or its lactone results in the liberation of the amino group of
the residue that followed methionine. Accordingly, a residue of
methionine which originally occupied an endo-position is converted to
homoserine (lactone), which becomes the C-terminal residue of a peptide
fragment. The reaction takes place under acidic conditions in order to
denature the protein and to expose the side chains of methionine to attack
by CNBr, which may be added in excess.
Samples(2mg) were dissolved in 1ml of 70% Formic acid and digested
with CNBr (2mg CNBr/lmg protein) at 25°C (Seyer 1977) overnight.
After digestion, samples were diluted 10 fold with cold H20 and freeze-
dried.
2.3.2 Fractionation of CNBr peptides
Type I collagen CNBr peptides were fractionated by cation-exchange
FPLC (Bateman et al., 1986). Freeze-dried CNBr peptides (0.5mg) were
dissolved in 1ml of starting buffer (0.02M sodium formate, pH 3.8,
containing 0.07M NaCl and 2M urea) and denatured at 50°C for 3
minutes. The samples were filtered using 0.22pm filters (Sartorius). The
filtered samples (0.5mg/ml) were chromatographed at room temperature
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on a Mono S HR 5/5 cation-exchanger (Pharmacia). Following injection
of the sample, the starting buffer was delivered for 5 minutes at a flow
rate of lml/min. A 65-ml linear gradient was then commenced at the same
flow rate. The gradient was from 0.07 to 0.26M NaCl in 0.02M sodium
formate, pH 3.8, containing 2M urea. Fractions containing the separated
peaks were collected, dialysed against 0.1M acetic acid and concentrated
by freeze-drying. The identities of the separated CNBr peptides were
confirmed by SDS-PAGE (12% acrylamide) as by method of Bateman et
al., 1986).
2.3.3 Quantification of peptides obtained from collagen by treatment
with cyanogen bromide
Collagen quantitation was based on the Sircol Collagen Assay (Qubis
Ltd., Belfast). The assay is based on the specific binding by collagen of a
dye reagent that is free from interference from non-collagenous proteins
(Anderson & Elliot 1991). The assay is rapid, sensitive and easy to use.
The assay kit comprises components: the Sircol dye reagent, an alkali
reagent, a collagen standard and a salt-soluble reagent that precipitates
collagen.
The collagen standard (prepared from a lmg/ml stock solution of
collagen I in 0.5M acetic acid), and reagent blanks were used to produce
a straight-line calibration curve with a Dynatech automated
spectrophotometer at 540nm. The intensity of the colour at 540nm was
found to be proportional to the collagen concentration in the sample. The
collagen standard was run in duplicate at three concentrations, using 12.5,
25 and 50pl aliquots.
49
To the test sample (50pl of purified peptide in 50pl of 0.5M acetic acid)
lml of Sircol dye reagent was added. After mixing at room temperature
for 30 mins, the tubes were then centrifuged at 10,000g for 5 mins. The
supernatant, containing unbound dye, was then discarded. The collagen-
bound dye remained as a pellet at the bottom of the tube. To the collagen-
dye complex lml of alkali reagent (0.5M sodium hydroxide) was added.
This was vortexed to bring the bound dye into solution. The dye reagent
selectively precipitates the collagen molecules from mixed protein
populations.
The absorbances of assay blanks, standards and collagen peptides were
measured at 540nm. The reagent blank value was subtracted from all
readings (standards and unknowns). A standard curve was plotted from
which the collagen concentrations of unknown samples were obtained by
interpolation.
2.3.4 Digestion by Bacterial Collagenase
Samples (10mg collagen) were dissolved in lOmls of 50mM Tris-HCl pH
7.5 containing 0.15M NaCl, 5mM CaCl2, lOmM NEM and incubated for
24hrs at 37°C with bacterial collagenase at a ratio of enzyme:collagen
1:100 (w/w). The reaction was stopped by heating to 90°C for 4 hrs
(Levitsky et al., 1994).
2.3.5 Sequential Enzymatic Digestion
In order to create smaller peptides, the collagen was degraded with two
enzymes, sequentially. After collagenase treatment, further breakdown
was carried out by trypsin in one case, and with chymotrypsin in another.
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These enzymes can only degrade collagen after the triple helix has been
broken up by collagenase.
For the double enzymatic digestions, collagen (lOmg) was digested with
collagenase (lOOpg) in lOmls of buffer as described above. The
collagenase (Sigma) was inactivated as before. A second digestion was
carried out by the addition of trypsin or chymotrypsin (lOOpg/ml).
The new enzyme treatment was also carried out for 24hrs at 37°C. Again
the reaction was stopped by heating to 90°C for 4hrs.
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2.4 REVERSE PHASE HPLC
2.4.1. Introduction
Reverse-phase HPLC (High Performance Liquid Chromatography) has
proven to be an invaluable tool for the analysis and purification of
proteins and peptides. It is very effective in separating peptide fragments
from enzymatic digests because of its high resolving power. It is able to
resolve very similar polypeptides, some of which differ by a single amino
acid (Willard et al., 1988).
Polypeptides are large molecules and cannot "partition" into the
stationary-phase, as do small molecules. Polypeptides are adsorbed onto
the hydrophobic -"reverse phase"- surface from the mobile phase and
remain adsorbed until the organic component of the mobile phase reaches
a critical concentration, at which point the polypeptide is desorbed and
carried by the mobile phase to the column exit with little further
interaction with the reverse phase surface. Polypeptides are eluted quickly
once the critical organic concentration is reached, which accounts for the
sharp peaks and high resolution.
2.4.2 Method
Digested collagen peptides were resolved using a CI8 reverse phase
column (Dynamax 300A, 25cm long, 4.7mm ID). Acetonitrile was
obtained from Rathburn Chemicals Limited, Scotland and trifluoroacetic
acid from BDH Ltd, Poole, England. All solvents and buffers were
membrane filtered (0.22pm, Sartorius).
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Freeze-dried collagen samples (lmg) were dissolved in 1ml of 0.1% (v/v)
trifluoroacetic acid. Samples were filtered using 0.22pm HPLC filters.
Filtered samples were injected and chromatographed at room temperature
on a C18 column that was equilibrated with 0.1% (v/v) TFA. A 120ml
gradient of 0-40% acetonitrile was delivered at a flow rate of lml/min.




2.5.1 Cell types used
The cells used in the experiments were:
a) L929 mouse connective tissue fibroblasts (Sandford et al., 1948;
kindly supplied by Professor M. Ferguson, Department of Cell and
Structural Biology, Manchester University).
b) Bovine Aorta Endothelial Cells (Booyse et al., 1975; BAEC, kindly
supplied by Dr. S.Srivastava, Bioengineering Department, University of
Strathclyde).
c) Rat Wound Fibroblasts (RWF) - see Materials & Methods 2.5.3.2
(Finesmith et al., 1990).
d) 3T3 mouse embryo fibroblasts (Todaro & Green 1962; also supplied
by ProfM Ferguson).
BAEC are a primary cell line and after a large number of passages they
become senescent. Therefore, cells used in the experiments were between
15 and 30 passages. RWF also senesce and were therefore only used up
until 10 passages. Different cell lines senesce at different rates, hence the
RWF and BAEC cell lines were used at different passage numbers. L929
cells are from an established cell line i.e. they have the potential to be
subcultured indefinitely in vitro, therefore the passage number of these
cell types is not thought to be important.
Fibroblasts and endothelial cells types were studied as both are essential
to wound healing (Clark 1996). It was also important to examine for
differences between cell lines, hence three types of fibroblast cell lines
were chosen in these studies.
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The cells were grown in 25cm cell culture flasks and incubated at 37 C
in a high humidity atmosphere containing 5% C02/95% air.
2.5.2 Cell Culture Reagents
All cell types were maintained in Dulbecco's modification of Eagle's
medium (DMEM) containing 10% foetal calf serum (FCS), 1%
penicillin/streptomycin solution, 1% glutamine and 9mM sodium
bicarbonate (GIBCO/BRL). The amount of FCS in the formula was
adjusted to 0% or 2% for the proliferation experiments. The medium was
stored at 4°C and used within one month of the preparation date.
Hank's balanced salt solution (HBSS), without calcium and magnesium
(GIBCO/BRL) was used to rinse cell monolayers before use. This is done
to remove traces of the serum which would inactivate the action of
trypsin, used to detach cell monolayers. Trypsin solution was prepared by
ten-fold dilution of 10X concentration of trypsin-EDTA (GIBCO/BRL)
with HBSS.
2.5.3 Isolation of Cells
2.5.3.1 Rat Wound Fibroblasts
These cells were isolated following the method of Finesmith et al.,
(1990.) Adult Wistar rats were implanted with four polyvinyl alcohol
sponge discs (1cm diam.) beneath the panniculus carnosus, next to the
body musculature. The sponges were removed after 10 days and placed in
20 mis DMEM containing 20% FCS and amphotericin (25pg/ml),
streptomycin (1,000 pg/ml) and penicillin (1,000 U/ml) and placed on ice.
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Under sterile conditions encapsulated adventitia were removed, and the
sponges were minced and placed in DMEM with 10% FCS, 200 units of
bacterial collagenase (Type 1A, Sigma), penicillin and streptomycin in the
above concentrations, and amphotericin (2.5ug/ml) at 37°C, in a 5% CO2
atmosphere. After 4 hrs, the minced sponges were agitated by pipetting,
and the resulting supernatants were centrifuged at 1,200 rpm, 25°C for 7
minutes. The pellets were resuspended in DMEM with 20% FCS and
antibiotics (penicillin, lOOU/ml; streptomycin, lOOpg/ml; amphotericin,
2.5pg/ml) and placed in 75cm2 flasks. After the first passage the cells
were grown in 10 mis DMEM with 10% FCS and antibiotics in the above
concentrations, with the omission of amphotericin.
2.5.4 Microwell Plate Cultures
Medium was aspirated from the confluent cell monolayers and replaced
by 5ml of HBSS added 5 minutes before removal. Trypsin solution (1ml)
was then added to the flask, which was incubated until all the cells had
rounded and detached from the flask surface. DMEM-10% FCS (20mls)
was added to the cell suspension to inhibit the trypsin. Cells were
centrifuged at 1,200 rpm for 5 minutes and washed twice in DMEM. A
haemocytometer (improved Neubauer) was used to count the number of
cells per millilitre, then the cell suspension was diluted with DMEM to
give the desired concentration (5,000 cells/well). lOOpl volumes of cell
suspension were added to a 96 well plate (Costar UK Ltd) using a
multichannel pipette with sterile tips. 96 well plates are used for ease of
handling and economy of scale. Cell proliferation or attachment assays
were then carried out, as described below.
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2.5.5 Effect of collagen peptide on cell proliferation
To test the effects of collagen peptides on the proliferation of endothelial
cells and fibroblasts, the cells were prepared as before (section 2.5.2),
then suspended in DMEM containing 2% FCS and counted using a
haemocytometer. Cells were seeded at 5,000 cells per 96-well plate and
allowed to attach overnight to the tissue culture plastic. The collagen
fragments were then tested for their effect on cell proliferation over a
range of concentrations (lpg/ml-lOOpg/ml).
Collagen peptides, dissolved in DMEM containing 2% FCS and filter
sterilised, were incubated with adherent cells for 1, 2 and 5 days. Cell
number was then assessed using the Methylene Blue Assay (section 2.5.7)
and cell growth in the presence of collagen peptides expressed as a
percentage of cell growth in control cultures containing 2% DMEM.
Other controls used were DMEM containing no FCS (0%) as a negative
control and DMEM containing 10% FCS as a positive control. The cells
used in these experiments are grown in DMEM. These cells grow best
when the media is supplemented with 10% serum. This has been
considered the positive control in many experiments. Less serum is
needed in order to slow growth e.g. 2%. Cells grown with DMEM only
(0% serum added) have been used as negative controls, as cells grow
extremely slowly without the addition of serum. Cells grown in 2% serum
give optimal conditions for monitoring the effects of collagen peptides on
growth.
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2.5.6 Effect of collagen peptide on cell attachment
Cells were prepared as for the proliferation assay. Here both collagen
peptide preparations, dissolved in DMEM containing 2% FCS, plus cells
were added to the plates at the same time. The cells were then allowed to
attach to the tissue culture plastic for 0, 30, 60, 90, 120, 180 and 240
minutes. Attachment was then determined again using the Methylene Blue
Assay and attachment in the presence of collagen peptides was assessed
by comparison to control cells grown only in the presence of 2% DMEM.
2.5.7 Methylene Blue Assay
This is a method described by Oliver et al., 1989. At pH 8.4 methylene
blue is a basic dye that is positively charged. It binds to anionic groups in
fixed cell monolayers i.e. phosphate in DNA and RNA, and
phosphorylated proteins. Hence the amount of dye binding varies from
one cell type to another. The addition of HC1 lowers the pH to below pH
2 causing protonation of the acidic groups and liberation of the dye into
the elution solvent. Methylene Blue solution does not obey Beer's Law in
aqueous solution at low pH due to the formation of dimers. When ethanol
is added to the HC1, dimer formation is suppressed and Beer's Law is
obeyed.
Cell layers were fixed in a 96 well microwell plate with lOOpl methanol
for 5 minutes. These were then stained with lOOpl Methylene Blue (0.1%
(w/v) in lOmM borate buffer, pH 8.4) for 30 mins. The dye was rinsed
until clear with 400pl of lOmM borate buffer three times. Methylene Blue
was eluted from cell layers with lOOpl of 0.1M HC1 containing 20%
ethanol. The absorbance at 630nm was measured using a Dynatech
automated multichannel spectrophotometer. The mean, standard
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deviation and standard error for each sample (n=6) were calculated. To
test for statistical significance t-Test analysis was carried out comparing
each sample with the DMEM+2%FCS control. Six samples (n=6) were
required to obtain minimum standard deviation.
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2.6 CHEMOTAXIS
2.6.1 Boyden Chamber Assay {in vitro assay)
Chemotaxis of cells through Millipore filters was quantified by the
modified Boyden Chamber technique (Falk et al., 1980) using a
Neuroprobe 48-well microchemotaxis chamber. The original membrane
technique was first described by Boyden in 1962. This is a specially
designed chamber consisting of two compartments separated by a porous





Cells were prepared as before (see section 2.5.4), 50pl of 4 x 10^ cells/ml
in DMEM, and placed in the top compartment. The putative attractant
(27pil) was added to the lower compartment.
Samples being tested must contain at least 50% serum-free maintenance
medium (DMEM), as the samples should be in the same solution as the
cells. Glycylglycine-buffered saline (GGBS; 0.015M glycylglycine/0.14M
NaCl) pH 7.2 was used to dilute and suspend test samples (fibroblasts
migrate better in this compared to other saline solutions; Postlethwaite &
Kang 1988). Therefore each sample was prepared in 50% GGBS + 50%
DMEM. 27pl of each test sample was added to the Boyden Chamber
wells. A polyvinylpyrrolidone (PVP)-free polycarbonate filter (Co-Star)
was placed over the samples. A rubber gasket was put over the filter and










Figure 2.2: Boyden Cheraotaxis Chamber
Cells are introduced into the upper chamber. Cells respond to a concentration
gradient when a putative attractant placed in the lower chamber diffuses through the
filter into the upper chamber. Cells reaching the bottom surface of the membrane are
fixed, stained and counted.
37°C to reach temperature equilibrium. The fibroblasts were then added
to the top chamber (50pl) and incubated for 2.5 hours in a C02 incubator.
The filter was then removed and dipped in H20 to remove non-attached
cells. Attached cells were fixed in methanol and stained with Diff-Quick, a
modified Giemsa stain. The membrane was then dried on a glass slide.
Cells were counted at x40 magnification. Twenty fields of view were
required to give an accurate mean value for the number of cells counted.
All samples were tested in triplicate and this was repeated three times on
separate occasions. The SEM was calculated for each sample.
DMEM+GGBS was used as a negative control to account for random
cellular migration.
2.6.2 Checkerboard assay
Most chemoattractants can increase both directed (chemotaxis) and
random (chemokenesis) motility of responding cells, but these can be
distinguished by using the Checkerboard assay of Zigmond and Hirsch
(1973). In this assay cells are set as described for the Boyden Chamber
Assay. The cells are exposed to:
1) A range of attractant concentrations but no gradient (this
provides a dose-response curve for non-chemotactic effects of the
attractant).
2) A range of positive gradients
3) A range of negative gradients.
If the factor has a chemotactic effect, cells would be expected to
penetrate deeper into the filter in 2 than in 1, and less far into the filter in
3 than in 1. Here the concentration gradient of the putative attractant is
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varied in the upper and lower compartments of the chamber. Chemicals
that stimulate migration equally when placed in an equal concentration
below and above the filter are characterised as affecting random motility.
Attractants that are much more potent when placed below the filter are
judged to elicit true directed motility.
In the top wells of the chamber, various concentrations of the collagen
peptides (lOOng/ml-lOpg/ml) were applied together with fibroblasts at a
concentration of 4 x lO^/ml (total volume 50pl). In the bottom wells, the
same concentrations of the peptides (27pl) were placed such that several
possible concentrations above and below the filter were tested. Each
combination was tested in triplicate. Filters were stained and cells counted
as for the chemotaxis assay.
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2.7 PVA SPONGE MODEL FOR CELLULAR INFILTRATION
2.7.1 PVA Sponge Preparation
PVA (polyvinyl alcohol) is used as an inert substance which is porous and
allows cells to migrate into it, therefore it can be used to measure cellular
infiltration. Sponges were prepared and sterilised prior to implantation
into rats. The sponges were cut to a uniform size (1cm diameter) and
weighed. Thus the dimensions of the sponges are controlled prior to their
implantation and therefore the invasion of granulation tissue is not
affected by this parameter. 1cm discs were bored out of a PVA block
using an electric drill and cork borer and then saturated with water. These
were then dried in an oven and weighed. Sponges in the 14-20mg range
were used for implantation. The sponges were washed overnight in tap
water, then in deionised water prior to autoclaving. They were then ready
to be implanted.
2.7.2 Implantation Method
PVA sponges were implanted subcutaneously into adult male Wistar rats
(4 sponges per rat, 2 per side). Five rats were used at each time point for
each sample under investigation. Three days after implantation, two
sponges per rat were injected with 0.1ml of collagen peptide sample
(conc. varying from 100pg/ml-3mg/ml) and two sponges with 0.1ml of
PBS control buffer. The rats were killed at days 7 and 10 and the sponges
removed.
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2.7.3 Homogenisation and preparation of PVA sponges for analysis
The PVA sponges were prepared for biochemical and histological
analysis. Immediately after the sponges were removed from the rats the
adventitious tissue was removed. The sponges were kept on ice at all
times in order to restrict degradation of protein and DNA. The sponges
were halved and weighed, one half for histology, the other for
biochemical analysis (protein, DNA and collagen). The sponges were
homogenised using an Ultraturrax blade followed by centrifugation
(3,000rpm, 25°C for 15mins). 2ml of the supernatant was removed for
the hydroxyproline assay and the remainder was used for DNA and
protein assays.
2.7.4 Histology
Histological analysis of extracted sponges was kindly carried out by
Stirling Royal Infirmary. Each sponge was assessed for content of
granulation tissue (a loose collection of fibroblasts, inflammatory cells and
neovasculature) by examining Haemotoxylin and Eosin (H&E) stained
sections of each sponge. Haematoxylin binds to nucleic acids, allowing
them to be visualised; the eosin is then used as a counter stain to highlight
other components, such as mitochondria and cytoplasmic constituents
(Young & Heath 2000). Three sections of each sponge were cut at 50pm
intervals over a total distance of 100pm. The granulation tissue in each
set of sponges (control against collagen peptide) was assessed
microscopically by comparing the content of the sponge containing the
peptide to those containing PBS control.
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2.7.5 Biochemical Testing
2.7.5.1 Assay for Protein
The method used for determination of protein content in the PVA
sponges after their removal from rats was based on that of Bradford
(1976). This assay is based on the principle that the binding of the dye to
any protein present in the sample causes a shift in the absorption
maximum of the dye from 465nm (red form) to 595nm (blue form). Serial
dilutions of protein standards (BSA, Sigma) were prepared, from which a
standard curve was produced. Protein concentrations in the sponge
samples could be calculated from this. 5ml of protein binding dye was
added to 50pl of each sample in triplicate, the sample was vortexed and
its absorbance read at 595nm.
2.7.5.2 Assay for DNA
The method used to determine the DNA content in the PVA sponges is
described by Gendimenco et al., (1988). This method is a modification of
the diphenylamine colorimetric assay (Burton 1956). A coloured solution
absorbing maximally at 600nm is produced by reacting acid-hydrolysed
DNA with phenylamine in the presence of sulphuric acid, acetic acid and
acetaldehyde. Serial dilutions of calf thymus DNA (Sigma) were prepared
from which a standard curve was produced. 0.5mg of samples were
resuspended in 0.5mls of 0.5M perchloric acid and then heated at 90°C
for 30mins. Aliquots (50pl) of samples and standards were added in
triplicate to 96-well plates, and 100pi of diphenylamine colour reagent
was added to each. The plates were sealed and incubated at 37°C
overnight. The absorbance at 600nm was measured using a Dynatech
automated multichannel spectrophotometer. From these values and the
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standard curve the DNA content ofPVA sponges could be derived.
2.7.5.3 Assay for Collagen
Hydroxyproline is an amino acid unique to collagen and therefore its
estimation gives an accurate estimate of the collagen content in the
sample. The hydroxyproline content was determined using HPLC of
dansylated amino acids where it was also possible to determine the
concentration of proline (Negro et al., 1987). Hydroxyproline
concentrations are different for each collagen type e.g. 14.2% in collagen
I and 17.23% in collagen III (Miller & Gay 1982).
Sponge samples were hydrolysed in 6M HC1 overnight at 105°Cin sealed
tubes. Samples were dissolved in 0.25ml lithium borate buffer. Samples
were then dried with compressed nitrogen in a fume hood, filtered
(0.45pm filter) and dansylated before being loaded onto the HPLC
autosampler in preparation for analysis. Hydroxyproline standards were
prepared and analysed in order for a standard curve to be formed from
which the levels of hydroxyproline and hence collagen, in the sponges
could be calculated. The HPLC column used was Spherisorb CI8 column
ODS, 3 pm, (25cm x 4.6mm). The mobile phase used was 86% (25mM
acetic acid + 25mM sodium dihydrogen orthophosphate) and 14%
acetonitrile. The amino acids were washed from the column with
acetonitrile and the derivatised amino acids were detected by UV
absorbance at 254nm.
66
2.8 AMINO ACID SEQUENCING
The isolated active collagen peptide was subjected to automated
sequencing on an Applied Biosystems Model 477A Microsequencer with
a Model 120A on-line phenylthiohydantoin (PTH) analyser (Hayes et al.,
1989). This process was carried out by Dr. A Cronshaw, Edinburgh
University. Applied Biosystems chemicals were used throughout this
procedure.
2.9 SYNTHETIC PEPTIDE SYNTHESIS
The collagen peptide with the strongest chemotactic properties was
synthesised by the Chemistry Department, University of Edinburgh on a
fully automated Applied Biosystems 43OA peptide synthesiser. The
FmocABu based method of peptide synthesis was used which involves the
use of the base-labile 9-fluorenylmethoxycarbonyl Na protecting group in
conjunction with acid-labile side protection and peptide-resin linkage
(Carpino & Han 1972). The following protecting groups were used;
Hyp(OtBu), Glu(OtBu), Arg(Pmc). Gin was incorporated without side
chain protection. The peptide was synthesised on a 0.25mM scale using
Fmoc-Glycine functionalised 4-alkoxybenzylalcohol (Wang) resin and all
amino acids were incorporated using double coupling cycles. Each
synthetic cycle involved 1) treatment with acetic anhydride (to cap any
free amino groups prior to Na deprotection), 2) Fmoc removal by
treatment with the organic base piperidine and 3) coupling of the next
amino acid in the sequence. In this way the desired peptide was built up
from the C to N terminus. The peptide was then cleaved from the resin
with simultaneous removal of side chain protecting groups by treatment
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with a mixture of TFA/ethanedithiol/triisopropylsilane/thioanisole and
water for 3 hours at room temperature. The resin was then removed by
filtration, the TFA evaporated and the peptide isolated by precipitation
with diethyl ether and filtration. The crude peptide was then purified by
reverse phase HPLC and lyophilised. Laser Desorption Mass Spectrum
and analytical HPLC were carried out on the pure peptide.
2.10 STATISTICAL SIGNIFICANCE
Statistical significance was set at a p value of less then 0.05, and
described as highly significant at a p value of less then 0.01.
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CHAPTER 3:
BIOLOGICAL EFFECTS OF COLLAGEN I AND III
CNBr PEPTIDES
3.1 INTRODUCTION
Collagen is a protein present throughout the animal world and is the main constituent
of skin. Cell-collagen interactions are essential to cell movements in inflammation,
wound healing, trophoblast implantation, fetal development and cancer (Minafra et
al., 1985). Collagen Types I, II and III and their derived-peptides have been shown to
be chemotactic towards a variety of cell types (see Chapter 1.3.3.3).
Cyanogen bromide (CNBr) cleavage of collagen chains and tryptic cleavage of
individual CNBr peptides was used to prepare fragments for structural microanalysis.
The action of CNBr upon proteins is unique in its selective attack on methionine
residues (Gross 1967).
Cyanogen-bromide-derived peptides from collagen have been shown to have
biological activities in vitro. An example of this is their effects on the attachment and
migration of neural crest cells (Perris et al., 1993). In addition, peptides CB3, CB6,
CB7, CB8 from the collagen al(I) chain and CB3 and CB4 from the al chain of
collagen III support platelet adhesion (Saelman et al., 1993), with al(I) CB3 showing
the greatest activity. Figure 3.1 illustrates the number of residues of the major
peptides from human collagen a 1(1) and collagen III after cleavage by cyanogen
bromide.
The aim of this study was to isolate and purify the major CNBr peptides of Types I
and III collagen and to test these fragments for their effects on cell behaviour. In this
study cell proliferation and chemotaxis were examined.
70
al (I) chain
Peptideno. _^.0,1 2 4 5
N-terminus —► " C-terminus




No. of residues ^
3 7 6 1 8 10 2
C-terminus
92 37 99 125 40 149 237 236
FIGURE 3.1: Diagram to illustrate the positions of the CNBr peptides in collagen
al(I) and al(III) chains (Zijenah & Barnes 1990).
On top of the line the CNBr peptide number is shown, and below the line are the
corresponding number of residues.
3.2 PURIFICATION AND CHARACTERISATION OF COLLAGENS I AND
III
Collagens I and III are the predominant collagens in skin. Skin, therefore, can be used
as an extremely inexpensive source of collagen, with high availability. Collagens I and
III were isolated from porcine skin, as this skin was readily available and inexpensive.
It is more difficult to obtain human skin in high amounts and also due to current
health and safety considerations it was thought best to minimise the usage of human
products as far as possible.
Collagens I and III were isolated from porcine skin (see Section 2.1) by a method of
limited pepsin digestion and salt precipitation (Miller & Gay, 1982). The freeze-dried
collagens were then analysed by SDS-PAGE on an 8% gel (Figure 3.2) and found to
consist of the al(I), a2(I) and al(III) bands. In Figure 3.2 the a components from
Type I and III collagens are shown. The P and T components are also shown higher
up the gel. In lane 3 of Figure 3.2, two bands were observed which correspond to
a 1(1) and a2(I) chains. In lane 4, one band was observed which corresponds to the
a(III) chain. This is the same protein profile as seen by Bateman et al., 1986.
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1 2 3 4
FIGURE 3.2: Separation of Collagens I and III by SDS-PAGE
Collagens I and III were isolated from porcine skin by pepsin digestion and salt
precipitation (Miller & Gay, 1982). The separated collagens were analysed on
SDS-PAGE. The a, (3 and y components are shown.
Lanes Key:
1 - Type I (10pg)
2-Type III (lOpg)
3 - Type I (lOOpg)
4 - Type III (lOOpg)
3.3 DIGESTION BY CNBr
After the purification of Collagens I and III, proteins were digested with CNBr in
order to provide peptides which could then be tested for their specific activities in this
study.
The method in brief is as follows, Collagens I and III from pig skin (section 2.3.1),
were dissolved in 70% formic acid (2mg collagen/ml acid) and then digested
overnight in CNBr (lmg protein/2mg CNBr). Analysis by SDS-PAGE was carried
out and results are shown in Figures 3.3 & 3.4
3.4 ISOLATION OF PEPTIDES
One of the aims of this study was to isolate and test the major collagen al(I) CNBr
peptides for their effects on cell proliferation and chemotaxis. To isolate the CNBr
collagen-peptides, the CNBr digests were fractionated, by cation-exchange FPLC
(Section 2.3.2) according to the method of Bateman et al. (1986). Results are shown
in Figures 3.5 and 3.6. The first peak was due to unbound material passing through
the column, whilst the last peak was due to undigested collagen being eluted. There
was no need to separate the a 1(1) and a2(I) chains before CNBr digestion since their
CNBr-peptides have different molecular weights and would be separated after the
FPLC (Bateman et al., 1986). Quantitation of purified CNBr collagen peptides was
based on the Sircol Collagen Assay (Section 2.3.3). Approx. 30-50pg of each CNBr
peptide was purified per FPLC run.
Collagens I and III a chains have been successfully separated by CM-cellulose cation
exchange chromatography by Piez et al., (1963). However, this technique is tedious
and the eluted chains and the peptides are excessively diluted so that fractions must be
desalted and concentrated before further analysis. In contrast, a Mono-S cation-
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Figure 3.3: Separation of CNBr Peptides of Collagen 1 by SDS-PAGE
Collagen I was digested with CNBr and then fractionated by cation-
exchange FPLC, as for method Bateman et al., 1986. The separated CNBr
peptides were then analysed on SDS-PAGE
Lane Key:
1 - Crude Digest
2+6 - CB3 -13kDa
3 - CB7 -25kDa
4 - CB8 -24kDa
5 - Crude Digest
7 - MolecularWeight Standards
8 - CB6 -17.5kDa
1 2 3 4 5 6
Figure 3.4: Separation of CNBr Peptides from Collagen III by SDS-PAGE
Collagen III was digested with CNBr and then fractionated by cation-exchange FPLC,
as for method Bateman et al., 1986. The separated CNBr peptides were analysed on
SDS-PAGE.
Lanes Key:
1 - Crude Digest
2 - Crude Digest
3 - CB5 - 29kl)a
4 - CB8 - 11.5kDa
5 - CB4 - 15kDa
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Figure 3.5: FPLC fractionation of porcine collagen al(I) CNBr peptides by
Mono S cation-exchange chromatography
0.5mg/ml of CNBr peptide was chromatographed at room temperature. A 65ml
linear gradient of 0.07 to 0.026M NaCl in 0.02M sodium formate, pH 3.8, was
delivered at a flow rate of lml/min. Absorbances were measured at 214nm.
Time (mins)
Figure 3.6: FPLC fractionation of porcine collagen al(III) CNBr peptides by
Mono S cation-exchange chromatography
0.5mg/ml of CNBr peptide was chromatographed at room temperature. A 65ml
linear gradient of 0.07 to 0.026M NaCl in 0.02M sodium formate, pH 3.8, was
delivered at a flow rate of lml/min. Absorbances were measured at 214nm.
exchange column resolves all the major peptides in a rapid and reproducible fashion
(Bateman et al., 1986). The difficulties of separation of CB7 and CB8 have been well
documented (van der Rest & Fietzek 1982; van der Rest et al., 1980, Miller et al.,
1983). Pure peptides were produced except for al(I) CB7 and CB8, which also
contained some incompletely cleaved fragments. These large partially cleaved
peptides can be separated from CB7 and CB8 by gel permeation chromatography.
The method used in these experiments has been shown by Bateman et al., 1986, to
give the best separation.
3.5 IDENTIFICATION OF PEPTIDES BY SDS-PAGE
Peptides were analysed by SDS-PAGE (12% acrylamide) to confirm the identity and
purity of the separated CNBr peptides, as shown in Figures 3.3 & 3.4. Gels were
dried and analysed by scanning densitometry, purity was approximately 80%.
3.6 EFFECTS ON CELL PROLIFERATION
The isolated CNBr fragments CB3, 6, 7, 8 from Type I collagen and CB3, 4, 5, 8
from Type III collagen (see Figures 3.3-3.6) were examined for their ability to
stimulate both fibroblast (L929 cells and rat wound fibroblasts-RWF) and bovine
aorta endothelial cell (BAEC) proliferation. The cell line L929 comes from an
established cell line in mice and RWF cells come from a primary cell line. L929 is a
modified and established cell line that is far-removed in character from its original cell
origin. However, L929 cells are more robust and easy to handle and therefore were
used in the setting-up and standardisation of the assays. Rat wound fibroblasts are
nearer to the natural environment ofwound healing, and were investigated in parallel.
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Peptides at a range of concentrations (lpg-100pg/ml) were added to cell monolayers,
which were then incubated over one day, two day and five day periods. It was
decided to choose this range of concentrations with reference to previously published
work (Postlethwaite et al., 1978). Cells were set up in 96-well microplates for ease of
handling and economy of scale. The numbers of cells present were quantified using
the Methylene Blue dye-binding assay (Section 2.5.7; Oliver et al., 1989).
The Methylene Blue dye-binding assay (Oliver et al., 1989) was used to quantify cell
numbers after growth in the presence of collagen-derived peptides. Although, this
assay is reproducible, rapid, inexpensive and easy to perform, it does have limitations.
The automated microplate photometer for reading optical densities of cells restricts
the range of cell numbers that can be quantitated. As with all experiments, preliminary
experiments to optimise the assay conditions (e.g. cell density and culture conditions)
used were carried out.
The cells used in these experiments were grown in Dulbecco's Modified Eagle's
Media (DMEM). Optimum growth conditions were obtained when the media was
supplemented with 10% fetal calf serum (FCS). Therefore, the positive control was
DMEM + 10% serum. Less serum (2%) was used in order to obtain slower growth.
Cells grown in DMEM only i.e. Serum-free media (0% serum added) were used as
negative controls. Cell growth is dependent upon seeding density and the
concentration of serum in culture medium (Laurent et al 1989). In order to optimise
cell culture conditions for this assay it was found that cells seeded at 5000 cells/well
and cells supplemented with 2% serum gave the best conditions for assaying the
effects of collagen peptides on cell proliferation. Cell growth in the presence of
collagen peptides was calculated as a percentage of cell growth in DMEM containing
2% FCS. Cells grown in 10% serum give higher values, however to see an effect with
these peptides, too high a count was obtained to measure in this study. Cells were
overgrowing and detaching from the cell sheet. As optimal results were seen with 2%
serum, this concentration was used as a standard. All results (including positive and
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negative controls) are shown in Chapter 3.
3.6.1 Collagen I CNBr peptides [al(I)]
Collagen I CNBr-derived peptides (in DMEM + 2% serum) were added to cells
(L929, RWF and BAEC) and the effect on cell proliferation/growth studied over a 5
day period. The results from these experiments are shown below.
Cell proliferation in the presence of al(I) CB8, on the three cell types was studied.
Results for these experiments are recorded in Tables 3.1-3.3 and graphically shown in
Figure 3.7. At 10pg/ml after 5 days, growth of both L929 and RWF cells was
increased by almost 40%, while BAEC cell growth was increased by approximately
60%. These were highly statistically significant (Altman 1994). After 2 days, growth
was increased by 53% in BAEC, 20% in RWF and 12% in L929 cells. However, after
the first day of growth in the presence of CB8, growth in all three cell lines was
inhibited. Growth in the presence of CB8 was concentration dependent, 1Opg/ml
giving optimum BAEC cell proliferation (Figure 3.8).
Cell proliferation in the presence of al(I) CB3, on the three cell types was studied.
Peptide CB3 at a concentration of 100p.g/ml increased growth of both BAEC and
RWF cells as shown in Tables 3.4-3.6 and graphically in Figure 3.9. Growth was
increased by almost 20% after 5 days which was statistically significant. After 2 days,
there was no increase in growth in any of the cell lines and after 1 day, growth was
inhibited in all three cell lines. Growth in the presence of CB3 was concentration
dependent, optimum growth occurring at lOOpg/ml (Figure 3.10).
Peptide CB7 at a concentration of lOOpg/ml increased cell growth in BEAC and
RWF cells as shown in Tables 3.7-3.9 and these results are represented in graphical
form in Figure 3.11. After 5 days, BAEC cell growth was increased by 14% and RWF
growth was increased by 20%. Cell growth was not increased after 2 days in any of
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BAEC 0% serum 2% serum 10% serum 2% serum
+CB8
Day 1 0.745 0.903 1.450 0.799
(0.03) (0.02) (0.01) (0.04)
Day 2 0.778 1.147 1.964 1.757
(0.02) (0.02) (0.01) (0.05)
Day 5 1.010 1.384 2.114 2.220
(0.03) (0.08) (0.09) (0.02)
Table 3.1: Effects ofal(I) CB8 on BAEC proliferation.
CB8 at lOpg/ml was added to cell line BAEC (in DMEM supplemented with 2 % serum) and
growth after 1, 2 and 5 days was measured using the Methylene Blue assay. The data above
represents absorbances at 630nm. Standard errors are shown (brackets). Control values are
shown. Negative control - cells grown in DMEM only (0% serum). Positive control - cells grown
in DMEM with 10% serum.
L929 0% serum 2% serum 10% serum 2% serum
+CB8
Day 1 0.780 0.910 1.415 0.862
(0.04) (0.03) (0.09) (0.03)
Day 2 0.825 1.050 1.995 1.171
(0.06) (0.02) (0.06) (0.02)
Day 5 1.036 1.703 2.698 2.375
(0.01) (0.04) (0.06) (0.06)
Table 3.2: Effects ofal(I) CB8 on L929 proliferation.
CB8 at 10p.g/ml was added to L929 cells (in DMEM supplemented with 2 % serum) and growth
after 1, 2 and 5 days was measured using the Methylene Blue assay. The data above represents
absorbances at 630nm. Standard errors are shown (brackets). Control values are shown. Negative
control - cells grown in DMEM only (0% serum). Positive control - cells grown in DMEM with
10% serum.
RWF 0% serum 2% serum 10% serum 2% serum
+CB8
Day 1 0.301 0.547 0.899 0.420
(0.02) (0.04) (0.06) (0.09)
Day 2 0.336 0.610 0.980 0.730
(0.03) (0.04) (0.03) (0.03)
Day 5 0.480 0.950 1.504 1.30
(0.06) (0.04) (0.07) (0.04)
Table 3.3: Effects ofal(I) CB8 on RWF proliferation.
CB8 at lOpg/ml was added to RWF cells (in DMEM supplemented with 2 % serum) and growth
after 1, 2 and 5 days was measured using the Methylene Blue assay. The data above represents
absorbances at 630nm. Standard errors are shown (brackets). Control values are shown. Negative
control - cells grown in DMEM only (0% serum). Positive control - cells grown in DMEM with
10% serum.
DAY
FIGURE 3.7: Effects of al(I) CB8 on cell proliferation
The cell lines used were BAEC, L929 and RWF. Peptide CB8 was added at a
concentration of lOpg/ml and the growth of the three cell types was measured
over 5 days. Cells were seeded at a density of 5000 cells/well in 96-microwell
plates containing lOOpl of DMEM + 2% FCS. Each value represents the
mean of 6 wells (Student's t-Test). Standard errors are shown, *p<0.05,
**p<0.01.
Cone. ( ftg/ml)
FIGURE 3.8: Dependence of BAEC proliferation on the concentration of
a 1(1) CB8
Optimum proliferation (after 5 days) of BAEC occurs at a peptide concentration
of lOpg/ml. Cells were seeded at a density of 5000 cells/well in 96-microwell
plates containing lOOpl of DMEM + 2% FCS. Each value represents the mean
of 6 wells (Student's t-Test). Standard errors are shown.
BAEC 0% serum 2% serum 10% serum 2% serum
+CB3
Day 1 0.690 0.803 1.185 0.676
(0.01) (0.01) (0.02) (0.02)
Day 2 0.700 0.829 1.272 0.800
(0.02) (0.02) (0.02) (0.02)
Day 5 0.998 1.46 2.008 1.697
(0.03) (0.02) (0.02) (0.02)
Table 3.4: Effects of al(I) CB3 on BAEC proliferation.
CB3 at lOOpg/ml was added to cell line BAEC (in DMEM supplemented with 2 % serum) and
growth after 1, 2 and 5 days was measured using the Methylene Blue assay. The data above
represents absorbances at 630nm. Standard errors are shown (brackets). Control values are
shown. Negative control - cells grown in DMEM only (0% serum). Positive control - cells grown
in DMEM with 10% serum.
L929 0% serum 2% serum 10% serum 2% serum
+CB3
Day 1 0.894 1.200 1.576 1.117
(0.01) (0.02) (0.03) (0.02)
Day 2 0.921 1.379 2.115 1.35
(0.02) (0.02) (0.05) (0.03)
Day 5 1.201 2.033 2.424 2.012
(0.03) (0.06) (0.1) (0.09)
Table 3.5: Effects ofal(I) CB3 on L929 proliferation.
CB3 at lOOpg/ml was added to L929 cells (in DMEM supplemented with 2 % serum) and growth
after 1, 2 and 5 days was measured using the Methylene Blue assay. The data above represents
absorbances at 630nm. Standard errors are shown (brackets). Control values are shown. Negative
control - cells grown in DMEM only (0% serum). Positive control - cells grown in DMEM with
10% serum
RWF 0% serum 2% serum 10% serum 2% serum
+CB3
Day 1 0.315 0.519 0.851 0.417
(0.02) (0.01) (0.1) (0.02)
Day 2 0.325 0.623 0.940 0.622
(0.03) (0.03) (0.03) (0.03)
Day 5 0.450 0.902 1.24 1.08
(0.02) (0.02) (0.05) (0.03)
Table 3.6: Effects of al(I) CB3 on RWF proliferation.
CB3 at lOOpg/ml was added to RWF cells (in DMEM supplemented with 2 % serum) and growth
after 1, 2 and 5 days was measured using the Methylene Blue assay. The data above represents
absorbances at 630nm. Standard errors are shown (brackets). Control values are shown. Negative











































FIGURE 3.9: Effects of al(I) CB3 on cell proliferation
The cell lines used were BAEC, L929 and RWF. Peptide CB3 was added at a
concentration of lOOpg/ml and the growth of the three cell types was
measured over 5 days. Cells were seeded at a density of 5000 cells/well in 96-
microwell plates containing 100pi of DMEM + 2 FCS. Each value



























FIGURE 3.10: Dependence of BAEC proliferation on the concentration of
al(I) CB3
Optimum proliferation (after 5 days) of BAEC occurs at a peptide concentration
of lOOpg/ml. Cells were seeded at a density of 5000 cells/well in 96-microwell
plates containing lOOpl of DMEM + 2% FCS. Each value represents the mean
of 6 wells (Student's t-Test). Standard errors are shown.
BAEC 0% serum 2% serum 10% serum 2% serum
+CB7
Day 1 0.319 0.430 1.175 0.324
(0.04) (0.07) (0.07) (0.01)
Day 2 0.400 0.597 1.211 0.464
(0.02) (0.03) (0.05) (0.03)
Day 5 0.531 0.921 1.527 1.054
(0.02) (0.06) (0.07) (0.05)
Table 3.7: Effects ofal(I) CB7 011 BAEC proliferation.
CB7 at lOOpg/ml was added to cell line BAEC (in DMEM supplemented with 2 % serum) and
growth after 1, 2 and 5 days was measured using the Methylene Blue assay. The data above
represents absorbances at 630nm. Standard errors are shown (brackets). Control values are
shown. Negative control - cells grown in DMEM only (0% serum). Positive control - cells grown
in DMEM with 10% serum.
L929 0% serum 2% serum 10% serum 2% serum
+CB7
Day 1 0.347 0.610 1.262 0.611
(0.01) (0.02) (0.03) (0.04)
Day 2 0.468 0.630 1.277 0.669
(0.03) (0.01) (0.03) (0.01)
Day 5 0.724 1.441 2.485 1.457
(0.06) (0.07) (0.04) (0.06)
Table 3.8: Effects of a 1(1) CB7 on L929 proliferation.
CB7 at lOOpg/ml was added to L929 cells (in DMEM supplemented with 2 % serum) and growth
after 1, 2 and 5 days was measured using the Methylene Blue assay. The data above represents
absorbances at 630nm. Standard errors are shown (brackets). Control values are shown. Negative
control - cells grown in DMEM only (0% serum). Positive control - cells grown in DMEM with
10% serum.
RWF 0% serum 2% serum 10% serum 2% serum
+CB7
Day 1 0.349 0.578 1.204 0.560
(0.01) (0.05) (0.07) (0.01)
Day 2 0.467 0.869 1.999 0.978
(0.03) (0.02) (0.05) (0.02)
Day 5 0.692 1.807 2.455 2.158
(0.04) (0.06) (0.04) (0.02)
Table 3.9: Effects of al(I) CB7 on RYVF proliferation.
CB7 at lOOpg/ml was added to RWF cells (in DMEM supplemented with 2 % serum) and growth
after 1, 2 and 5 days was measured using the Methylene Blue assay. The data above represents
absorbances at 630nm. Standard errors are shown (brackets). Control values are shown. Negative



































FIGURE 3.11: Effects ofal(I) CB7 on cell proliferation
The cell lines used were BAEC, L929 and RWF. Peptide CB7 was added at a
concentration of lOOpg/ml and the growth of the three cell types was
measured over 5 days. Cells were seeded at a density of 5000 cells/well in 96-
microwell plates containing lOOpl of DMEM + 2% FCS. Each value
represents the mean of 6 wells (Student's t-Test). Standard errors are shown,
*p<0.05, **p<0.01.
the cell lines. After day one, BAEC cell growth was inhibited.
Peptide CB6 had no significant effect on cell proliferation/growth on any of the cell
types and at any of the concentrations tested. Results are shown in Tables 3.10-3.12.
Figure 3.12 shows the effect ofCB6 at lOOpg/ml.
3.6.2 Collagen III CNBr peptides [al(III)]
Similarly, Collagen III CNBr-derived peptides were examined for their effects on the
proliferation/growth of BAEC, L929 and RWF cell lines. The results are shown
below.
Peptide CB4 significantly stimulated cell growth in L929 and BAEC cells as shown in
Tables 3.13-3.15 and Figure 3.13. At a concentration of lng/ml after 5 days of
growth, L929 growth was stimulated by 35% and BAEC cells stimulated by 13%
(Figure 3.13). This was highly significant. The effect was concentration dependent
(Figure 3.14), proliferation being optimum at lng/ml. Higher concentrations were
inhibitory. RWF cell growth was not increased after 5 days. After 2 days, RWF and
BAEC growth was inhibited. After day 1, all three cell line's growth was inhibited
(Figure 3.13).
CB8 increased growth of all cell types tested as shown in Tables 3.16-3.18 and Figure
3.15. After 5 days, BAEC growth increased by 19%, RWF growth increased by 15%
and L929 growth increased by 13%. Growth was inhibited in all three cell lines after
days 1 and 2. Growth of BAEC cells was concentration-dependent, optimum growth
occurring at a concentration of lng/ml (Figure 3.16).
CB5 and CB3 had no biologically significant effects on cell proliferation/growth as
shown in Tables 3.19-3.24 and Figures 3.17 & 3.18.
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BAEC 0% serum 2% serum 10% serum 2% serum
+CB6
Day 1 0.451 0.648 1.200 0.618
(0.01) (0.03) (0.02) (0.04)
Day 2 0.563 0.860 1.272 0.811
(0.03) (0.02) (0.02) (0.04)
Day 5 0.885 1.599 2.008 1.598
(0.06) (0.02) (0.02) (0.01)
Table 3.10: Effects ofal(I) CB6 on BAEC proliferation.
CB6 at lOOpg/ml was added to cell line BAEC (in DMEM supplemented with 2 % serum) and
growth after 1, 2 and 5 days was measured using the Methylene Blue assay. The data above
represents absorbances at 630nm. Standard errors are shown (brackets). Control values are
shown. Negative control - cells grown in DMEM only (0% serum). Positive control - cells grown
in DMEM with 10% serum.
L929 0% serum 2% serum 10% serum 2% serum
+CB6
Day 1 0.359 0.617 1.216 0.650
(0.06) (0.01) (0.04) (0.03)
Day 2 0.480 0.793 1.452 0.855
(0.03) (0.02) (0.02) (0.09)
Day 5 0.703 1.514 2.289 1.595
(0.01) (0.04) (0.05) (0.03)
Table 3.11: Effects ofal(I) CB6 on L929 proliferation.
CB6 at 1 OOpg/ml was added to L929 cells (in DMEM supplemented with 2 % serum) and growth
after 1, 2 and 5 days was measured using the Methylene Blue assay. The data above represents
absorbances at 630nm. Standard errors are shown (brackets). Control values are shown. Negative
control - cells grown in DMEM only (0% serum). Positive control - cells grown in DMEM with
10% serum.
RWF 0% serum 2% serum 10% serum 2% serum
+CB6
Day 1 0.325 0.469 0.948 0.450
(0.02) (0.01) (0.05) (0.05)
Day 2 0.415 0.597 1.175 0.597
(0.02) (0.07) (0.2) (0.02)
Day 5 0.589 0.942 1.492 0.985
(0.04) (0.04) (0.06) (0.09)
Table 3.12: Effects ofal(I) CB6 on RWF proliferation.
CB6 at 100jig/ml was added to RWF cells (in DMEM supplemented with 2 % serum) and growth
after 1, 2 and 5 days was measured using the Methylene Blue assay. The data above represents
absorbances at 630nm. Standard errors are shown (brackets). Control values are shown. Negative




FIGURE 3.12: Effects ofal(I) CB6 on cell proliferation
The cell lines used were BAEC, L929 and RWF. Peptide CB6 was added at a
concentration of 100pg/ml and the growth of the three cell types was
measured over 5 days. Cells were seeded at a density of 5000 cells/well in 96-
microwell plates containing lOOpl of DMEM + 2% FCS. Each value
represents the mean of 6 wells (Student's t-Test). Standard errors are shown,
*p<0.05, **p<0.01.
BAEC 0% serum 2% serum 10% serum 2% serum
+CB4
Day 1 0.423 0.729 1.135 0.524
(0.01) (0.01) (0.02) (0.01)
Day 2 0.510 0.835 1.329 0.750
(0.02) (0.02) (0.03) (0.02)
Day 5 0.563 1.505 2.015 1.700
(0.01) (0.03) (0.04) (0.03)
Table 3.13: Effects ofal(III) CB4 on BAEC proliferation.
CB4 at lng/ml was added to cell line BAEC (in DMEM supplemented with 2 % serum) and growth
after 1, 2 and 5 days was measured using the Methylene Blue assay. The data above represents
absorbances at 630nm. Standard errors are shown (brackets). Control values are shown. Negative
control - cells grown in DMEM only (0% serum). Positive control - cells grown in DMEM with
10% serum.
L929 0% serum 2% serum 10% serum 2% serum +
CB4
Day 1 0.526 0.685 1.213 0.575
(0.01) (0.01) (0.03) (0.01)
Day 2 0.627 0.821 1.456 1.020
(0.03) (0.02) (0.04) (0.02)
Day 5 0.698 1,426 2.231 1.930
(0.02) (0.03) (0.04) (0.04)
Table 3.14: Effects ofal(IU) CB4 on L929 proliferation.
CB4 at lng/ml was added to L929 cells (in DMEM supplemented with 2 % serum) and growth
after 1, 2 and 5 days was measured using the Methylene Blue assay. The data above represents
absorbances at 630nm. Standard errors are shown (brackets). Control values are shown. Negative
control - cells grown in DMEM only (0% serum). Positive control - cells grown in DMEM with
10% serum.
RWF 0% serum 2% serum 10% serum 2% serum
+CB4
Day 1 0.410 0.596 1.195 0.538
(0.01) (0.01) (0.04) (0.01)
Day 2 0.491 0.706 1.309 0.651
(0.01) (0.01) (0.05) (0.01)
Day 5 0.526 1.342 2.016 1.341
(0.03) (0.03) (0.03) (0.03)
Table 3.15: Effects ofal(IH) CB4 on RWF proliferation.
CB4 at lng/ml was added to RWF cells (in DMEM supplemented with 2 % serum) and growth
after 1, 2 and 5 days was measured using the Methylene Blue assay. The data above represents
absorbances at 630nm, Standard errors are shown (brackets). Control values are shown. Negative



















FIGURE 3.13: Effects of ccl(III) CB4 on cell proliferation
The cell lines used were BAEC, L929 and RWF. Peptide CB4 was added at a
concentration of lng/ml and the growth of the three cell types was measured
over 5 days. Cells were seeded at a density of 5000 cells/well in 96-microwell
plates containing lOOpl of DMEM + 2% FCS. Each value represents the































FIGURE 3.14: Dependence of L929 proliferation on the concentration of
a 1(111) CB4
Optimum proliferation (after 5 days) of L929 cells occurs at a peptide
concentration of 1 ng/ml. Cells were seeded at a density of 5000 cells/well in 96-
microwell plates containing lOOpl of DMEM + 2% FCS. Each value represents
the mean of 6 wells (Student's t-Test). Standard errors are shown.
BAEC 0% serum 2% serum 10% serum 2% serum
+CB8
Day 1 0.481 0.674 1.212 0.512
(0.01) (0.01) (0.02) (0.01)
Day 2 0.534 0.801 1.493 0.783
(0.03) (0.01) (0.03) (0.02)
Day 5 0.892 1.523 2.314 1.806
(0.03) (0.03) (0.02) (0.03)
Table 3.16: Effects ofal(III) CB8 on BAEC proliferation.
CBS at lng/ml was added to cell line BAEC (in DMEM supplemented with 2 % serum) and
growth after 1, 2 and 5 days was measured using the Methylene Blue assay. The data above
represents absorbances at 630nm. Standard errors are shown (brackets). Control values are
shown. Negative control - cells grown in DMEM only (0% serum). Positive control - cells grown
in DMEM with 10% serum.
L929 0% serum 2% serum 10% serum 2% serum
+CB8
Day 1 0.499 0.624 1.201 0.555
(0.05) (0.01) (0.04) (0.01)
Day 2 0.583 0.794 1.302 0.741
(0.03) (0.02) (0.02) (0.02)
Day 5 0.821 1.499 2.018 1.701
(0.01) (0.03) (0.05) (0.02)
Table 3.17: Effects ofal(III) CBS on L929 proliferation.
CBS at lng/ml was added to L929 cells (in DMEM supplemented with 2 % serum) and growth
after 1, 2 and 5 days was measured using the Methylene Blue assay. The data above represents
absorbances at 630nm. Standard errors are shown (brackets). Control values are shown. Negative
control - cells grown in DMEM only (0% serum). Positive control - cells grown in DMEM with
10% serum
RWF 0% serum 2% serum 10% serum 2% serum
+CB8
Day 1 0.333 0.521 0.986 0.443
(0.02) (0.01) (0.04) (0.01)
Day 2 0.402 0.600 1.149 0.544
(0.02) (0.01) (0.03) (0.01)
Day 5 0.516 0.956 1.483 1.101
(0.03) (0.02) (0.04) (0.02)
Table 3.18: Effects ofal(III) CB8 on RWF proliferation.
CB8 at lng/ml was added to RWF cells (in DMEM supplemented with 2 % serum) and growth
after 1, 2 and 5 days was measured using the Methylene Blue assay. The data above represents
absorbances at 630nm. Standard errors are shown (brackets). Control values are shown. Negative









































FIGURE 3.15: Effects of al(III) CB8 on cell proliferation
The cell lines used were BAEC, L929 and RWF. Peptide CB8 was added at a
concentration of lng/ml and the growth of the three cell types was measured
over 5 days. Cells were seeded at a density of 5000 cells/well in 96-microwell
plates containing lOOpl of DMEM + 2% FCS. Each value represents the







0.1 10 100 1000
Cone, (ng/ml)
FIGURE 3.16: Dependence of BAEC proliferation on the concentration
of al(III) CB8
Optimum proliferation (after 5 days) of BAEC occurs at a peptide
concentration of 1 ng/ml. Cells were seeded at a density of 5000 cells/well.
Cells were grown in microwell plates containing lOOpl ofDMEM + 2% FCS.
Each value represent the mean of 6 wells (student's t-Test). Standard errors
are shown.
BAEC 0% serum 2% serum 10% serum 2% serum
+CB3
Day 1 0.435 0.681 1.198 0.677
(0.02) (0.01) (0.03) (0.01)
Day 2 0.529 0.793 1.272 0.793
(0.02) (0.02) (0.03) (0.02)
Day 5 0.821 1.509 2.001 1.572
(0.03) (0.03) (0.06) (0.03)
Table 3.19: Effects ofal(lll) CB3 on BAEC proliferation.
CB3 at 100pg/ml was added to cell line BAEC (in DMEM supplemented with 2 % serum) and
growth after 1, 2 and 5 days was measured using the Methylene Blue assay. The data above
represents absorbances at 630nm. Standard errors are shown (brackets). Control values are
shown. Negative control - cells grown in DMEM only (0% serum). Positive control - cells grown
in DMEM with 10% serum.
L929 0% serum 2% serum 10% serum 2% serum
+CB3
Day 1 0.484 0.607 1.229 0.623
(0.02) (0.01) (0.04) (0.01)
Day 2 0.539 0.783 1.418 0.813
(0.01) (0.01) (0.04) (0.02)
Day 5 0.818 1.525 2.204 1.573
(0.03) (0.03) (0.06) (0.03)
Table 3.20: Effects of ccl(IIl) CB3 on L929 proliferation.
CB3 at lOOpg/ml was added to L929 cells (in DMEM supplemented with 2 % serum) and growth
after 1, 2 and 5 days was measured using the Methylene Blue assay. The data above represents
absorbances at 630nm. Standard errors are shown (brackets). Control values are shown. Negative
control - cells grown in DMEM only (0% serum). Positive control - cells grown in DMEM with
10% serum.
RWF 0% serum 2% serum 10% serum 2% serum
+CB3
Day 1 0.328 0.468 0.945 0.469
(0.01) (0.01) (0.03) (0.01)
Day 2 0.416 0.592 1.086 0.592
(0.01) (0.01) (0.05) (0.01)
Day 5 0.508 0.938 1.563 0.945
(0.02) (0.02) (0.07) (0.02)
Table 3.21: Effects ofal(III) CB3 on RWF proliferation.
CB3 atlOOpg/ml was added to RWF cells (in DMEM supplemented with 2 % serum) and growth
after 1, 2 and 5 days was measured using the Methylene Blue assay. The data above represents
absorbances at 630nm. Standard errors are shown (brackets). Control values are shown. Negative


































FIGURE 3.17: Effects of al(III) CB3 on cell proliferation
The cell lines used were BAEC, L929 and RWF. Peptide CB3 was added at a
concentration of lOOpg/ml and the growth of the three cell types was
measured over 5 days. Cells were seeded at a density of 5000 cells/well in 96-
microwell plates containing lOOpl of DMEM + 2% FCS. Each value
represents the mean of 6 wells (Student's t-Test). Standard errors are shown.
BAEC 0% serum 2% serum 10% serum 2% serum
+CB5
Day 1 0.441 0.641 1.119 0.666
(0.02) (0.01) (0.04) (0.01)
Day 2 0.561 0.864 1.273 0.891
(0.03) (0.02) (0.04) (0.02)
Day 5 0.874 1.600 1.936 1.631
(0.03) (0.03) (0.05) (0.03)
Table 3.22: Effects ofal(III) CB5 on BAEC proliferation.
CB5 at lOOpg/ml was added to cell line BAEC (in DMEM supplemented with 2 % serum) and
growth after 1, 2 and 5 days was measured using the Methylene Blue assay. The data above
represents absorbances at 630nm. Standard errors are shown (brackets). Control values are
shown. Negative control - cells grown in DMEM only (0% serum). Positive control - cells grown
in DMEM with 10% serum.
L929 0% serum 2% serum 10% serum 2% serum
+CB5
Day 1 0.386 0.617 1.204 0.617
(0.02) (0.01) (0.03) (0.01)
Day 2 0.491 0.784 1.413 0.800
(0.04) (0.02) (0.05) (0.02)
Day 5 0.601 1.419 2.184 1.450
(0.01) (0.03) (0.06) (0.03)
Table 3.23: Effects ofal(III) CB5 on L929 proliferation.
CB5 at lOOpg/ml was added to L929 cells (in DMEM supplemented with 2 % serum) and growth
after 1, 2 and 5 days was measured using the Methylene Blue assay. The data above represents
absorbances at 630nm. Standard errors are shown (brackets). Control values are shown. Negative
control - cells grown in DMEM only (0% serum). Positive control - cells grown in DMEM with
10% serum.
RWF 0% serum 2% serum 10% serum 2% serum
+CB5
Day 1 0.328 0.584 0.941 0.561
(0.01) (0.01) (0.03) (0.01)
Day 2 0.410 0.621 1.125 0.593
(0.01) (0.01) (0.04) (0.01)
Day 5 1U98 0.944 1.525 0.945
(0.02) (0.02) (0.06) (0.02)
Table 3.24: Effects ofal(III) CB5 on RWF proliferation.
CB5 at 1 OOpg/ml was added to RWF cells (in DMEM supplemented with 2 % serum) and growth
after 1, 2 and 5 days was measured using the Methylene Blue assay. The data above represents
absorbances at 630nm. Standard errors are shown (brackets). Control values are shown. Negative


























FIGURE 3.18: Effects ofal(III) CB5 on cell proliferation
The cell lines used were BAEC, L929 and RWF. Peptide CB5 was added at a
concentration of lOOpg/ml and the growth of the three cell types was
measured over 5 days. Cells were seeded at a density of 5000 cells/well in 96-
microwell plates containing lOOpl of DMEM + 2% FCS. Each value
represents the mean of 6 wells (Student's t-Test). Standard errors are shown.
Cells grown in DMEM only (negative control) did exhibit a little growth (Tables 3.1-
3.24). This could be due to background levels of serum, as cells were grown in the
presence of serum before being used in these experiments. This could have been
counteracted by starving the cells before starting the assay, however these conditions
were found to be deleterious. Perhaps a true serum-free medium where proteins are
controlled could be used in the future.
3.7 EFFECTS OF COLLAGEN PEPTIDES ON CELL ATTACHMENT
An inhibitory effect on cell growth in the presence of collagen peptides was frequently
seen soon after plating (Day 1). This occurred with both Collagen I and III peptides
(Figures 3.7, 3.9, 3.11, 3.13, 3.15). In order to test whether the peptides were
preventing attachment of cells to the tissue culture plastic, a cell attachment assay was
carried out (Section 2.5.6).
Cell attachment of all three cell lines (BAEC, L929 & RWF) in the presence of
peptides al(I) CB3 and al(III) CB8 were monitored (Figures 3.19 & 3.20). Cells
were grown in the presence of the collagen peptide (concentration- 100pg/ml) and
DMEM + 2% FCS over a period of 4 hours. Cell number was quantified using the
Methylene Blue dye-binding assay (Section 2.5.7; Oliver et cil., 1989), Cell
attachment/growth was measured after 60, 90, 120, 180 and 240 minutes.
These peptides did not affect the attachment of cells to tissue culture plates, as
assessed by comparison with control cells grown only in the presence of DMEM +
2% FCS. Cells grown in the presence of collagen peptide exhibited similar growth
curves as cells grown in DMEM + 2% FCS only (Figures 3.19 & 3.20).
It was shown (Figures 3.19 & 3.20) that this inhibition on initial cell growth was not
















FIGURE 3.19: Cell attachment in the presence of a collagen peptide
L929, BAEC and RWF cell lines were grown in the presence of collagen
peptide al (I) CB3 + DMEM with 2% FCS, at a concentration of 100pg/ml.
Control was cells grown in DMEM with 2% FCS in 96-microwell plates and
seeded at a density of 5000 cells/well. Each value represents a mean of 6 wells






FIGURE 3.20: Cell attachment in the presence of a collagen peptide
L929, BAEC and RWF cell lines were grown in the presence of collagen
peptide al (III) CB8 + DMEM with 2% FCS, at a concentration of lOOpg/ml.
Control was cells grown in DMEM with 2% FCS in 96-microwell plates and
seeded at a density of 5000 cells/well. Each value represents a mean of 6 wells
(student's t-test). Standard errors are shown.
plastic. This inhibition may however be due to initial changes in the cellular
environment to which the cells eventually adapt i.e. cells may take time to adjust to
the addition of the collagen peptide.
3.8 EFFECTS ON CHEMOTAXIS
An important part of wound healing is the migration of cells, in particular fibroblasts,
to the wound site. The ability of a test substance to induce chemotaxis depends on the
presence of appropriate cell surface receptors (Schiffman et al., 1979). Collagen
peptides bind to cell surface receptors in fibroblasts (Grotendorst 1984), this may also
be the case for L929 fibroblasts. Tn addition, the collagen peptides also contain certain
sequences, which are involved in the interaction with the cellular receptors (Ruoslahti
& Pierschbacher 1987). Since the different peptides react in different ways, some may
contain more recognition sequences and therefore can stimulate chemotaxis to a
greater extent. With the peptides that stimulate cell proliferation, a similar mechanism
of action is thought to occur. Again cell surface receptors and recognition sequences
on the collagen molecule maybe involved (Ruoslahti et al., 1994).
Therefore, CNBr collagen peptides were tested for their effect on fibroblast
chemotaxis in vitro, using the Boyden Chamber technique (Section 2.6.1).
The Boyden Chamber Assay is a simple, rapid assay which allows handling of many
samples. The volume of chemotactic factor needed is very low (25pi) as is the cell
number needed per chamber (Falk et al., 1989). Briefly, 50pl of 4 x 105 L929 cells
were placed in the upper compartment of the assay chamber, 25pi of collagen peptide
was added to the lower chamber. Cells responding to a concentration gradient of
collagen peptide will migrate through a porous membrane filter. Cells reaching the
bottom surface of the membrane were fixed, stained and counted. The results of these
experiments are shown in Figures 3.21-3.24.
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FIGURE 3.21: Effects of al(I) CB3 on fibroblast chemotaxis.
The migration of L929 fibroblasts in response to collagen peptide fragment
a 1(1) CB3 was measured. CB3 was added to lower compartments of a Boyden
Chamber at the concentrations shown above. The net cell migration from the
upper compartment was measured by counting the number of cells per field of
view at x40 magnification. Cells which migrated after incubation were fixed to
the filter, stained and counted. Points represent the observed chemotactic
activity plus or minus standard error for triplicate wells minus the activity of











FIGURE 3.22: Effects ofal(I) CB8 on fibroblast chemotaxis.
The migration of L929 fibroblasts in response to collagen peptide fragment
a 1(1) CB8 was measured. CB8 was added to lower compartments of a Boyden
Chamber at the concentrations shown above. The net cell migration from the
upper compartment was measured by counting the number of cells per field of
view at x40 magnification. Cells which migrated after incubation were fixed to
the filter, stained and counted. Points represent the observed chemotactic
activity plus or minus standard error for triplicate wells minus the activity of












FIGURE 3.23: Effects of al(III) CB4 on fibroblast chemotaxis.
The migration of L929 fibroblasts in response to collagen peptide fragment
ocl(III) CB4 was measured. CB4 was added to lower compartments of a Boyden
Chamber at the concentrations shown above. The net cell migration from the
upper compartment was measured by counting the number of cells per field of
view at x40 magnification. Cells which migrated after incubation were fixed to
the filter, stained and counted. Points represent the observed chemotactic
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FIGURE 3.24: Effects ofal(III) CB8 on fibroblast chemotaxis.
The migration of L929 fibroblasts in response to collagen peptide fragment
al(III) CB8 was measured. CB8 was added to lower compartments of a Boyden
Chamber at the concentrations shown above. The net cell migration from the
upper compartment was measured by counting the number of cells per field of
view at x40 magnification. Cells which migrated after incubation were fixed to
the filter, stained and counted. Points represent the observed chemotactic
activity plus or minus standard error for triplicate wells minus the activity of
buffer control (56 +/- 1.2).
All of the CNBr fragments (CB3, CB6, CB7 & CB8 from otl(I) and CB3, CB4, CB5
& CB8 from al(III)) examined from Collagens I and III exhibited chemotactic
activity towards fibroblasts. Chemotaxis was always concentration-dependent,
producing a bell shaped response curve. Results for the peptides which induced
optimal chemotaxis are shown.
Of the Collagen I fragments, al(I) CB3 and al(I) CB8 were the most chemotactic,
with CB3 showing the greatest effect (Figure 3.21). At lpg/ml (optimal
concentration) chemotaxis was increased by 62% above control levels (random cell
migration/movement) with CB3. CB8 increased chemotaxis to a similar degree
(Figure 3.22), with lOOOpg/ml giving greatest activity.
The CNBr fragments from collagen III, CB4 and CB8, were the most chemotactic.
Peptide al(III) CB4 increased cell chemotaxis by 44%, at an optimal concentration of
lOOOpg/ml (Figure 3.23). Peptide al(III) CB8, at a concentration of lOOOpg/ml
stimulated chemotaxis by 45% (Figure 3.24).
3.9 SUMMARY
The major CNBr peptides from Collagens I and III were isolated and purified in this
section. The biological effects of these CNBr-derived peptides were examined. From
Collagen I, CB8 stimulated cell proliferation to the greatest extent, however CB4
from Collagen III was found to stimulate cell proliferation at a more potent
concentration. These effects were concentration-dependent. An inhibitory effect on
cell proliferation was observed, soon after the addition of collagen peptides to the cell
lines. This inhibition was not due to the prevention of cell attachment. In the studies
on chemotaxis, peptide a 1(1) CB3 increased chemotaxis to the greatest degree, at a
more potent concentration than observed with the other collagen-derived peptides.
These studied on the effects of collagen peptides on chemotaxis and proliferation
were investigated further in Chapter 4.
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CHAPTER 4:
ISOLATION OF A BIOACTIVE COLLAGEN PEPTIDE
4.1 INTRODUCTION
It has previously been shown that collagen-derived peptides are chemotactic
towards a variety of cell types. These peptides generated during wound formation
are thought to play an important role in the repair of wounded tissue. In many
studies collagen has been degraded by a number of different processes and the batch
of peptides generated examined for their biological effects on cell behaviour
(Postlethwaite et al., 1978; Riley et ah, 1984; Albini & Adelmann-Grill 1985;
Laskin et al., 1986; Malone et al., 1991). However, no specific bioactive peptide(s)
from collagen has ever been isolated and sequenced.
The aim of this study was to generate a variety of collagen-derived peptides, to be
tested for their effects on cell behaviour, in particular chemotaxis (directed cell
movement), in order to isolate the peptide(s) which would stimulate cell movement
to the greatest extent. Chemotaxis is an important cell behaviour, as it is crucial to
wound repair to attract cells which contribute to healing to the wound site. The
peptide(s) could then be tested for other biological activities both in vitro and in
vivo, and eventually used to enhance the process ofwound healing.
4.2 ENZYMATIC DIGESTION OF COLLAGENS
In order to generate a range of collagen peptides, which could then be tested for
their ability to stimulate chemotaxis, Collagen types I, III and V (in their native
forms) were digested with a variety of reagents (Section 2.3), namely (a) CNBr
(Chapter 3), (b) bacterial collagenase, (c) bacterial collagenase followed by trypsin
and finally (d) bacterial collagenase followed by chymotrypsin. After heat-
inactivating the enzymes at 95°C for 4hrs: (Levitsky et al., 1994), these crude
collagen digests were then tested in vitro, in the Boyden Chamber, for their
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potential to stimulate chemotaxis (see below).
The concentration of collagen and collagen peptides was determined throughout
this study using the Sircol Collagen Assay (see Materials & Methods 2.7.5.3).
Chemotaxis was assayed by using the Boyden Chamber (see Materials & Methods
2.6.1). 50pl of L929 fibroblast cells at a concentration of 4 x 10^ cells/ml in
DMEM were placed in the top compartment of the chamber. 27pl of the digested
collagen fragments in Glycylglycine Buffered Saline (GGBS)+Dulbecco's Modified
Eagle's Media (DMEM) was placed in the bottom compartment. The chamber was
incubated at 37°C for 2 Vi hours. Fibroblasts which migrated through the PVA filter
towards the collagen fragments were fixed in methanol, stained in Diff-Quick and
counted. Cells were counted at x40 magnification. Twenty fields of view were
counted to give a mean value for number of cells migrated. Buffer only controls
(GGBS+DMEM) were used in all experiments and represented background levels
of chemotactic activity.
It is important to determine what effect varying the conditions of collagen
degradation had upon the chemotactic properties of the peptides produced. For this
purpose collagen was digested at a range of enzyme concentrations and as a
function of both time and temperature. Peptides recovered from these were then
tested for chemotactic activity. The results of an analysis in which Type I collagen
was digested with collagenase are shown in Table 4.1. It appears from these data
that conditions which produced more extensive degradation (higher enzyme to
protein ratio, elevated temperature or longer time) produced peptides with greater
chemotactic activity.
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Type I + collagenase 18hrs; 25°C 100.3+/-2.0 65.3+/-1.1 64.0+/-1.4
Type I + collagenase 24hrs; 25°C 112.6+/-1.8 75.8+/-1.7 69.0+/-1.6
Type I + collagenase 18hrs; 37°C 136.2+/-2.2 90.0+/-1.9 72.5+/-1.5
Type I + collagenase 24hrs; 37°C 150.3+/-2.1 121.5+/-2.0 78.7+/-1.4
Buffer Only n/a 57.6+/-1.4 57.6+/-1.4 57.6+/-1.4
Buffer + collagenase n/a 92.3+/-1.7 57.4+/-1.5 57.4+/-1.4
a - (mean +/- SEM), n=9
Table 4.1: Collagen I degradation conditions and their effects on chemotaxis
Collagen I (lmg/ml) was degraded by bacterial collagenase at different conditions
(temperature, time and enzyme concentration). The chemotactic response of L929
fibroblasts to the collagen peptides generated from each condition was measured using the
Boyden Chamber Assay. Buffer used was GGBS + DMEM. Results show the mean of
nine samples with standard errors (SEM).
However, enzymes themselves can be chemotactic, as shown by the data in Table
4.1. The most chemotactic effect was observed with Type I collagen degraded with
collagenase, with an enzyme to protein ratio of 1:10, incubated at 37°C for 24
hours. Lesser chemotactic effects were seen with Type I collagen degraded with
collagenase at enzyme to protein ratios of 1:100 and 1:1000.
The enzymes (collagenase, trypsin and chymotrypsin) were tested alone (without
collagen) for their chemotactic potencies. The results of this are shown in Table
4.2. The digestions were carried out for 37°C for 24hrs. At concentrations of
lpg/ml and 10pg/ml the enzymes had no effects on chemotaxis (similar to control
values i.e. approx. 57 cells migrated per field of view), however at 100pg/ml the
enzymes were found to be chemotactic (Table 4.2). Collagenase and chymotrypsin
combined were most chemotactic. Trypsin was least chemotactic. A possible reason
for the difference between the enzymes could be that they contain different
receptors on their surfaces which only certain cells will recognise and bond to,
therefore stimulating the cell to move, as in chemotaxis.
Therefore, in order to reduce the chemotactic effects the enzymes themselves
exhibit, only concentrations of enzyme which did not elicit a chemotactic response
would be used. From the results in Tables 4.1 and 4.2, the standard conditions for
degradation of collagen used would be at 37°C for 24 hours, using an enzyme
concentration of 10p,g/ml.
Collagens I, III and V were degraded using the standardised conditions previously
mentioned. Their degradation products were then tested for chemotactic activity.
Results from these experiments are shown in Tables 4.3, 4.4 and 4.5. Native
collagens I, III and V were found to be chemotactic as well as the peptides of these







bacterial collagenase 57.4+/-1.4 57.4+/-1.5 92.3+/-1.7
trypsin 57.2+/-1.6 57.8+/-1.8 66.9+/-1.4
chymotrypsin 58.1+/-1.9 57.9+/-1.7 70.2+/-1.6
collagenase + trypsin 58.2+/-2.0 57.5+/-1.8 78.4+/-1.4
collagenase + chymotrypsin 57.4+/-1.3 57.6+/-1.5 93.6+/-1.8
Buffer only 57.6+/-1.4 57.6+/-1.4 57.6+/-1.4
a - mean +/- SEM, n=9
Table 4.2: The ability of enzymes to stimulate fibroblast chemotaxis
The enzymes named above were examined at three concentrations (lpg/ml, lOpg/ml
&100pg/ml) for their ability to induce chemotaxis in L929 fibroblast cells. The Boyden
Chamber Assay was used to measure chemotaxis. Buffer used was GGBS + DMEM.
Results show the mean of nine samples with standard errors (SEM).
Substance Tested Maximum Chemotactic Activity
(cells/field)3
Type I collagen 83.1+/-1.8
Type I + collagenase 121.5+/-2.0
Type I + trypsin 58.3+/-1.4
Type I + chymotrypsin 58.1+/-1.5
Type I + CNBr 72.3+/-1.8
Type I + collagenase + trypsin 95.6+/-1.4
Type I + collagenase + chymotrypsin 147.6+/-2.2
Buffer control 57.6+/-1.4
a - (mean +/- SEM), n=9
Table 4.3: Degradation of Collagen I and its effect on chemotaxis
Collagen I or its degradation products were incubated for 24hrs at 37°C with different
enzymes (enzymexollagen 1:100 w/w). Collagen degraded by CNBr was also tested for
its ability to induce chemotaxis in L929 fibroblasts. The Boyden Chamber Assay was used
to measure chemotaxis. Buffer used was GGBS + DMEM. Results show the mean of nine
samples with standard errors (SEM).
Substance Tested Maximum Chemotactic Activity
(cells/field)3
Type III collagen 78.2+/-1.5
Type III + collagenase 101.0+/-1.8
Type III+ trypsin 58.0+/-1.4
Type III + chymotrypsin 57.2+/-2.0
Type III + CNBr 64.8+/-1.8
Type III + collagenase + trypsin 85.2+/-1.4
Type III+ collagenase + chymotrypsin 88.4+/-1.6
Buffer control 57.6+/-1.4
a - (mean +/- SEM), n=9
Table 4.4: Degradation of Collagen III and its effect on chemotaxis
Collagen III or its degradation products were incubated for 24hrs at 37°C with different
enzymes (enzyme:collagen 1:100 w/w). Collagen degraded by CNBr was also tested for
its ability to induce chemotaxis in L929 fibroblasts. The Boyden Chamber Assay was used
to measure chemotaxis. Buffer used was GGBS + DMEM. Results show the mean of nine
samples with standard errors (SEM).
Substance Tested Maximum Chemotactic Activity
(cells/field)3
Type V collagen 69.3+/-1.4
Type V + collagenase 76.5+/-1.6
Type V + trypsin 57.8+/-1.5
Type V + chymotrypsin 65.4+/-2.0
Type V + CNBr 78.0+/-1.8
Type V+ collagenase + trypsin 82.6+/-1.9
Type V + collagenase + chymotrypsin 57.6+/-1.4
Buffer control 57.6+/-1.4
a - (mean +/- SEM), n=9
Table 4.5: Degradation of Collagen V and its effect on chemotaxis
Collagen V or its degradation products were incubated for 24hrs at 37°C with different
enzymes (enzyme:collagen 1:100 w/w). Collagen degraded by CNBr was also tested for
its ability to induce chemotaxis in L929 fibroblasts. The Boyden Chamber Assay was used
to measure chemotaxis. Buffer used was GGBS + DMEM. Results show the mean of nine
samples with standard errors (SEM).
trypsin and finally collagenase followed by chymotrypsin. Table 4.3 shows the
results of Type I collagen degradation. The most chemotactic was collagen digested
with collagenase and chymotrypsin. This was three times the control level (147.6
compared to 57.6). Type I collagen digested with collagenase followed by trypsin,
and also Type I digested with collagenase followed by chymotrypsin were not
chemotactic.
From the results in Tables 4.3, 4.4 and 4.5 the optimal conditions for producing
maximum chemotactic activity were as follows. Table 4 .4 shows the results of Type
III collagen digestion. The digestion which produced the greatest chemotactic effect
was with collagen digested with collagenase. Table 4.5 shows the results of Type V
collagen digestion. The digestion which produced the greatest chemotactic effect
was with Type V digested with collagenase and then trypsin.
In Figure 4.1 the concentration-dependence of the peptides which displayed
maximal chemotactic behaviour for each collagen type is shown. With Collagens I
and III, optimum chemotaxis occurred at a concentration of lOOpg/ml. With Type
V, 10pg/ml produced optimal chemotaxis. The digest which displayed the most
pronounced chemotactic behaviour was that obtained by digestion of collagen I
molecules with both collagenase and chymotrypsin. Chemotaxis was increased by
almost three times compared to the control sample (GGBS + DMEM).
As Collagen I degradation products were the most chemotactic, future experiments
will be focused on Collagen I.
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FIGURE 4.1: Chemotactic response of L929 fibroblasts to Type I, III
and V collagen peptides
Collagen types I, III and V (lmg/ml) were degraded by a variety of methods
in order to produce chemotactic peptides. The degradation methods resulting
in maximal chemotactic behaviour for each collagen type were as follows:
Type I - collagenase + chymotrypsin, Type III - collagenase, Type V -
collagenase + trypsin. Chemotaxis was carried out in the Boyden Chamber
Assay. Points represent the observed chemotactic activity +/- SEM minus the
activity of buffer (DMEM + GGBS), 57.6+/- 1.4. p*<0.01 (Student's t-Test),
n=9.
4.3 ISOLATION AND SEPARATION OF COLLAGEN PEPTIDES
Since collagen I digested with collagenase/chymotrypsin (Section 4.2) produced the
most chemotactic samples the next step was to isolate the most bioactive collagen
peptide(s) from this preparation. To this end the above digest was fractionated
using reverse-phase HPLC (Figure 4.2). Collagen samples were dissolved in 0.1%
(v/v) trifluoroacetic acid, filtered and then injected onto a C18 reverse-phase
column. The column was eluted with a 120ml gradient of 0-40% acetonitrile,
delivered at a flow rate of lml/min. Fractions were collected every 10 minutes.
4.4 IDENTIFICATION OF THE ACTIVE PEPTIDE
Each fraction obtained from the HPLC separation was freeze-dried, resuspended in
GGBS/DMEM and then individually tested in the Boyden chamber for chemotactic
activity. All of the fractions contained some activity, however fractions separated
between 30-40 min (Figure 4.3, fraction 4: F4) after HPLC showed the most
chemotactic activity. All of these separated fractions contained some chemotactic
activity. Each bar represented chemotactic activity minus buffer control
(GGBS/DMEM), which was 57.2 in this case. Fraction 4 stimulated chemotaxis by
almost 100% (a chemotactic activity of 55), compared to control values. After
examination of the FfPLC profile (figure 4.2), it was decided to run fraction 4 (F4)
again through the CI8 column and collect the largest peak (* in figure 4.2). The
HPLC profile of this peak is shown in Figure 4.4. Its purity was found to be
approximately 95%. The peak was then freeze-dried and assayed for its chemotactic
activity in the Boyden Chamber Assay. These results are shown in Figure 4.5. The
isolated peak was found to stimulate L929 fibroblast chemotaxis at an optimal
concentration of lOOng/ml (Fig 4.5). This is the same level of potency as the
isolated ten minute fraction (F4), therefore this peak was responsible for the
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Figure 4.2: Separation of collagen peptides by reverse-phase HPLC
Collagen I chains digested with collagenase and chymotrypsin were separated by
reverse-phase chromatography (CI8 Dynamax column) into fractions (F1-F8). A
0-40% acetonitrile gradient in 0.1% trifluroacetic acid, at a flow rate of lml/min
was delivered. Absorbances were measured at 214nm. The most chemotactic
fragment was collected between 30-40mins (F4). The peak indicated by * was the
fraction thought responsible for this activity.
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FIGURE 4.3: Chemotactic effect of collagen fractions on L929 fibroblasts
Collagen I digested by collagenase and chymotrypsin was fractionated by
reverse-phase HPLC. The fractions collected at 10 minute intervals were
tested individually for their effects on chemotaxis in the Boyden Chamber
Assay. Bars represents the observed chemotactic activity +/- SEM minus the
activity of buffer (GGBS+DMEM) control (57.2+/-1.1). n=9.
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Figure 4.4: HPLC profile of the most chemotactic collagen peptide
Collagen I was digested with collagenase and chymotrypsin. The peptides generated
were tested for chemotactic activity. The most chemotactic peptide was isolated and
its purity checked by reverse-phase HPLC. The freeze-dried peptide was dissolved in
0.1% trifluroacetic acid, filtered and injected onto a C18 reverse-phase column. The
column was eluted with a gradient of 0-40% acetonitrile at a flow rate of lml/min.
Absorbances were measured at 214nm.
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FIGURE 4.5: Chemotactic activity of isolated collagen peptide
The collagen I fraction isolated after enzymatic degradation and HPLC
purification (* in Fig 4.2) was tested over a range of concentrations for its
ability to induce L929 fibroblast chemotaxis. Chemotaxis was carried out in
the Boyden Chamber Assay. Cells were seeded at a density of 5000 cells/well
and grown in microwell plates containing lOOpl of DMEM + 2% FCS.
Standard errors are shown.
chemotactic activity of this fraction.
4.5 IN VIVO EFFECTS OF THE ACTIVE PEPTIDE
PVA (polyvinyl alcohol) implants have been used successfully to study wound
healing in experimental models (Cooney et al., 1997; Shah et al., 1999). PVA
sponges can be used to measure cellular infiltration as they act as a stable dead
space into which cells can migrate. The PVA sponge animal model was used in this
project to analyse the chemotactic effects of collagen peptides in vivo (Section 2.7).
Sponges were subcutaneously implanted into male Wistar rats and after three days
were injected with lOOptl of the crude digest of peptides (O.lmg/ml) derived from
collagenase and chymotrypsin degradation of Collagen I. Seven and ten days post-
implantation the sponges were removed and analysed both histologically and
biochemically (i.e. quantitation of total DNA, protein and collagen). It was the
ratios of collagen, DNA and protein in the experimental PVA sponges (injected
with collagen peptide) compared to control PVA sponges (PBS buffer only) which
was measured.
The ratios of collagen, DNA and protein in the experimental sponges were greater
(>1) than in control sponges, 7 days post-implantation (Figure 4.6).These increases
were even greater after 10 days. The collagen I digest, from the previous section, at
a concentration of 0.1 mg/ml, was found to have significant stimulatory activity on
DNA content of tissue after 10 days compared to control sponges (Figure 4.6).
For histological analysis, sections (5 micron) were cut from PVA sponges which
had been fixed in formalin, embedded in paraffin and stained with haematoxylin and
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FIGURE 4.6: Biochemical analysis of PVA sponges injected with collagen
I peptide(s)
Protein, DNA and collagen contents were measured in PVA sponges injected
with lOOpl of O.lmg/ml of collagen peptides (derived after degradation with
collagenase and chymotrypsin). Sponges were removed from rats and analysed
7 and 10 days post injection. Results are expressed as a ratio of experimental
(sponge + collagen peptide) to control sponge (PBS only). Standard errors are
shown, n=10. *p<0.05 (Student's t-Test).
these stained sections. Granulation tissue is composed of fibroblasts and
inflammatory cells (macrophages/monocytes).
The granulation tissue was assessed microscopically (i.e. 'eyeballing') by relating
the content of the sponges containing collagen peptide to those containing PBS
control. From Figure 4.7, where a= PVA sponge, b= fibrin (thin ribbons) and c=
granulation tissue (cellular material), it could be seen that the digest had an overall
stimulatory effect at 0.1 mg/ml after 10 days post injection (Figure 4.7) as seen by
the formation of granulation tissue. More fibrin and fibroblasts/inflammatory cells
can be seen in the collagen peptide sponge (B).
4.6 AMINO ACID SEQUENCE OF PEPTIDE
The amino acid sequence of the chemotactic peptide, isolated by HPLC (Fig 4.2)
from collagen I (digested with collagenase and chymotrypsin) was determined using
an Applied Biosystems microsequencer (kindly carried out by Dr A Cronshaw). The
peptide (Figure 4.8) was found to be 22 amino acids in length and corresponded (by
reference to Swiss-Prot data base)to the a2 chain of collagen I (residues 25-46).
The peptide was isolated from porcine collagen I. This peptide sequence was found
to be identical with the corresponding sequence in bovine collagen I. However, the
porcine collagen sequence varies by only one amino acid from the human sequence
(residue 36; Thr —> Hyp) and differs by three amino acids from that of rat (Fig 4.8;
Barnes etal., 1982).
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Figure 4.7: PVA sponge histology
PVA sponges were assessed for granulation tissue content in
Haematoxylin and Eosin stained sections (magnification x40).
(A) control sponge (PBS only) - little cellular invasion
(B) sponge containing collagen I peptides (O.lmg/ml), removed
after 10 days post-implantation - moderate cellular invasion.
a=PVA sponge b=fibrin c=granulation tissue
2567893012345367894013456
(i)Gly-Pro-Hyp-Gly-Glu-Hyp-Gly-Glu-Hyp-GIy-Gln-Hyp-Gly-Pro-Ala-Gly-Ala-Arg-Gly-Pro-Ala-Gly (ii)Gly-Pro-Hyp-Gly-Glu-Hyp-Gly-Glu-Hyp-Gly-Gln-Thr-Gly-Pro-Ala-GIy-Ala-Arg-GIy-Pro-Ala-GIy (iii)Gly-Pro-Hyp-Gly-Glu-Hyp-Gly-Glu-Hyp-Gly-Gln-Hyp-Gly-Pro-Ala-Gly-Ala-Arg-Gly-Pro-Ala-Gly (iv)Gly-Pro-Ala-Gly-Glu-Hyp-Gly-Glu-Hyp-Gly-Gln-Hyp-Gly-Pro-Ala-Gly-Pro-Arg-Gly-Pro-Hyp-Gly Figure4.8:Speciescomparisonftheaminoidseque cofthisol tc llape tid Acollagenpeptidefromiskin(i)obtainebyenzymaticdig i na dHPLCpurificatiowassh wntbchem ta tic forfibr blasts.Itwfoundtbe22aminocidinle g hancorrespo edthchaifColl gI(residu s25- 46).Thesequenceidenticaltohatfbovincollage( ii).Tsamr gioninhumai )andr(diff rbyoand threeaminocidsrespectively.
4.7 SUMMARY
In this section, peptides derived from Collagen Types I, III and V were generated
and their chemotactic potencies determined. It was found that Collagen I digested
sequentially with collagenase and chymotrypsin produced peptides with greatest
chemotactic effects. The most bioactive peptide from this digest was isolated and its
sequence determined. The peptide was then synthesised on a larger scale and its
biological activities examined further (Chapter 5).
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CHAPTER 5:
BIOLOGICAL EFFECTS OF A SYNTHETIC COLLAGEN
PEPTIDE
5.1 INTRODUCTION
Collagen peptides have been shown to be chemotactic towards a variety of cell types.
In Chapter 4 an HPLC-purified peptide isolated from Collagen I after sequential
enzymatic digestion with bacterial collagenase and chymotrypsin was found to
stimulate fibroblast cell migration by 100%. The 22-amino acid sequence of the
peptide was found to be from the a2 chain of Collagen I. It was decided that the
peptide would be synthesised chemically so that it could then be tested for its
biological activities in a variety of systems. In order to localise the chemotactic
domain of this 22-amino acid collagen peptide, a variety of synthetic collagen peptides
containing amino acid sequences from within this larger peptide were also made and
then tested for their chemotactic potential.
Cell migration is essential for the formation of granulation tissue (Chen &
Abatangelo, 1999), chemotaxis is directional cell migration. Therefore it is crucial to
wound repair to attract cells, that contribute to healing, to the wound site.
5.2 LARGE SCALE PURIFICATION OF PEPTIDE
Thirty milligrams of the 22-amino acid peptide were synthesised by Edinburgh
University Chemistry Department using a fully automated Biosystems 43OA peptide
synthesiser. The FMCABu (9-fluorenlymethoxycarbonyl/tertiary butyl) based method
of peptide synthesis was used (Carpino & Han, 1972).
The peptide underwent laser desorption mass spectral analysis to confirm its
molecular mass and also amino acid sequencing to confirm that it had the correct
sequence.
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5.3 HPLC ANALYSIS OF PEPTIDE
The peptide was chromatographed on a C8 reverse-phase column (Aquapore) with a
gradient of 90% (H2O/0.1% TFA) to 90% (aceteonitrile/0.1% TFA) and a flow rate
of lml/min (by Edinburgh University Chemistry Dept.) and shown to be 95% pure
(Figure 5.1).
5.4 CHEMOTACTIC EFFECTS
This peptide was tested for its ability to stimulate chemotaxis with fibroblasts and
endothelial cells. Chemotaxis was carried out in the Boyden Chamber Assay as before
(see Section 2.6). Briefly, 50pl of L929 fibroblast cells at a concentration of 4 x 105
cells/ml in DMEM were placed in the top compartment of the chamber. 25pl of
digested collagen fragments and the synthetic peptide (in GGBS+DMEM) were
placed in the bottom compartment. The synthesised peptide was chemotactic towards
L929 fibroblasts (Figure 5.2) to a similar degree as the collagen-derived sample (see
Section 4.4) of the peptide, except that the collagen-derived peptide was slightly more
potent. A reason for this slight difference could be that the collagen-derived peptide
had some impurities in it, which could also be chemotactic. The synthetic peptide had
less impurities (95% pure as stated in Section 5.3). The similar activity of both the
synthetic and collagen-derived peptide samples suggests however that the observed
chemotaxis is largely due to the amino acid sequence of the collagen and not to some
unknown impurities.
The peptide was also tested against other fibroblast cells, in order to examine its
ability to stimulate chemotaxis in different cell lines. The L929 and 3T3 fibroblasts are
continuous cell lines (cells modified in order to produce a continuously growing cell
line), whereas RWF are primary cell lines (cells recently isolated from tissue or
organs and have a limited lifespan). Primary cells are more likely to reflect the
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Figure 5 1 : HPLC profile of the synthetic collagen peptide
Purity of the synthesised 22-amino acid peptide was determined by HPLC analysis
Column: C8 Aquapore; Gradient: 90% (H2O/0.1% TFA) -» o
;acetomtnle/0.1%TFA), flow rate lml/min].
conc. (ng/ml)
FIGURE 5.2: Effects of both collagen-derived and synthetic collagen
peptides on fibroblast chemotaxis
The fibroblast cell line examined was L929. A collagen-derived peptide was
compared with a synthetic collagen peptide for their ability to stimulate
chemotaxis. The peptides were added to lower compartments of a Boyden
Chamber at the concentrations shown above. The net cell migration from the
upper compartment was measured by counting the number of cells per field of
view. Points represent the observed chemotactic activity +/- SEM for triplicate
wells minus the activity ofbuffer control (56+/- 1.3).
true activity and functions that they display in their natural environment (Morgan &
Darling 1993). Hence, it was important to examine the effect of the peptide on these
cell lines.
RWF and 3T3 cells were shown to be chemotactic to a similar degree as the L929
fibroblast cells (Figure 5.3).
The peptide was not significantly chemotactic towards endothelial cells (Figure 5.4),
even though a bell-shaped chemotaxis curve was produced. This data suggests that
endothelial cells do not have cell surface receptors which recognise and bind to the
collagen peptide, whereas fibroblasts cells appear to have receptors which are
recognised.
The collagen peptide stimulated chemotaxis in a variety of fibroblast cell types, this
suggests that fibroblasts have cell surface receptors which bind a region of this
collagen peptide.
5.5 "CHECKERBOARD ASSAY" FOR VERIFICATION OF DIRECTIONAL
MIGRATION
To determine whether the cell migration was directional in nature (chemotactic), a
"checkerboard" analysis was performed, following the method ofZigmond and Hirsch
(1973). As chemoattractants can also increase cell movement in a random nature
(chemokinesis), this method was used in an attempt to distinguish between these two
kinds of cell migration.
The checkerboard was set up essentially as described for the Boyden Chamber Assay.
The cells, in the uppermost chambers, are exposed to: 1) A range of attractant
concentrations but no gradient (equal concentrations of peptide in the upper and
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FIGURE 5.3: Chemotactic effects of the synthetic collagen peptide on
different fibroblast cell lines.
The cell lines examined were L929, RWF and 3T3 fibroblasts. The synthetic
collagen peptide was added to the lower compartments of a Boyden Chamber
at the concentrations shown above. The net cell migration from the upper
compartment was measured by counting the number of cells per field of view.
Points represent the observed chemotactic activity +/- SEM for triplicate wells
minus the activity of buffer control (56+/- 1.6).
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FIGURE 5.4: Effects of the synthetic collagen peptide on endothelial cell
chemotaxis
The endothelial cell line examined was BAEC. The synthetic collagen peptide
was added to lower compartments of a Boyden Chamber at the concentrations
shown above. The net cell migration from the upper compartment was measured
by counting the number of cells per field of view. Points represent the observed
chemotactic activity +/- SEM for triplicate wells minus the activity of buffer
control (57+/- 1.0).
lower chambers. This provides a dose-response curve for non-chemotactic effects of
the peptide). 2) A range of positive gradients where the peptide concentration is
always higher in the lower chamber. 3) A range of negative gradients where the
peptide concentration is always lower in the lower chamber.
Chemicals that stimulate migration when placed at equal concentrations below and
above the filter are characterised as affecting random motility. Attractants that are
much more potent when placed below the filter are judged to elicit true directed
motility.
In the top wells of the chambers, varying concentrations (0, lOOng/ml, lpg/ml,
lOpg/ml) of the collagen peptide were added to fibroblasts at a concentration of 4.8 x
lO^/ml. The same concentrations of collagen peptide were placed in the bottom wells;
such that several possible concentrations above and below the filter were tested
(Figure 5.5). Each combination was tested in triplicate. Filters were stained and cells
counted as for the chemotaxis assay.
From the results in Figure 5.5 it can be seen that in the absence of a gradient (i.e.
equal concentrations of collagen peptide in both chambers; shown in figure in bold),
cell migration was still observed. This indicates that the collagen peptide is affecting
random motility of fibroblast cells (chemokinesis).
In the presence of a positive gradient (i.e. higher peptide concentration in lower
chamber), the number of cells migrating towards the peptide increased. In contrast, in
the presence of a negative gradient (i.e. lower peptide concentration in lower
chamber), the number of cells migrating through the filter decreased. These results
indicate that cell migration was also directional with cells moving towards a positive
concentration of collagen peptide.
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concentration above membrane
0 lOOng/ml l|ig/ml 10|Ug/ml
concentration
below membrane
0 58 60 60 63
(1.5) (1.2) (1.3) (1.4)
lOOng/ml 77 63 62 65
(1.1) (1.3) (1.3) (1.5)
ljig/ml 96 68 66 68
(1.1) (1.2) (1.2) (1.4)
lOjig/ml 65 61 70 70
(1.6) (1.3) (1.4) (1.3)
Figure 5.5: "Checkerboard" analysis of cell migration to the 22-amino acid
collagen peptide.
The fibroblast cell line examined was L929. In the top compartment of a Boyden
Chamber, varying concentrations of collagen peptide (as above) were added
together with cells. In the lower compartment the same concentrations of peptide
were placed. Therefore, cells could be exposed to a range of positive and negative
gradients as well as to no gradient. The net cell migration was measured by
counting the number of cells per field of view. Points represent the observed
chemotactic activity and standard errors (bracketed). The activity of buffer control
was 56+/- 1.0.
5.6 EFFECTS ON CELL PROLIFERATION
Cell proliferation is essential to tissue repair (Chen & Abatangelo, 1999). The peptide
was tested for its ability to stimulate fibroblast cell growth in vitro. Cells were set up
in 96-well microplates and the numbers of cells present after 1, 2 and 5 days of cell
growth were quantified using the Methylene Blue dye-binding assay (Section 2.5.7;
Oliver et al., 1989). It was found that the peptide increased growth in all fibroblast
cell types (L929, 3T3, RWF; Figure 5.6). L929 growth was increased by 25% after
five days, a highly significant level (high statistical significance p<0.01). RWF and
3T3 cell growth were increased by 12% and 15% respectively (both statistically
significant, p<0.05).
5.7 IN VIVO EFFECTS
The PVA sponge animal model was used to analyse the effects of collagen peptides in
vivo in terms of their ability to stimulate cellular infiltration and granulation tissue
formation (Chapter 2.7).
PVA sponges were subcutaneously implanted into male Wistar rats and the synthetic
collagen peptide was injected (lOOpl) into the sponges 3 days post implantation. The
sponges were removed 7 and 10 days post implantation and analysed both
histologically and biochemically (protein, DNA and collagen content). The peptide
was tested in this assay at 4 different concentrations: lOOng/ml, lpg/ml, lOpg/ml and
3mg/ml.
The protein content of PVA sponges containing collagen peptide was compared to
control sponges (PBS buffer only) over 7 and 10 day periods, post-implantation
(Figure 5.7). The level of protein recovered from sponges containing the
synthetic collagen peptide (at a concentration of 10pg/ml) after both 7 and
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FIGURE 5.6: Effects of the synthetic collagen peptide on fibroblast
proliferation
The fibroblast cell lines used were L929, 3T3 and RWF. A synthetic collagen
peptide was added at a concentration of 500ng/ml and the growth in all three
cell lines was measured over 5 days as shown. Cells were seeded at a density
of 5000 cells/well in 96-microwell plates containing lOOpl of DMEM+2%
FCS. Each value represents the mean of 6 wells (Student's t-Test). Standard
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FIGURE 5.7: PVA sponge protein content
PVA sponges injected with the synthetic collagen peptide (lOOpl at the
concentrations shown above) were removed from rats 7 and 10 days post
implantation. The protein content of the sponges was determined using the
Bradford Protein Assay (1976). Results are expressed as a ratio of experimental
sponge (sponge + collagen peptide) to control sponge (PBS only - no collagen
peptide). Standard errors are shown. *p<0.05, **p<0.01, n=10.
10 days was found to be 19% greater than in the control sponge. At peptide
concentrations of lOOng/ml and 3mg/ml, assayed after 7 days, the protein levels
within the control sponges were greater than in sponges containing collagen.
The synthetic collagen peptide had a similar, modest stimulatory effect upon cellular
infiltration as indicated by the increase in DNA content of the sponges over the 7 and
10 day periods of analysis. The results (Figure 5.8) show that the amount of DNA
recovered from the sponges increased in proportion to the concentration of peptide
being tested, except at the highest peptide concentration (3mg/ml) where the level of
DNA recovered was actually less than in the control. For the three lower peptide
concentrations tested, there was a consistent increase in the amount of DNA
recovered after 10 days compared to that recovered after 7 days. Under the most
stimulatory conditions (10pg/ml test peptide, assayed after 10 days) the DNA content
of the sponges was 20% greater than that in the control, a difference which was found
to be statistically significant.
The PVA sponges injected with the synthetic collagen peptide were also analysed for
collagen content, compared to control sponges. The results (Figure 5.9) show that the
amount of collagen recovered from the sponges containing the peptide increased in
proportion to the concentration of peptide being tested, except at the highest peptide
concentration, (3mg/ml), where the level of collagen recovered was less than in
controls. The peptide was most stimulatory at lOpg/ml (assayed after 10 days). The
collagen content of the sponges was 21% greater than in the control, a highly
significant difference. There was a consistent increase in the amount of collagen
recovered after 10 days compared to that recovered after 7 days.
Each PVA sponge was also assessed for granulation tissue content by examining
haematoxylin and eosin (FI&E) stained sections. Granulation tissue is composed of
fibrin, fibroblasts, inflammatory cells (macrophages/monocytes), matrix and blood




lOOng/ml lpg/ml lOpg/ml 3mg/ml
Peptide Cone.
FIGURE 5.8: PVA sponge DNA content
PVA sponges injected with the synthetic collagen peptide (lOOpl at the
concentrations shown above) were removed from rats 7 and 10 days post
implantation. The DNA content of the sponges was determined using the
method as described by Gendimenco et al., 1988. Results are expressed as a
ratio of experimental sponge (sponge + collagen peptide) to control sponge
(PBS only - no collagen peptide). Standard errors are shown. *p<0.05,
**p<0.01, n=10.
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FIGURE 5.9: PVA sponge collagen content
PVA sponges injected with the synthetic collagen peptide (lOOpl at the
concentrations shown above) were removed from rats 7 and 10 days post
implantation. The protein content of the sponges was determined using the
method based on hydroxyproline content and determined by HPLC (Negro et
al., 1987). Results are expressed as a ratio of experimental sponge (sponge +
collagen peptide) to control sponge (PBS only - no collagen peptide). Standard
errors are shown. *p<0.05, **p<0.01, n=10.
the formation of granulation tissue compared to control sponges (i.e. not injected with
collagen peptide) as shown in Figure 5.10. Greater amounts of fibrin, fibroblasts and
inflammatory cells have been attracted into the sponge. At a higher concentration of
3mg/ml the peptide was inhibitory to the formation of granulation tissue within the
PVA sponge compared with control (Figure 5.11).
In vivo, the peptide showed effects on the accumulation of collagen, DNA and protein
in PVA sponges implanted into rats and removed after 7 and 10 days post injection.
Protein, DNA and collagen content of the sponges increased significantly compared
with control values after 10 days. This effect was concentration-dependent, with the
optimum tested concentration being lOpg/ml. At 3mg/ml the DNA, protein and
collagen levels were actually lower than controls. Histological analysis of the sponges
supported the findings that the collagen peptide increases the amount of granulation
tissue in the PVA sponges in a dose-dependent manner. More fibrin, fibroblasts and
inflammatory cells migrated into sponges injected with collagen peptide (lOpg/ml)
than control sponges. However, in agreement with the biochemical results, sponges
containing 3mg/ml of collagen peptide inhibited formation of granulation tissue
compared to control sponges.
5.8 LOCALISATION OF THE SYNTHETIC PEPTIDE'S CHEMOTACTIC
DOMAIN
In order to define the amino acid sequence responsible for the chemotactic activity of
the synthetic collagen peptide, a group of overlapping peptides from within the
peptide was synthesised. Five peptides, each of eight amino acids in length and
overlapping by 4 amino acids, were prepared and tested for their chemotactic ability
in vitro (Figure 5.12). Peptide 4 contained the most chemotactic activity (Figure
5.13). Peptides 1, 3 and 5 were also chemotactic, but to a lesser degree (Figure
5.13). Peptide 2 was found to be least chemotactic.
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Figure 5.10: PVA sponge histology
PVA sponges were assessed for granulation tissue content in
Haematoxylin and Eosin stained sections (magnification x40).
(A) control sponge (PBS only) - little cellular invasion
(B) sponge containing Collagen I peptides (lOpg/ml, removed after 10
days post-implantation) - good cellular invasion.
a=PVA sponge b=fibrin c=granulation tissue
a
Figure 5.11: PVA sponge histology
PVA sponges were assessed for granulation tissue content in
Haematoxylin and Eosin stained sections (magnification x40).
(A) control sponge (PBS only) - little cellular invasion
(B) sponge containing Collagen I peptides (3mg/ml, removed after
10 days post-implantation)- poor cellular invasion.
a=PVA sponge b=fibrin c=granulation tissue
Residue number
Peptide 1: Gly-Pro-Hyp-Gly-Glu-Hyp-Gly-Glu 25-32
Peptide 2: GIu-Hyp-GIy-Glu-Hyp-Gly-Gln-Hyp 29-36
Peptide 3: Hyp-GIy-Gln-Hyp-Gly-Pro-Ala-Gly 33-40
Peptide 4: Gly-Pro-Ala-Gly-AIa-Arg-GIy-Pro 37-44
Peptide 5: Ala-Gly-Ala-Arg-Gly-Pro-Ala-GIy 39-46
Figure 5.12 : Synthetic Overlapping Peptides. 5, 8 amino acid peptides


















FIGURE 5.13: Chemotactic effects of 8 amino acid long overlapping
peptides from 22 amino acid collagen sequence (see Fig 5.12)
Five overlapping peptides, each of 8 amino acids in length, derived from a 22
amino acid collagen peptide, were synthesised. The peptides at a concentration
of lOOng/ml were added to lower compartments of a Boyden Chamber. The net
cell migration from the upper compartment was measured by counting the
number of cells per field of view. Points represent the observed chemotactic
activity +/- SEM for triplicate wells minus the activity of buffer control (56+/-
1.1). '
Based on the above results, nine additional peptides, varying between 2 and 4 amino
acids in length (Table 5.1), were synthesised and tested for their chemotactic ability in
the Boyden Chamber Assay. Only one of these peptides, Gly-Pro-Ala-Gly, was found
to contain any significant activity, stimulating chemotaxis by 64%. None of the starter
peptides which comprise sub-domains of the G-P-A-G peptide (Gly-Pro, Pro-Ala, or
Ala-Gly) exhibited chemotactic activity to a substantial level. These results suggest
that the peptide Gly-Pro-Ala-Gly is a potent stimulator of fibroblast chemotaxis.
In order to confirm that Gly-Pro-Ala-Gly was the most chemotactic domain, smaller
peptides of between 2-4 amino acids in length were synthesised and tested (Table
5.1). Gly-Pro-Ala-Gly was the only peptide stimulating chemotaxis to any significant
level. From these results, the importance of the sequences surrounding a chemotactic
domain can be seen, as these may be inhibit chemotaxis.
5.9 INVESTIGATION OF POSSIBLE CELL SURFACE RECEPTORS
As previously mentioned (see Chapter 1.6), cell surface receptors of the integrin
family are known to bind regions of the collagen molecule. Integrin types oc^, a2pj
bind to collagen (Knight et al., 2000),. although the actual form of the collagen
molecule is crucial to binding (Tuckwell et al., 1996). Triple helical collagen is known
to interact in the binding to these receptors, but it is still unclear whether or not non-
triple helical collagen peptides will bind to the receptors. It is thought that collagen
peptides use another form of receptor binding which is not integrin mediated
(Tuckwell et al., 1996).
In order to investigate whether the binding of collagen was integrin mediated,
antibodies to the integrins were employed to block the binding process in the Boyden
Chamber Chemotaxis Assay. The antibodies used were integrin specific mouse
monoclonals. If the process were integrin-dependent then the chemotactic
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Table 5.1 : Chemotactic effect of synthesised collagen peptides on L929
fibroblasts.
Collagen peptides 2-4 amino acid long (conc. 50ng/ml) were examined for
chemotactic potency. Points represent the observed chemotactic activity +/-
SEM for triplicate wells minus the activity ofbuffer control (56.6+/- 1.3).
activity of collagen peptides should be impaired in this assay. Pepsin solubilised
collagen (PSC) was used as a triple-helical collagen control and the synthetic 22-
amino acid collagen peptide as a non-triple helical test. From the results in Figure
5.14 it can be seen that the antibodies to integrins o^pj and a,p2 inhibited chemotaxis
by the triple helical collagen whilst antibodies to a,p3 integrin had no effect. Under
these conditions the antibodies had no-effect upon the activity of the synthetic
collagen peptide.
Since the collagen peptide was at a higher molarity than the triple helical collagen, it is
possible that the integrin antibody concentration was not high enough to inhibit the
peptides. Therefore, the antibodies were tested at higher concentrations (Figures 5.15,
5.16, and 5.17). These results showed that even at the highest concentration (1:1) the
integrin antibodies did not block the chemotactic effects of the collagen peptide.
5.10 SUMMARY
The biological activities of a chemically synthesised 22-amino acid collagen peptide,
previously isolated (Chapter 4), were examined. This synthetic collagen peptide was
found to stimulate chemotaxis in three fibroblast cells lines, but was not significantly
chemotactic for endothelial cells. The chemotactic domain of this peptide was
localised. The tetra peptide Gly-Pro-Ala-Gly was found to be the minimum sequence
essential in order to elicit a chemotactic response.
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FIGURE 5.14: Effects of integrin antibodies on collagen chemotaxis
induced by triple-helical and non-triple helical collagen.
Triple helical collagen (pepsin solubilised) and non-triple helical 22 amino
acid collagen peptide were examined for their effects on L929 fibroblast
chemotaxis, with the addition of integrin antibodies. The collagen/peptides at a
concentration of 500ng/ml and the antibodies at a dilution of 1:500 were added
to lower compartments of a Boyden Chamber at the concentrations shown
above. The net cell migration from the upper compartment was measured by
counting the number of cells per field of view. Points represent the observed
chemotactic activity +/- SEM for triplicate wells minus the activity of buffer
control (56+/- 1.8).
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Integrin cqPi antibody dilution
FIGURE 5.15: Effects of o^Pi antibody concentration on collagen peptide-
mediated chemotaxis.
The antibody to the integrin otiPi was examined for its ability to block L929
fibroblast chemotaxis. Collagen peptide conc. 500ng/ml. The antibody at the
dilutions shown above was added to lower compartments of a Boyden
Chamber at the concentrations shown above. The net cell migration from the
upper compartment was measured by counting the number of cells per field of
view. Points represent the observed chemotactic activity +/- SEM for triplicate
wells minus the activity of buffer control (56+/- 1.5).
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FIGURE 5.16: Effects of a2Pi antibody concentration on collagen peptide-
mediated chemotaxis.
The antibody to the integrin a2Pi was examined for its ability to block L929
fibroblast chemotaxis. Collagen peptide conc. 500ng/ml. The antibody at the
dilutions shown above was added to lower compartments of a Boyden
Chamber at the concentrations shown above. The net cell migration from the
upper compartment was measured by counting the number of cells per field of
view. Points represent the observed chemotactic activity +/- SEM for triplicate
wells minus the activity ofbuffer control (56+/-1.5).
0
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FIGURE 5.17: Effects of a3Pi antibody concentration on collagen peptide-
mediated chemotaxis.
The antibody to the integrin a3Pi was examined for its ability to block L929
fibroblast chemotaxis. Collagen peptide conc. 500ng/ml. The antibody at the
dilutions shown above was added to lower compartments of a Boyden
Chamber at the concentrations shown above. The net cell migration from the
upper compartment was measured by counting the number of cells per field of
view. Points represent the observed chemotactic activity +/- SEM for triplicate




Wound healing is a complex response to tissue injury which is essential to the survival
of living organisms. The repair process encompasses several events with different cell
types, cytokines, coagulation factors and matrix proteins involved (reviewed by Clark
1993). The extracellular matrix (ECM) was initially thought only to function as a
support, however many of the matrix components have now been identified as having
a variety of additional biological properties (Raghow 1994). The major component of
the ECM is collagen, a glycoprotein composed of three polypeptide chains based on
the general structure Gly-X-Y (see Section 1.3.1; van der Rest & Garrone 1991).
Collagen has been employed in the formulation of medical materials (Pachence 1996)
due to its good safety profile and its ready and cheap availability. It has uses as a
dressing for burns, pressure sores and leg ulcers (Chvapil et al., 1986). Collagen
membranes have also been used as drug carriers (Miyata et ah, 1979), and in an
injectable form, zyderm collagen implant (ZCI) has been used as an implant for
replenishing natural skin collagen (Ruszczak & Schwartz 1999). These commercially
successful collagen-based medical devices all use collagen's physical rather than
biological properties. These biological properties of collagen have been shown to be
involved in haemostasis (Morton et al., 1987), cell attachment (Anderson 1992), cell
proliferation (Thoumie et al., 1995) and cell migration (Postlethwaite & Kang 1976).
During the wounding process, the extracellular matrix is degraded, forming
breakdown products, and these breakdown products have been shown to play a role
in wound healing. Collagen and collagen-derived peptides have chemotactic
properties, stimulating the migration of neutrophils, monocytes, macrophages and
fibroblasts (Postlethwaite et al., 1978; Malone et al., 1991). Cyanogen bromide
(CNBr)-derived collagen peptides effect the attachment and migration of neural crest
cells (Perris et al., 1993).
It was the aim of this study to further investigate collagen's biological role in the
context of wound healing. It was decided to isolate collagen peptides with the most
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biologically active properties. These peptides could then be assessed for their abilities
to enhance the healing process in vivo.
6.2 BIOLOGICAL EFFECTS OF COLLAGEN AND COLLAGEN-DERIVED
PEPTIDES
Collagen comprises nineteen different types (I-XIX; Sakai 1995). More than 90% of
all fibrous protein is Type I Collagen (Pachence 1996) and it is the most abundant
collagen type in skin (Trojanowska et a/., 1997). Collagens III and V are the other
predominant collagen types in skin. In this study Collagens I, III and V were purified
by a variety of methods and their peptides generated. Collagens I and III were
isolated from pig skin, a cheap and readily available source. Type V was purified from
pig placenta. Other collagen types could have been isolated, however finding a
convenient source would have been outwith the scope of this study (see Table 1.1). In
the first part of this study, predominantly Types I and III were studied. Later, all three
were investigated.
6.2.1 Collagens I and III - CNBr-derived peptides
The biological effects of CNBr peptides derived from collagen were examined in
Chapter 3. Collagen peptides can be generated by many methods [CNBr, matrix
metalloproteinases (MMPs), various collagen degrading enzymes]. MMPs are very
good natural proteases, however they are not readily available commercially and their
isolation is difficult, hence they were not used here. In this investigation CNBr
digestion was used as collagen peptides derived from CNBr digestion had already
been shown to have biological activities (Perris et al., 1993; Saelman et al., 1993).
CNBr and enzymatic digestion (see Section 2.3) are very cheap and rapid ways of
generating peptides.
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Collagens I and III were purified from pig skin and the major CNBr peptides [a 1(1)
CB3, 6, 7, 8 and al(III) CB3, 4, 5, 8] isolated by FPLC (Sections 3.2-3.4). In
Collagen I these major peptides were isolated from the al chain only. The effects of
these peptides on fibroblast and endothelial cell proliferation, and chemotaxis were
investigated. Three different cell lines were examined; L929 fibroblasts, rat wound
fibroblasts (RWF) and bovine aorta endothelial cells (BAEC). L929 cells, derived
from an established cell line, are robust and easy to handle and were used in the
setting up and standardisation of the assays used. RWF are primary cell lines and
hence were used as they are nearer to the natural environment found at the wound
site. BAEC are a primary endothelial cell line. Both fibroblasts and endothelial cell
types are essential to wound healing. Cell proliferation was assessed by using the
Methylene Blue Dye-Binding Assay (Oliver et al., 1986). Chemotaxis was measured
in the Boyden Chamber Assay (Falk et al., 1980).
The CNBr-derived peptides were isolated by cation-exchange FPLC (Figures 3.5 &
3.6) as for the method of Bateman et al., 1986. Peptides were analysed by SDS-
PAGE to confirm identity and purity (Figures 3.3 & 3.4). This method resolves all the
major peptides in a rapid and reproducible fashion. However, purity levels did vary
with each peptide. Collagen I peptides CB7 and CB8 contained some incompletely
cleaved fragments. In retrospect, these partially cleaved peptides could have been
further separated by gel permeation chromatography. The purity of Collagen III
peptide CB5 could also have been improved if the FPLC gradient was run over a
longer period of time (i.e 120 mins). This would have helped to separate the peaks on
the FPLC trace (Figure 3.6).
The Methylene Blue Dye-Binding Assay (Oliver et al., 1989) was used to quantify
cell numbers after growth in the presence of collagen-derived peptides. This is a
reproducible, rapid and inexpensive method. However, it does have limitations. The
automated microplate reader for measuring optical densities of cells restricts the range
of cell numbers that can be quantitated. Preliminary experiments to optimise the
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assays were carried out in order to minimise this effect. Hence, cells were grown in
DMEM containing 2% serum. Cells grown in 10% serum reached levels which could
not be measured accurately using this method.
Cell migration was measured using the Boyden Chamber Assay (Falk et al., 1989). It
is a simple and rapid assay. Cells responding to a concentration gradient of collagen
peptide diffuse towards the peptide through a membrane filter. Cells reaching the
bottom surface of the membrane are fixed, stained and counted. A limitation of this
method is that some cells may not adhere to the membrane and will 'fall off.
Reducing incubation time to 2.5 hours minimised this effect.
6.2.1.1 Effects of CNBr-derived peptides on cell proliferation
It was found that Collagen I peptides CB3, CB8 & CB7 and Collagen III peptides
CB4 & CB8 stimulated cell proliferation. These results are summarised in Table 6.1,
column 2.
Peptide CB8 from Collagen I, increased BAEC cell growth/proliferation by 60%, at a
concentration of lOpg/ml after 5 days. CB3 from Collagen I, at a concentration of
lOOpg/ml increased growth of both BAEC and RWF cells by 20% after 5 days.
Peptide CB7 at lOOpg/ml also increased growth of RWF cells by 20%. CB6 had no
significant effect on cell proliferation. CB4 from Collagen III increased L929 growth
by 35% at a concentration of lng/ml. CB8 from Collagen III also at a concentration
of lng/ml increased growth by 19%. CB5 and CB3 al(III) had no significant effects
on cell proliferation.
Therefore, it was shown that although CB8 al(I), at a concentration of lOpg/ml
produced the greatest increases in growth, CB4 al(III) was more potent being active
at a lower concentration (lng/ml). These effects were concentration-dependent,
which will be discussed in Section 6.4.
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Peptide Maximum % increase in cell
proliferation













CB3 RWF lOOpg/ml 20 L929 1 jag/ml 62
CB6 nd nd nd L929 lmg/ml 30
CB7 RWF lOOpg/ml 20 L929 1mg/ml 35
CB8 BAEC lOpg/ml 60 L929 lmg/ml 64
Collagen al(III)
CB3 nd nd nd L929 lmg/ml 25
CB4 L929 lng/ml 35 L929 lmg/ml 44
CB5 nd nd nd L929 lmg/ml 15
CB8 BAEC lng/ml 19 L929 lmg/ml 45
nd - denotes on all cell types no cell proliferation was detected
Table 6.1: A summary of the effects of CNBr-derived collagen peptides on cell
proliferation and chemotaxis
The maximum effects on cell proliferation and chemotaxis by Collagen I and III CNBr-
derived peptides are shown. Potency levels are as indicated.
6.2.1.2 Effects of CNBr-derived peptides on cell chemotaxis
All of these isolated CNBr peptides were shown to be chemotactic to some extent.
al(I) CB3, al(I) CB8, al(III) CB4 and al(III) CB8 were the most chemotactic
peptides isolated. These results are summarised in Table 6.1, column 3.
a 1(1) CB3 showed the greatest effect, increasing chemotaxis by 62% above control
levels, at a concentration of lng/ml. al(I) CB8 increased chemotaxis to a similar
degree, however was found to be less potent, being active at a concentration of
lmg/ml. CB4 and CB8 al(III) increased chemotaxis by 44% and 45% respectively, at
a concentration of lmg/ml.
As mentioned, a number of chemotactic factors have been found in wounds and it is
thought that they act as attractants to regulate the number of cells and the order in
which they enter the wound, with each cell type responding only to specific
attractants. Chemoattractants show an enormous range in their effective doses in
vitro, suggesting different functions in vivo. Collagen peptides could create a low and
prolonged signal in the presence of tissue debris and bring in phagocytic cells for
continuing clean up and also fibroblasts to repair damaged tissue. More potent
molecules such as TGF-J3 would be expected to diffuse into the surrounding tissue
and reach their cellular target more efficiently.
6.2.2 Collagens I, III and V - enzyme-derived peptides
Collagens I, III and V were degraded by enzymatic digestion (see Chapter 4). The
enzymes used were collagenase, trypsin and chymotrypsin. The peptide mixtures
generated (from al and a2 chains where applicable) were tested for chemotactic
activity in the Boyden Chamber Assay. Many regions of the collagen chain (from
different collagen types) were shown to be capable of eliciting a chemotactic response
(Figure 4.1). It was demonstrated that peptides produced by bacterial collagenase of
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digestion of collagens I and III were chemoattractants for fibroblasts (Tables 4.3-4.4).
However, the work described in this chapter shows that the degree of chemotactic
potency depends on both the collagen type and the digestion method employed.
Peptide mixtures derived from Collagen I by a double digestion with bacterial
collagenase and chymotrypsin proved to be the most potent chemoattractant,
increasing chemotaxis by three times that of control levels. Chemotaxis was again
found to be concentration-dependent.
The optimal conditions for producing chemotactic peptides were determined in
Chapter 4 (temperature, time, enzyme concentration). These were found to be a
digestion time of 24hrs, at 37°C, with an enzyme concentration of 10pg/ml. It was
found that Collagen I digested with collagenase and chymotrypsin produced peptides
with the greatest chemotactic effects, compared to the other collagen types tested
(Figure 4.1). Hence, Collagen I peptides were focused upon in subsequent
experiments. The most bioactive peptide from Collagen I was isolated by HPLC. This
peptide was found to be a potent chemoattractant. Its sequence was determined and
was found to be 22 amino acids in length and corresponded to the a.2 chain of
collagen (residues 25-46). This work is summarised in a schematic representation in
Figure 6.1.
The work in this study was in agreement with Postlethwaite et al. (1978), who
showed that Collagens I and III after bacterial collagenase digestion were fibroblast
chemoattractants. In contrast Albini & Adelmann-Grill (1985) demonstrated that
digestion with bacterial collagenase abolished the chemotactic activity of collagen.
Different experimental conditions used could be a possible explanation for these
conflicting results i.e. variations in buffers, cell lines, enzymes.
In vivo, collagen is degraded by various enzymes after wound formation. Initially,
mammalian collagenase (MMP 1) cleaves the collagen molecule across the three
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FIGURE 6.1:
Schematic representation of the isolation of a bioactive peptide from Collagen I
chains to give two triple helical fragments. These fragments become denatured at
physiological temperature and the denatured chains are readily digested by most
proteases (Figure 1.2). Therefore in a wound, many sizes of collagen peptide are
found, some even thought to be as small as three amino acids in length (Postlethwaite
& Kang 1976). These initial in vitro studies are relevant to what is thought to occur
during collagen degradation in a wound, since a variety of collagen peptides were
generated (Chapter 4).
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6.3 BIOLOGICAL EFFECTS OF A SYNTHETIC COLLAGEN PEPTIDE
A 22-amino acid collagen peptide from Collagen I was isolated as discussed in
Chapter 4. This peptide sequence was synthesised chemically on a large scale, using
FMC/'Bu based method of synthesis.
The biological activities of the peptide were examined and its chemotactic domain
localised. This work is summarised in schematic form in Figure 6.2.
6.3.1 Chemotactic effects
The synthetic collagen peptide stimulated chemotaxis in the three fibroblast cell lines
(L929, 3T3, RWF) to similar extents. However, the peptide was not significantly
chemotactic for endothelial cells (see Section 6.4.4).
In order to verify that the cell migration, promoted by the peptide, was directional
(chemotaxis), the 'Checkerboard Assay' (Zigmond & Hirsch 1973) was carried out.
This method is used to distinguish between directional (chemotactic) and random
(chemokinetic) migration. The cell migration stimulated by this peptide was shown to
be both random and directional in nature.
In order to define where the activity resides in the amino acid sequence of this
synthetic collagen peptide, a group of overlapping peptides from within the peptide
were synthesised. One peptide was found to contain more chemotactic activity than
the others. Based on this result, nine additional di and tri peptides were synthesised.
None of these shorter peptides exhibited chemotactic activity to any substantial level.
From this it was concluded that a tetra-peptide, and more specifically Gly-Pro-Ala-
Gly was the minimum sequence essential to eliciting a chemotactic response. From
these results the importance of sequences surrounding a chemotactic domain were
shown. Some were found to be inhibitory, others stimulatory. The Gly-Pro-Ala-Gly
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FIGURE 6.2:
Schematic representation of the synthetic collagen peptide's properties
sequence occurs several times throughout the collagen molecule. However other
peptides containing this sequence were not isolated by HPLC as they were not found
to be chemotactic, which supports this theory. This would indicate that an important
area in chemotaxis is not only the sequence but the context.
6.3.2 Effects on cell proliferation
The peptide increased cell proliferation in all fibroblast cell types tested (L929, 3T3,
RWF). Cell proliferation/growth in these cell lines increased by 25%, 15% and 12%
respectively (Section 5.6, Figure 5.6), after 5 days at a concentration of 500ng/ml.
This indicates that these cells types have cell-surface receptors which are recognised
by collagen-peptides.
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6.4 CELL-SURFACE INTERACTIONS : RECEPTORS
A major role of the ECM is in the regulation of cell/cell communication (MacNeil
1994). Specific attachment sequences on ECM proteins are recognised by cell surface
receptors (Yamada & Geiger 1997).
6.4.1 Chemotaxis
The first event in chemotaxis is the detection of the chemoattractant by specific cell
surface receptors (Martin et al., 1983). Cells lacking such receptors are unresponsive
(Wilkinson 1988). All stimulatory peptides must bind to a receptor on the host cell in
order to be biologically active. The mechanisms by which collagen and its degradation
products attract fibroblasts and cause migration has not been clarified. Even though
different collagen peptides, different cell types and different effects on cells have been
examined, the same receptor-ligand binding principle is valid. The collagen peptides
have a sequence which is recognised by the cell surface receptor. Binding then occurs
which sets off a variety of intracellular actions eventually resulting in changes to the
cell. The results in this thesis show that different sequences within the collagen
peptides are involved in the stimulation of different activities (migration, proliferation,
chemotaxis etc.). There is also the possibility that different cellular receptors may be
involved (see below). Although native Collagens I, III and V had some chemotactic
behaviour (Tables 4.3-4.5), the peptides generated from these collagens displayed, in
general, elevated chemotactic potency. In certain circumstances sequences which may
be recognised by the cell may get blocked or shielded (Postlethwaite et al., 1978).
However, after tissue damage, when the collagen becomes degraded, sites on the
molecule may be 'unshielded', so as to permit binding to cells and provide a stronger
chemotactic stimulus (Malone et al., 1991). It may be for this reason that the native
collagen molecules were not as chemotactic as some of their derived peptides.
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6.4.2 Concentration-dependence
It was found that with both chemotaxis and cell proliferation, the effects of the
collagen peptides on cell behaviour were concentration-dependent. This is in
agreement with work already done in this field (Postlethwaite et al., 1978; Malone et
al., 1991). The chemotactic response is usually a concentration dependent process,
producing a typical bell-shaped response curve. This effect is well known in the
literature (Postlethwaite et al., 1976; Albini & Adelmann-Grill 1985). The
concentration effect is due to the degree of receptor occupancy (Grotendorst 1984).
Cells respond to the first hit (signalled event) by the redistribution of receptors to the
point of hit, this occurs by polarisation with the first hit point at the front of the cell.
At low concentrations only a minority of cells polarise but they polarise well. As the
concentration of chemoattractant is raised to an optimum, the proportion of
responding cells rises to almost 100%. At supra-optimal concentrations the cells
protrude more than one pseudopod and therefore polarise poorly. Hence, once the
ligand concentration is raised above optimum, receptors become occupied
simultaneously at many points on the cell surface and the cell is unable to redistribute
receptors and show clear polarisation (Wilkinson & Haston 1988).
6.4.3 Chemotaxis v Proliferation
It is likely that different peptide sequences and different cell receptors are involved in
chemotaxis and proliferation, since the CNBr peptides do not react in the same ways
for these two cell activities. For example, CB5 al(III) had no effect on cell
proliferation (see Section 3.6.2, Tables 3.22-3.24, Figure 3.18) but increased cell
chemotaxis by 30% (see Section 3.8, Table 6.1). Perhaps different sequences on the
collagen molecule are needed to switch on these activities. A specific sequence on the
molecule may bind to a cell receptor and stimulate the cell to move into the wound
site and then another different sequence may be involved in stimulating the cell to
grow.
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Peptides al(I) CB3 and al(I) CB8 were the CNBr fragments which stimulated
fibroblast cell growth (see Section 3.6.1, Tables 3.1-3.6, Figures 3.7 & 3.9) and
chemotaxis (see Section 3.8, Figures 3.21-3.22), suggesting that these fragments
contain binding sites recognised by the fibroblasts. These peptides did not, however,
stimulate growth and chemotaxis to the same extent, which implies that different
receptors and recognition sites are involved in the interactions. CB4 and CB8 were
the Type III collagen peptides which stimulated fibroblast growth (see Section 3.6.2,
Tables 3.13-3.18, Figures 3.13 & 3.15) and chemotaxis (see Section 3.8, Figures
3.23-3.24), again the degrees of stimulation varied with the two fragments, suggesting
similar cell-collagen interactions as the Type I peptides.
An example of similar effects in the literature have been shown by Watson & Gibbins,
1998. Studies on cyanogen bromide fragments of collagen provided evidence that
adhesion and activation of platelets by collagen was mediated through distinct
receptors. These two events are mediated through distinct regions of the collagen
molecule. It has been proposed that the activation of platelets by collagen occurs
through a 'two-step' interaction, in which integrin a2Pi provides an initial site of
adhesion that brings a second site in the collagen molecule into the vicinity of a
receptor responsible for activation.
6.4.4 Synthetic collagen peptide
The 22-amino-acid peptide, described in Chapter 4, was synthesised and its biological
effects tested (Chapter 5). The peptide was tested for its ability to stimulate fibroblast
chemotaxis in three different cell lines (L929, RWF, 3T3) using the Boyden Chamber
Assay. The synthetic collagen peptide stimulated chemotaxis in all three fibroblast cell
types, from which it may be concluded that fibroblasts have cell surface receptors
which bind a region of this collagen peptide. However, the peptide was not
significantly chemotactic for endothelial cells, implying that these cells have different
cell surface receptors which do not recognise and therefore do not bind the collagen
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peptide.
Known collagen peptide sequences which bind to cell surface receptors are D-G-E-A
(Asp-Gly-Glu-Ala) and R-G-D (Arg-Gly-Asp) (Staatz et al., 1991; Hynes 1992). In
this work neither of these were identified as the collagen peptide recognition
sequences. A new tetra-peptide Gly-Pro-Ala-Gly was identified as being recognised
by fibroblast cell surface receptors during stimulation of chemotactic activity. This
peptide is therefore likely to be the minimum amino acid sequence from Type I
collagen which makes the most efficient contact with the appropriate receptor(s) on
fibroblast membranes. It has been suggested that the chemotactic activity is unmasked
as the size of the collagen-derived peptides decreases (Malone et al., 1991). Previous
work by Laskin et al. (1994), has shown the importance of Gly-Pro in stimulating
macrophage migration: our work partly agrees with this finding (Gly-Pro are an
essential part of an active peptide) but in this study it was found that shortening of the
collagen-derived tetramer destroyed the chemotactic activity of the peptide towards
fibroblasts. Perhaps macrophages and fibroblasts recognise similar but not identical
amino acid sequences from collagen peptides.
6.4.5 Known cell-surface receptors
It would be of great importance to identify and isolate collagen-related cell surface
receptors. However, there are already conflicting results on this matter. Many
different putative collagen receptor molecules have been identified (Ruoslahti et al.,
1994), notably integrins, which are a group of cell surface molecules that mediate the
attachment of cells to collagen. Integrins alPl and oc2Pl are known to be involved in
cell-collagen interactions although other non-integrin collagen receptors and collagen
binding proteins have been documented (Akiyama et al, 1990). Integrin 013P1 has
been proposed as a collagen receptor (Elices et al., 1991), however this is
controversial (Gullberg et al., 1992; Tuckwell et al., 1996; Messent et al., 1998).
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It has been shown that a binding site for the integrin oi2Pl is located within the a 1(1)
CB3 fragment of collagen (Staatz et al., 1990) and that the amino acid sequence Asp-
Gly-Glu-Ala (D-G-E-A) is an important structural determinant of the ot2(31
recognition site (Staatz et al., 1991). However, the importance of the D-G-E-A
sequence as a structural determinant of the cc2Pl recognition site is now widely
doubted, having been found to be inactive by other groups (Cardarelli et al., 1992;
Tuckwell et al., 1996). Binding sites for alPi have been shown to be present in both
al(I) CB3 and al(I) CB8; al(I) CB3 also contains a binding site for a2Pl (Gullberg
et al., 1992). Recent work by Knight et al., 2000, has identified an integrin a2Pl
binding site in a 1(1) CB3 containing an essential G-E-R sequence. These findings
point to the conclusion that Collagen I contains separate binding sites for alPi and
062(31 integrins. The results in this thesis are in accordance with these findings.
6.4.6 Structural significance
The structure of peptide species, whether single-stranded or, triple-helical, is a
relevant factor when considering their interactions with other extracellular matrix
components (Rossi et al., 1996). Conformation and length of a peptide are also
extremely important in determining chemotactic potency. According to Malone et al.,
(1991), chemotactic activity is unmasked as the size of the collagen derived peptide
decreases. Larger peptides generated after digestion may interfere with receptor
binding through steric hindrance (Laskin et al., 1994). Steric hindrance is a term
intended to denote the influence exerted in a reacting group by the spatial
arrangement of neighbouring atoms. Substituting groups can prevent the approach to
other groups by reason of their size (Daintith, 1990). A critical length may be required
for maximal activity. Larger peptides may inhibit binding to the cell surface receptor
and hence chemotactic activity will be blocked.
It has been suggested that conformation-dependent collagen binding sites may exist
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(Gullberg et al., 1992). The D-G-E-A binding site for the a2Pl integrin was
described as a single linear sequence (Santoro et al., 1991). Tuckwell et al., (1996),
described the inability of CNBr fragments to reproduce the cell-binding of native
collagen. This demonstrated a strict dependence on collagen conformation. Binding of
denatured type I collagen has been postulated to be mediated by avP3 or asPi
integrins rather than a2P integrin, or via a fibronectin bridge (Messent et al., 1998).
The identification of this bridge adds to the mechanisms by which cells can bind to
denatured collagen. This work suggests that collagen-integrin binding requires an
intact triple helix. There is the possibility that the CNBr peptides used in the work
presented here could renature to the triple helical conformation. Circular dichroism
measurements could reveal this. Since the time limitations of this study prevent
further investigations into receptors and binding sites no conclusions on this can be
made, but the complexity of this matter has already been pointed out. Work by Rossi
et al., 1996, has shown that the circular dichroism profile of CNBr peptides at
increasing temperatures showed that the melting temperature for triple-helical
peptides is about 6-10°C lower than that of the parent native Type I collagen,
indicating that CNBr peptides are most likely to be non-triple helical.
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6.5 IN VIVOWOUND HEALING STUDIES
Even though the collagen peptides were isolated in vitro, it is probable that the
peptide occurs naturally in the tissue breakdown process. In the body, collagen
molecules are cleaved by mammalian collagenase to give two triple helical fragments
(Gross & Nagai 1965). Both fragments denature at physiological temperatures and
are readily degraded by most proteases (Stark & Kuhn 1968). It is more than likely
that a whole range of peptides are generated. Other molecules of the ECM can also be
degraded and a variety of peptides with biological properties isolated: Elastin peptides
(Fulop et al., 1998), fibronectin fragments (Elices et al., 1994), laminin peptides
(Hershkaie et al., 1995) and hyaluronic acid (Chen & Abatangelo 1999) all stimulate
cellular migration. Again it is possible that the mechanisms resulting in the formation
ofECM-derived bioactive peptides have the potential to take place naturally. It could
be possible to examine wound fluids and tissues to look for the actual presence of
these peptides. This has been done for instance in synovial fluid (from rheumatoid
arthritis; Miyake et al., 1993) and periodontal disease fluid( Layik et al., 2000).
6.5.1 Animal Models
In order to provide backup and support to in vitro findings in many wound healing
studies, an in vivo (animal) model may be used.
Many species of animal have been used to model the healing process in humans.
Winter (1968) studied the role of occlusion using the domestic pig while Silver (1969)
studied angiogenesis using the rabbit ear chamber model. Genetically modified mice
have recently become an invaluable tool in wound healing. These knockout and
transgenic mice could be used to study many areas of wound healing (Scheid et al.,
2000). Due to variations in morphology and physiology among animals, as well as
among humans, it is difficult to have one model to suit all needs. Often the choice of
an animal model is directed by practical issues such as cost, housing costs, and animal
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husbandry (Davidson 1998). The fact that they are 'models' also shows that they are
only trying to be representative of a process and hence not definite in showing how
the wounding process actually functions. The model chosen in this study was the PVA
sponge model (Coomes et al., 1997; Shah et al., 1999).
6.5.1.1 PVA sponge model
PVA (polyvinyl alcohol) sponges containing the synthetic collagen peptide were
injected into rats and removed after 7 and 10 days post-implantation. The sponges
were then analysed both biochemically and histologically. The DNA, protein and
collagen content of collagen-containing sponges were compared with control (PBS
only) sponges. Sections of sponge, stained with haematoxylin and eosin, were
examined microscopically for fibrin and granulation tissue content. Again collagen
sponges were compared to control sponges.
From the results in Chapter 5, it was found that PVA sponges containing the collagen
peptide increased DNA, protein and collagen content of the test sponge compared to
control sponges. Histologically, the collagen containing sponges were also observed
to have increased fibrin and granulation tissue content compared to controls. Both of
these effects were shown to be concentration-dependant.
The PVA sponge was used as a model of wound healing but it more accurately
reflects the host response to a foreign body. The sponge is a defined volume which
with time fills with various components, as does the wound itself, i.e. first a fibrin
structure, then inflammatory cells, next fibroblasts, then the laying down and maturing
of collagen structures and lastly apoptosis. In this study sponges were removed after 7
and 10 days, in order to measure collagen production and granulation tissue
formation. However, sponges can be removed at other times, this will depend on
which factors are being monitored. It should be noted that none of these timings are
exact, as the response of the animals can vary with age, nutrition, etc. However, in
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this model it was the comparison between control and collagen peptide injected
sponges which is important.
The PVA sponge is a defined volume and provides a reliable method of collecting
granulation tissue (Broadley et al 1989). The sponge itself is inert and does not
interfere with any of the subsequent tests. Limitations of the choice model are that
epithelial components cannot be measured. This is true, however, of all dead-space
models of this type (stainless steel chambers, PTFE tubing; Davidson 1998). In the
histological analysis, inflammatory cells (monocytes/macrophages) and fibroblasts
cannot be distinguished between. A way this could be addressed for further study
would be by differential staining.
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6.6 CONCLUSIONS AND FUTUREWORK
It was a further object of this study to identify collagen peptides which are
chemotactic at much lower concentrations than other known chemoattractants. The
collagen tetra-peptide (Gly-Pro-Ala-Gly) elicited a maximal chemotactic response at
50ng/ml. In prior studies, Postlethwaite et al. 1978, found that collagen peptides
induced maximal activity at a concentration of 900|Lig/ml. In 1985, Albini & Adelman-
Grill found that collagen digested with mammalian collagenase stimulated fibroblast
migration in the range of 25-50|_ig/ml. Cell derived and plasma fibronectin stimulate
migration of fibroblasts in a dose-dependent manner, with maximal migration
occurring at a concentration of 2|_ig/ml. Non-gelatin binding FN fragments are
chemotactic at a concentration ranging from 2.5-50pg/ml, with maximal response at
1 Opg/ml (Postlethwaite et al., 1981). Elastin-derived peptides also elicit chemotactic
responses, maximal at 0.5-2.0pg protein/ml (Senior et al., 1982). Growth factors are
more potent chemoattractants for fibroblasts. PDGF gave maximal response at
concentrations between 5-20ng/ml (Siegbaln et al., 1990). FGF was maximal between
100-200ng/ml, EGF being maximal at 10-50ng/ml and TGF-p being the most potent
chemoattractant at a concentration of lpg/ml (Grant et al., 1992). The peptide
concentration (50ng/ml) of the collagen peptide identified in this study was of a
similar range to many of these chemotactic growth factors. This peptide is therefore a
potent chemoattractant and could be used in future studies on wound healing.
It must be noted that there has been very little recent work on collagen and its
biological uses. This could be due to the fact that collagen peptides in prior studies
were not potent enough and would not have much effect on wound healing especially
compared to growth factors. Though of course scientific research does follow trends
and fashions and it could be that growth factor research is a developing research area.
Growth factors are easier to get, you can buy them commercially, whereas with many
of the collagen types purification is a difficult and laborious process. Growth factors
may also be easier to work with. However, even growth factors (Singer & Clark
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1999) have not reached commercial success at this time. Therefore, the uses of this
collagen peptide may also be limited.
Further work on identification and isolation of the cell surface receptors involved in
these processes would be extremely useful. The work of Tuckwell et al. (1996),
suggested that only triple helical collagen was involved in integrin-mediated receptor
binding. Non-triple helical collagen peptides may use another non-integrin mediated
receptor mechanism. The initial studies in this work appear to agree with the findings
of Tuckwell et al., in that the collagen peptides isolated in this work do not bind to
integrin receptors on the fibroblasts.
The importance of in vivo work is that the findings could be translated into potential
uses in speeding up wound healing. From this preliminary in vivo study, further
studies using the collagen tetrapeptide may be carried out i.e. pig model system. This
model is better matched chronologically and physiologically to the patient population
(Davidson 1998). The eventual use of the peptide could be in topical application to a
wound with the collagen peptide in a pharmaceutically acceptable carrier. Suitable
carriers include: creams and ointments and hydrogels containing cellulose. The
peptide could also be coated onto, or incorporated into a solid wound dressing such
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